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Summary  
 
Introduction 
To research and develop robust, effective shared-decision support requires a 
clear definition of the decision-making process. Elwyn and Miron-Shatz have 
developed a model incorporating deliberation, but it is uncertain the extent 
this proposed decision process is addressed in existing measures of decision-
making. This review aims to systematically identify and analyse measures 
considering the process from the patient’s perspective, determining the extent 
items cover a decision process model incorporating deliberation. 
 
Method 
A systematic and robust search strategy was developed to identify studies 
reporting the development and psychometric evaluation of an instrument 
measuring shared decision-making in the health-care setting, specifically from 
the patient’s perspective of the decision making process. The search strategy 
incorporated seven electronic databases supplemented by manual searches.  
As well as descriptive details of the study, scales were mapped against the 
decision process model, and the methodological quality of study design and the 
adequacy of instrument measurement properties were appraised using 
reproducible standards. 
 
Results 
Of the 7,563 references identified, ten studies involving the development of 
measures were included and an additional nine addressed the further 
evaluation of instruments. The methodological quality was highly variable, 
both between and within studies and none of the scales scored consistently 
	  vii 
well for measurement properties when compared with the criteria of adequacy. 
One scale was found to map against all stages of deliberation, but none 
addressed all stages of the decision process model.  
 
Conclusion 
The results indicate that current measures of decision-making do not consider 
all steps of the decision process proposed by Elwyn and Miron-Shatz. The 
Decision Making Quality Scale (DMQS), developed by Hollen and based on the 
work of Janis and Mann, addressed aspects of deliberation not covered by other 
measures. Recommendations for a new instrument specification include 
methodological improvement and consideration of the work of Janis and Mann.   
Word count 297 
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1. Introduction 
 
This chapter first describes shared decision-making and provides context for 
the rapid growth in this field, before summarising current definitions of a good 
decision and decision-making process, with consideration of deliberation as a 
new approach for evaluation. Measurement instruments are described and the 
recommended steps in their development summarised, along with the process 
of systematic review.  Finally, all strands are brought together with the 
research question, project aims and objectives  
 
1.1. Shared decision-making 
1.1.1. Defining shared decision-making 
 
Shared decision-making is a rapidly growing field with a similarly evolving 
definition. (Charles et al., 1997) It is often considered as a middle ground 
between the extremes of paternalistic health care, where the clinician makes all 
decisions, and informed choice, which is led by the patient. (Collings and 
Coulter, 2015) Shared decision-making, in contrast, sees the management plan 
developed by both the practitioner and the patient, acknowledging the 
expertise and differing perspectives brought by both parties with subsequent 
decisions incorporating clinical evidence and the unique context of the 
individual patient. (Collings and Coulter, 2015, Makoul and Clayman, 2006) It 
has been described by Al Mulley as an approach that allows patients to get “the 
care they need and no less, and the care they want and no more.” (Collings and 
Coulter, 2015) 
 
In 1997, Charles and colleagues proposed fixed factors needed for shared 
decision-making to occur: that the interaction involves at least two participants 
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with both taking steps to participate, where sharing information is a pre-
requisite and a treatment decision is made with which both parties agree. 
(Charles et al., 1997) This became, for a time, the most cited definition of the 
SDM concept. (Makoul and Clayman, 2006)  
 
Within ten years, Makoul and Clayman performed a systematic review to 
identify elements frequently used to define shared decision-making and used 
these to develop a “clinically sound and conceptually relevant” model. They 
outlined nine essential components, as listed in the table below. (Makoul and 
Clayman, 2006) While this definition builds on that of Charles and colleagues 
by providing greater detail, it arguably also fails to address the more nuanced 
and challenging features of shared decision-making in healthcare, where 
decisions may be stressful, weighted with potentially life-changing 
consequences and requiring both support and, for some, periods of reflection. 
This limits its use as a framework in practical contexts.  
 
Table 1: Makoul and Clayman, 2006 – defining shared decision-making  
Makoul	and	Clayman’s	definition	of	SDM	
Define/explain	problem	
Present	options	
Discuss	pros/cons	(benefits/risks/costs)	
Patient	values/preferences		
Discuss	patient	ability/self-efficacy	
Doctor	knowledge/recommendations	
Check/clarify	understanding	
Make	or	explicitly	defer	decision	
Arrange	follow-up	
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In 2012, a model of shared decision-making developed by Elwyn and colleagues 
reflected a growing appreciation of the complexity of decision-making, 
grounded in the practicalities of clinical practice. Deliberation is identified as a 
component of shared decision-making, and defined as a “process of considering 
information about the pros and cons of [..] options, to assess their 
implications, and to consider a range of possible futures, practical as well as 
emotional.” (Elwyn et al., 2012) The model acknowledges the “psychological, 
emotional and social factors” involved, along with the contribution of other 
parties and reflection away from the healthcare encounter. (Elwyn et al., 2012) 
Patient-clinician interactions are grouped into option, choice and decision talk, 
with preferences passing from initial to informed as they are expressed and 
explored. Deliberation runs through the entirety of the process and, based on 
identified need, the decision support provided can range from brief to in-depth. 
(Elwyn et al., 2012) 
 
1.1.2. The growth of shared decision-making 
 
Since the early seventies, interest in shared decision-making has developed 
with each decade. Mentioned in 6 references in Medline in the 1970s, this 
number has increased to 1542 since 2010. It is now the subject of training and 
decision support aids, and has also featured in the policies and practice of 
governments and professional regulation governing bodies, such as the General 
Medical Council. (Collings and Coulter, 2015) 
 
A key factor encouraging this growth is the increasing acknowledgment of 
autonomy, an individual’s right to self-determine. (Elwyn et al., 2012) With 
greater access to information and appraisal of healthcare quality, the balance of 
power between patient and practitioner has shifted. (Charles et al.) Advances 
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in healthcare have increased life expectancy, the prevalence of long-term illness 
and the treatment options available. (Légaré et al., 2010b) The latter, in 
combination with a growing evidence base, has also introduced “close-call” 
choices into management plans, where no clear clinical benefit exists between 
treatments. (O'Connor et al., 2009) Taken in combination, the input of the 
patient to healthcare decisions is increasingly essential and likely to develop 
further in future as healthcare options increase and related decisions become 
more challenging. (Légaré et al., 2010b) 
 
1.1.3. Shared decision-making in current healthcare practice 
 
Shared decision-making is relevant in a broad range of healthcare contexts 
from acute minor illnesses to major life-changing healthcare decisions, and 
personal treatment plans for chronic illness to screening and diagnostic tests. 
(Collings and Coulter, 2015) There may be fewer contexts where SDM is less 
suitable such as, for example, acute trauma or emergency surgery.  
 
Decision aids have been developed to support different facets of shared-
decision making for an extensive number of health conditions. (O'Connor et 
al., 2009) Aids have been defined by O’Connor and colleagues as “evidence-
based tools designed to help clients participate in making specific and 
deliberated choices among healthcare options in ways they prefer.” (O'Connor 
et al., 2009) Decision aid development has explored ways of communicating 
information about health conditions, available treatment options, outcome 
probabilities, risks and uncertainties as well as exploring patient views and 
preferences. (Collings and Coulter, 2015)  
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In recent Cochrane Collaboration systematic reviews, decision aids were found 
to improve patient-practitioner communication and facilitate more informed, 
values–based choices. (Stacey et al., 2014). While no negative impact on health 
outcomes or satisfaction was apparent in these reviews, the use of a decision 
aid was found to increase congruence between treatment choice and the 
explored values of the patient, with reduced numbers opting for elective 
surgery, prostate specific antigen screening and menopausal hormone therapy. 
(O'Connor et al., 2009, Stacey et al., 2014).  
 
Interventions aimed at facilitating shared-decision making may also carry wider 
implications for population-level healthcare planning, where commissioning 
aims to deliver healthcare that is appropriate to population needs while also an 
equitable and effective use of limited resources. (Collings and Coulter, 2015) 
Collings and Coulter argue that every shared management plan should be 
considered “micro-commissioning” and, with improved recording of shared 
decision-making, it could be possible to gather and summarise information to 
feed back into wider commissioning decisions, producing more responsive 
strategies. (Collings and Coulter, 2015) 
 
The importance of shared decision-making is likely to grow alongside the 
increasing evidence-base, treatment options and an ageing population, while 
the ethical imperative to involve patients in decisions about their lives will 
remain relevant. (Elwyn et al., 2012, Charles et al., Légaré et al., 2010b) 
However, there are barriers to the incorporation of shared decision-making as a 
routine element of healthcare practice, such as time pressure, practitioner 
access to skills and training, and patient awareness and support. (Agoritsas et 
al., 2015) In addition, the evidence base must become more established and 
detailed to ensure that shared decision-making can be defined, measured and 
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documented validly and reliably, and that interventions aimed at the 
practitioner-patient relationship are effective and safe. (Collings and Coulter, 
2015) As well as evaluating the effect of such interventions, their mechanism 
of action should also be well understood. As such, what constitutes "good" 
decisions and decision-making in healthcare must be established. (Makoul and 
Clayman, 2006) 
 
1.2. Measuring decision-making 
1.2.1. Defining a good decision 
 
How best to define a good decision has been widely debated across many 
fields. In healthcare, a good clinical decision has been described as one that 
chooses the “best course of action given current scientific evidence, healthcare 
resources, clinical circumstances and patient preferences”. (Légaré et al., 
2010b) While this acknowledges aspects of shared decision-making, such as 
patient preference and existing evidence, it misses the collaborative aspect of 
the clinician and patient contributing to the consultation. Several authors have 
contributed seminal work exploring good decisions and decision-making with 
relevance to shared decision-making.  
 
In 1997, O’Connor and colleagues asked physicians to select criteria for 
evaluating decision aids.  The actual decision made was the least supported 
marker of good decision-making. Instead, understanding options and their 
respective risks and benefits, clarity of decision trade-offs, accuracy of 
expectations, anxiety, decision commitment, uncertainty and satisfaction were 
ranked higher. (O'Connor et al., 1997) A further study in 2003 identified 
clarity about values along with selecting and implementing a choice consistent 
with these values as essential criteria for a satisfactory decision. (O'Connor et 
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al., 2003) Similar themes are seen in the Ottawa Decision Support Framework, 
where decision quality is identified as an informed, values-based enacted 
decision without regret or blame. (O'Connor, 2006) 
 
O’Connor and O’Brien-Pallas’ definition of an effective decision, that “an 
effective decision is one that is informed, consistent with decision-maker’s 
values and behaviourally implemented”, was amended by Marteau and 
colleagues in 2001. (Marteau et al., 2001)  This work, which aimed to develop 
a measure of informed choice, expanded on the term “informed” in the above 
definition, suggesting that a good decision is based on relevant and reliable 
information. (Marteau et al., 2001) In addition, a review team considering 
decision-making in the context of community healthcare and cancer screening 
highlighted that, in addition to accuracy of knowledge and value concordance, 
interventions aimed at decision-making should also facilitate participation at a 
level desired by the individual. (Briss et al., 2004) 
 
Sepucha and colleagues suggested that to assess decision quality, three sets of 
information are needed: decision-specific knowledge evaluated with a set of 
knowledge questions, patient values for relevant outcomes elicited with value-
scaling tasks and a correlation between the treatment chosen and the values 
identified. (Sepucha et al., 2004, Sepucha et al., 2007) It was further noted that 
patient satisfaction alone is an insufficient marker of decision quality as it is 
influenced by initial expectations. (Sepucha et al., 2007) As such, in a 
subsequent study, constructs of decision quality were identified as a choice 
that is based on realistic expectations as well as relevant knowledge, and 
demonstrates values-choice agreement. (Sepucha et al., 2013) 
 
The International Patient Decision Aid Standards (IPDAS) Collaboration, 
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through a Delphi process reported in 2005, suggested aspects of a good 
decision and decision process. For the decision, this was indicated by a match 
“between features which matter most to an informed patient and the chosen 
option”. (O'Connor et al., 2005, O'Connor et al., 2009) For the decision 
process, elements included recognising that a decision needs to be made, 
knowing the options available and what each involves, appreciating values 
influencing the decision, being clear which features matter most, discussing 
values with the health practitioner and involvement in the decision-making 
being in line with individual preference. (O'Connor et al., 2005, O'Connor et 
al., 2009) 
 
As noted by Elwyn and Miron-Shatz, patterns emerge in the existing 
definitions of good decisions and decision-making processes. (Elwyn and 
Miron-Shatz, 2010) These can be described by the order in which they occur in 
the decision process. (Scholl et al., 2011) Firstly, there are decision 
antecedents such as considering the extent a patient wishes to be involved in a 
decision. Next are elements incorporated in the decision process itself, for 
example eliciting values and evaluating knowledge sufficiency. Lastly, there is 
the ability to commit to a decision and subsequent outcomes such as value-
concordance, satisfaction or regret. (Scholl et al., 2011, Elwyn and Miron-
Shatz, 2010) 
 
1.2.2. Limitations of current approaches 
 
While there are common themes in the definitions of decision and decision-
making process quality, there are also variations. A review by Sepucha and 
colleagues in 2013 noted a lack of consensus in the approaches taken to 
measuring decision-making, which limits accurate evaluation of decision aids 
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and other interventions aimed at improving shared decision-making. (Makoul 
and Clayman, 2006) In addition, this makes comparisons and meta-analyses of 
intervention studies difficult, if not impossible. (Gopalakrishnan and 
Ganeshkumar, 2013) 
 
The work of Elwyn and Miron-Shatz further critique the existing definitions. 
They suggest that even if the decision process was sound, probability 
influences the subsequent outcome, and how the decision is perceived may 
change with time. (Elwyn and Miron-Shatz, 2010) As such, the decision-
making process, termed deliberation, and decision made or determination, 
should be considered separately. (Elwyn and Miron-Shatz, 2010) Further, the 
authors highlight limitations with using knowledge and preferences alone as 
indicators of a good decision-making process. Knowledge decays and the type 
of knowledge needed - what and how much - is debatable. In addition, 
preferences are fluid and change with time. (Elwyn and Miron-Shatz, 2010) 
They can seem illogical and are influenced by context, experiences and simply 
the phrasing of questions. (Slovic, 1995, O'Connor et al., 1996) 
 
Furthermore, the ideal parameters for knowledge or preferences may be 
misleading when considering that healthcare decisions are made without 
infinite time or resources. (Elwyn et al., 2001a) Heuristics, described by 
Gigerenzer and Gaissmaier as “strategies where some information is ignored in 
order to make decisions quickly or efficiently in comparison to complex 
methods”, are at times as effective despite seeming less rational or considered 
than other decision processes. (Gigerenzer and Gaissmaier, 2011, Goldstein 
and Gigerenzer, 2009) However, it remains important that decision processes 
are outlined and understood so that they can be explored further. (Gigerenzer 
and Gaissmaier, 2011) 
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1.3. Deliberation and determination 
1.3.1. A decisional process map incorporating deliberation 
In response to the limitations described above, Elwyn and Miron-Shatz 
proposed a new decision-process model incorporating deliberation. The model 
is described as “combining cognitive and emotional contributions” to the 
decision process, and complements the shared decision-making model 
developed by Elwyn and colleagues in 2012. (Elwyn and Miron-Shatz, 2010, 
Elwyn et al., 2012) The stages begin with an awareness that a choice needs to 
be made. Information searching and knowledge appraisal follow, with 
preferences constructed through imagining possible outcomes or 
counterfactuals, and affective forecasting where feelings about different futures 
are reviewed. The different options are ranked before progressing to 
determination (Elwyn and Miron-Shatz, 2010) and the model is summarised in 
Figure 1 below.  
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Figure 1: Model of decision-making process incorporating deliberation 
 
 
1.3.2. Practical implications 
Elwyn and Edwards described a “black box” of decision-making, where a 
limited understanding of the decision-making process creates uncertainty over 
how decision support interventions work, in turn inhibiting further progress. 
(Edwards and Elwyn, 2006) The deliberation model proposed by Elwyn and 
Miron-Shatz is a step towards clarifying these elements. The next is to 
establish whether the patient experience of deliberation is considered in 
current measures of shared decision-making, as the ability to measure patient 
deliberation using such tools would facilitate further exploration of decision 
support interventions and their mechanisms of action. (Scholl et al., 2011, 
Elwyn and Miron-Shatz, 2010) 
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1.4. Measurement instruments 
1.4.1. What is a measure? 
The Scientific Advisory Committee defines measurement scales as a 
“constellation of items contained in questionnaires and interview schedules, 
along with their instructions…” while Streiner and Norman consider them an 
“essential component of scientific research”. (Scientific Advisory Committee of 
the Medical Outcomes Trust, 2002, Streiner and Norman, 2008) While 
traditionally concerned with outcomes of healthcare such as survival, hospital 
readmission, laboratory and radiographic tests; due to increasing life 
expectancy and treatment options, there is growing focus on aspects previously 
considered immeasurable and subjective, such as quality of life and the patient 
experience. (Streiner and Norman, 2008, Valderas et al., 2008) Information on 
the acceptability and appropriateness of healthcare to the patient now shape 
provision of care from individual management plans through to wider service 
design. (Valderas et al., 2008, Health Knowledge, 2011) 
 
1.4.2. The importance of quality 
A broad range of measures reflecting different aspects of healthcare exist but 
their method of design and quality have also been noted to vary widely. 
(Scientific Advisory Committee of the Medical Outcomes Trust, 2002) The 
quality of an instrument’s development process and measurement properties 
are of considerable importance. Studies have indicated a bias towards 
interventions in comparison with controls where unpublished scales were used 
in studies of mental health treatment. (Marshall et al., 2000, Lockwood and 
Marshall, 1998) Another study highlights how the phrasing of questions may 
influence the perception of treatment side effects and subsequent work 
absenteeism. (O'Connor et al., 1996) As such, measures lacking rigor in their 
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development and with poor measurement property performance become a 
source of inaccuracy in research with significant consequences in the field of 
healthcare. (Mokkink et al., 2010b, Terwee et al., 2012) 
 
As such, instruments must be demonstrated to be valid and reliable, measuring 
what they are intend to measure and doing so in a reproducible manner. 
(Streiner and Norman, 2008) The development and measurement properties of 
an instrument should therefore be systematically evaluated in a robust and 
transparent manner, as done routinely in other areas of healthcare research. 
(Higgins and Green, 2011, Johnston and Graves, 2008, Mokkink et al., 2010b) 
However, Johnston and Graves note that the most well-used measure is often 
selected without consideration of “how valid or how reliable [it is] or in what 
ways”, with the measurement property terms “used as synonymous with good, 
rather than reflecting the quality of a measure for a particular construct or 
application.” (Johnston and Graves, 2008) As such, before a measure is used in 
research or clinical practice, its design and measurement properties should be 
evaluated using clear standards of quality. (Mokkink et al., 2010b) 
 
1.4.3. Developing and evaluating measures 
As highlighted by Streiner and Norman, the development of measurement 
scales is challenging and requires resources such as time and money, along 
with access to experience and expertise. As such, the recommended first step is 
to review existing instruments to avoid the unnecessary duplication of efforts 
in designing another. (Streiner and Norman, 2008) The development process 
and measurement properties of identified instruments should then be 
evaluated. (Johnston and Graves, 2008, Mokkink et al., 2010b) Until recently, 
textbooks and detailed guides were used to develop and review measures, 
which could be time consuming, inaccessible and hard to synthesise succinctly. 
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(Streiner and Norman, 2008, Johnston and Graves, 2008, Mokkink et al., 
2010b) This, along with the varying terminology used, has arguably 
contributed to the lack of standardised information available about measures, 
further impairing appraisal, comparison and choice. (Johnston and Graves, 
2008) 
 
1.4.4. Standards for measure development  
The COnsensus-based Standards for the selection of health Measurement 
INstruments (COSMIN) initiative has developed a checklist of quality 
standards for measure development. This was produced using a literature 
review followed by a multidisciplinary, international Delphi process to 
determine which measurement properties to include and what standards to 
apply to study design and statistical analysis. (Mokkink et al., 2010b, Mokkink 
et al., 2012) The checklist evaluates ten measurement properties, each with 
between five and eighteen items to assess whether a study meets a good 
methodological standard. Internal consistency, reliability, measurement error, 
content validity, construct validity, criterion validity and responsiveness are 
covered, along with interpretability, item response theory and generalisability. 
(Terwee et al., 2012, Mokkink et al., 2012) A scoring version was subsequently 
developed to facilitate the comparison of instruments in systematic reviews. 
This contains four possible responses per item (excellent, good, fair and poor), 
with an overall score for a measurement property derived from the lowest score 
obtained for that property. (Terwee et al., 2012, Schellingerhout et al., 2012) A 
summary of the parameters considered by the COSMIN checklist with their 
definitions is included in Appendix 1. A sample of the checklist is included in 
Appendix 2. 
	  15 
1.4.5. Criteria for measurement properties 
Terwee and colleagues suggest “the assessment of methodological quality of a 
study and the assessment of the quality of an instrument are fundamentally 
different things, and should be performed separately in systematic reviews.”  
(Terwee et al., 2012) Using the property of internal consistency as an example, 
the methodological standards consider features such as sample size, checking 
for scale unidimensionality and the use of appropriate statistical analysis in 
scale development, while the statistical value for item intercorrelation is 
considered under measurement property quality criteria. (Higgins and Green, 
2011, Terwee et al., 2007) 
 
Several quality criteria for scale measurement properties exist, such as the 
frequently cited Scientific Advisory Committee of Medical Outcomes Trust 
criteria. (Terwee et al., 2007) This considers eight attributes of the measure, 
including its conceptual and measurement model, reliability, validity, 
responsiveness, interpretability, respondent and administrative burden, 
alternative forms, cultural and language adaptations, along with specific review 
criteria. (Scientific Advisory Committee of the Medical Outcomes Trust, 2002) 
Further studies have clarified such criteria in order to make them more 
functional and easy to apply in practice. (Valderas et al., 2008, Terwee et al., 
2007) These include work by the authors of the COSMIN checklist, whose 
criteria have subsequently been used in combination with the COSMIN 
checklist and are detailed in Appendix 3. (Terwee et al., 2007, Schellingerhout 
et al., 2012) 
 
 
	  16 
1.5. Systematic reviews 
1.5.1. Overview 
A systematic review is a method of finding and summarising all available 
evidence to answer a clearly defined question. (Liberati et al., 2009, Shea et al., 
2007) The findings can be further summarised using statistical processes in 
meta-analyses. (Gopalakrishnan and Ganeshkumar, 2013) Systematic reviews 
are used for keeping up to date with the evidence base and guiding treatment 
decisions, policy development, guidelines and funding allocation. (Liberati et 
al., 2009) 
 
The first step of a systematic review is to identify a research question with pre-
agreed inclusion and exclusion criteria for which evidence is to be consulted.  
A transparent and reproducible methodology is then developed to 
systematically search for sources of information meeting the eligibility criteria. 
The resources found are critically appraised using pre-set criteria to assess the 
validity of the evidence provided. The findings and strength of evidence are 
then synthesised to formulate conclusions. (Shea et al., 2007,  (Khan, 2005, 
Higgins and Green, 2011) 
 
Systematic reviews are placed highest in the hierarchy of research evidence due 
to the increased ability to detect meaningful results gained by combining 
sources of information and different studies. (Hemingway and Brereton, 2009) 
This increases the reliability of the findings in comparison with other study 
designs. (Gopalakrishnan and Ganeshkumar, 2013) However, systematic 
reviews must use a robust, transparent method that is clearly reported in order 
to facilitate evaluation of possible sources of bias. (Higgins and Green, 2011) 
These include publication bias, where studies with positive results are more 
likely to be found in peer-reviewed journals and so be included in further 
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reviews. (Gopalakrishnan and Ganeshkumar, 2013) The value of conclusions 
drawn in a systematic review is also dependent on the quality of the available 
evidence. (Higgins and Green, 2011) 
Multiple guidelines for performing a systematic review are available, including 
those produced by the Cochrane Collaboration and the Centre for Reviews and 
Dissemination. (Higgins and Green, 2011, Centre for Reviews and 
Dissemination, 2009) There are also guidelines for evaluating systematic 
reviews such as the Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis statement and those produced by the Critical Appraisal Skills 
Programme. (Liberati et al., 2009, Critical Appraisal Skills Programme (CASP), 
2011) However, these resources do not fully address the methodology for a 
systematic review of measurement instruments, as they are primarily 
concerned with studies of interventions or diagnostic tests. 
 
1.5.2. Additional considerations for a systematic review of measures.  
Systematic reviews can be used to identify existing instruments and evaluate 
their quality, both in terms of how they were developed and their 
measurement properties. As such, the systematic review must appraise the 
design, analysis and interpretations of the development studies and consider 
any bias influencing the quality of the instrument produced. In addition, the 
measurement properties of the scale should be evaluated. (Mokkink et al., 
2010b, Terwee et al., 2012) 
 
Terwee and colleagues gathered all existing systematic reviews of patient-
reported outcome measures to evaluate the processes used. (Mokkink et al., 
2009) They found considerable variation in quality of review design and 
highlighted limited use of standards for measure development and criteria of 
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adequacy for the instrument measurement properties. (Mokkink et al., 2009) 
The following recommendations were made for conducting a systematic review 
of patient-reported outcome measurement instruments: 
• The literature search should incorporate terms describing the construct 
measured by the instrument, the population of interest and any other 
key characteristics needed.  
• Broad methodological search terms should be used due to the 
inconsistencies in database indexing and the wide terminology in use. 
• An additional search including the name of identified instruments is 
recommended in order that all development and evaluation studies are 
found.  
• The methodological quality of included studies should be appraised 
using reproducible standards.  
• The measurement properties of instruments found should be assessed 
using reproducible criteria of adequacy. 
 
1.6. Summary with thesis overview   
 
Shared decision-making is an increasingly important facet of modern health-
care practice with a growing field of research exploring the methods used and 
decision support interventions. Evaluating the effectiveness of any changes in 
clinical practice requires a clear definition of what constitutes a good decision. 
Elwyn and Miron-Shatz argue that it is the process leading to the decision that 
should be considered, rather than the decision itself, proposing a decision-
process model incorporating deliberation that focuses on the patient’s 
experience. (Elwyn and Miron-Shatz, 2010) 
 
However, it is unclear the extent deliberation is considered in existing 
measures of shared decision-making. In addition, an instrument’s development 
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process and measurement properties also influence its suitability for use in 
appraising interventions for use in clinical practice, and should therefore also 
be considered. As systematic reviews represent the most robust method of 
appraising the existing evidence field, this approach will be used to address 
research question: to what extent do existing measures of shared decision-
making incorporate assessment of deliberation by the patient? 
 
This review aims to analyse existing shared decision-making measurement 
scales, determining the extent their items map onto a decision process model 
incorporating patient deliberation. The research objectives are to perform a 
systematic search to identify studies concerning the development or evaluation 
of an instrument measuring decision-making, where the patient’s perspective 
is sought. Once these are identified, the descriptive and measurement 
properties of the instruments will be assessed along with the extent their items 
map onto stages in deliberation and determination in a process map of decision 
making. Based on the review findings, the need for a new instrument will be 
considered and specifications outlined, if indicated.   
 
The research aims and objectives are further summarised in the next sections. 
The full methods used in the study, for both the systematic review and 
instrument content mapping, are reported in Chapter 4. The results for the 
systematic review are detailed in Chapter 5, and the findings of the instrument 
content mapping reported in Chapter 6. The results are discussed and placed in 
the context of the knowledge to date and study method in Chapter 7, with the 
implications for developing a new measure of the decision-making process 
considered. Chapter 8 concludes the thesis and summarises the key learning 
points from the study.  
  
	  20 
2. Aims 
To analyse existing shared decision-making measurement scales where the 
patient’s perspective is sought, determining the extent their items map onto a 
decision process model incorporating patient deliberation.  
3. Objectives 
1. Perform a systematic search to identify studies concerning the 
development or evaluation of an instrument measuring decision-
making, where the patient’s perspective is sought.  
2. To assess the descriptive and measurement properties of the 
instruments. 
3. To determine the extent the existing instruments’ items map onto 
stages in deliberation and determination in a process map of decision 
making. 
4. Outline new instrument specification, if indicated. 
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4. Method 
 
This chapter begins by detailing the guidelines used to construct a robust 
systematic review and the additional resources consulted for a review of 
measurement instruments. Search strategy development is described, along 
with the eligibility criteria and study selection, data extraction and synthesis 
processes. The method of mapping instrument items against Elwyn and Miron-
Shatz’s decision process model is also reported. Finally, protocol amendments 
are detailed and discussed, along with the steps taken to keep the review 
findings timely.  
 
4.1. Systematic review 
4.1.1. Developing a systematic review 
4.1.1.1. Key steps of a systematic review  
A systematic review begins with the identification of a research question and 
eligibility criteria for the evidence drawn upon. A clear and reproducible 
method is developed to systematically search resources for records matching 
the criteria. These are then appraised to determine the validity of the evidence 
presented and their results noted, with the data gathered synthesised to inform 
a conclusion. (Shea et al., 2007, Khan, 2005, Higgins and Green, 2011) 
 
4.1.1.2. Resources for method development 
The method for this systematic review was developed using guidance from the 
Cochrane Collaboration and the Centre for Reviews and Dissemination. 
(Lefebvre et al., 2009, Centre for Reviews and Dissemination, 2009) It was 
then compared against guidelines for evaluating systematic reviews from the 
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Critical Appraisal Skills Programme and the Preferred Reporting Items for 
Systematic Reviews and Meta-Analysis statement. (Critical Appraisal Skills 
Programme (CASP), 2011, Moher et al., 2009) 
 
Additional guidance was sought from a healthcare librarian and information 
specialist, supplemented with resources from the Cardiff University Systematic 
Review Network (SysNet). (Mann, 2011) Similar systematic reviews of 
measurement instruments, both in shared decision-making and related fields, 
were consulted. (Pink et al., 2009, Joseph-Williams et al., 2011, Elwyn et al., 
2001b, Dorman, 2005, Scholl et al., 2011, Sepucha and Ozanne, 2010, Simon 
et al., 2007, Schellingerhout et al., 2012) The protocol was presented to 
colleagues in the Decision Laboratory at the Institute of Primary Care and 
Public Health, Cardiff University. 
 
4.1.1.3. Resources specific for a systematic review of measurement 
instruments 
This preliminary exploration and consultation indicated that the guidelines 
above did not fully address the process of conducting a systematic review of 
measurement instruments, as they were primarily concerned with studies of 
interventions or diagnostic tests. To address this, a Medline search was 
conducted using search terms for systematic reviews, guidelines and 
measurement instruments. The recommendations made in the identified 
resources were then incorporated into the systematic review design. (Mokkink 
et al., 2009) These included use of broad methodological search terms due to 
indexing variation and conducting an additional search with the names of 
included scales in order to identify all developmental studies. (Mokkink et al., 
2009) Further recommendations included the use of reproducible standards to 
appraise the methodological quality of included studies and reproducible 
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criteria of adequacy to evaluate the measurement properties of identified 
instruments. (Mokkink et al., 2009) 
 
4.1.2. Search strategy development 
4.1.2.1 Strategy foundations 
Search strategies classically include three sets or strings of search terms. (de 
Vet et al., 2008) In a systematic review of measurement scales, two search 
strings concern the construct to be measured and the population of interest, in 
this case shared decision-making and patients, in particular their perspective of 
the decision-making process. The final string relates to instrument evaluation 
and development. (Mokkink et al., 2009) Terms related to these fields were 
identified and combined, initially with the Boolean operator “OR” for terms 
within each search string. The three sets were then combined with the Boolean 
operator “AND” operator, producing a search strategy that identifies records 
incorporating all three concepts, as shown in Figure 2 below. (de Vet et al., 
2008) 
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Figure 2: Basic search strategy  
#1: construct search (shared decision-making) 
#2: population search (patient’s perspective on the decision process) 
#3: methodology search 
#4: #1 AND #2 AND #3  
 
Adapted from: (de Vet et al., 2008) 
 
4.1.2.2 Identifying search terms 
As a first step in identifying search terms, key words for the foundation 
conceptual studies were gathered, such as those for the work of Elwyn and 
Miron-Shatz. (Elwyn and Miron-Shatz, 2010) These were supplemented with 
further terms for essential studies that the search strategy should detect, which 
were chosen following discussion with the review supervisors. Search 
strategies used in previous reviews of shared decision-making were also 
Sara Southall 9 
 
Figure 3: Basic search strategy 
 
 
 
Development of Medline search strategy 
Potentially relevant terms were identified based on the concepts of interest. These were 
mapped against the standardised search term (in Medline, MeSH terms) using the ‘Map 
to subject heading’ function. The tree and scope of each MeSH term identified was 
r viewed to ensure relevance.  
 
 
  
Shared 
decision-
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instrument 
Relevant records 
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consulted. (Joseph-Williams et al., 2011, Pink et al., 2009, Scholl et al., 2011, 
Simon et al., 2007) Additional decision-making and participation-related terms 
were identified from the Cochrane Consumers and Communication Review 
Group search strategy for the specialised register. (Cochrane Consumer and 
Communication Review Group) 
 
Search filters have been developed to identify studies reporting instrument 
development and evaluation. (Terwee et al., 2009) The terms included in the 
filters were reviewed but the filters themselves were not used due to the risk of 
inaccuracy associated with variable indexing and other changes to databases 
over time. (de Vet et al., 2008, Mokkink et al., 2009)  
 
The terms identified were mapped against the standardised subject indexing 
used in databases. (Lefebvre et al., 2009) In Medline, these are called MeSH 
terms and found using the “Map to Subject Heading” function. (Cardiff 
University IT and Library Services, 2012) The scope and tree, or definition and 
filing location, of each identified MeSH term was reviewed to ensure relevance 
and to identify other related records that could be incorporated into the search 
through the “explode” function of the database. (Lefebvre et al., 2009) The use 
of index terms alone is discouraged due to dependence on the indexers’ 
interpretation of field, the description of the study given by authors and the 
format of information collated by databases. However, they are an essential 
tool for identifying records when used in conjunction with free text, as index 
terms are tailored to a database and have been developed to extract 
information efficiently from that resource. (Lefebvre et al., 2009) 
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4.1.2.3 Improving comprehensiveness or sensitivity 
A sensitive search strategy detects a greater number of records, with a 
comprehensive and broad approach missing fewer resources. However, this 
also means that a greater number of ineligible studies are detected. A sensitive 
search strategy is recommended for systematic reviews of measurement 
instrument studies due to varying terminology use and concerns of poor 
indexing. (de Vet et al., 2008, Mokkink et al., 2009) 
To improve the thoroughness of the search, free-text terms along with 
synonyms and variant spellings were incorporated into the strategy. 
Truncations, such as “scor*” for scoring, scored and score, were also used to 
broaden the search. In addition, the “explode” function was used for MeSH 
terms where the scope and tree of the term suggested this would yield further 
relevant records. (Lefebvre et al., 2009) 
 
4.1.2.4 Improving precision or specificity 
A more specific or precise search strategy yields fewer ineligible studies. 
(Lefebvre et al., 2009) A balance is needed between the sensitivity and 
specificity of a strategy to ensure that all relevant records are detected while 
also producing a manageable volume of results in view of time and resource 
restrictions. In this review, the proximity operator ADJn (where n is the 
maximum number of words allowed between the specified search terms) was 
used to improve the focus of search outputs for otherwise very broad free-text 
terms. (Cardiff University IT and Library Services, 2012) For example, records 
containing the free-text term “patient” in their title or abstract were only 
detected if “decision-making” was also identified at a maximum of three words 
away.  The Boolean operator “NOT” was not used, as it can lead to inadvertent 
exclusion of results. (Lefebvre et al., 2009) 
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4.1.2.5 Pilot searches 
The search strategy was refined through multiple trial searches. An iterative 
approach was taken, with the impact of each modification to the strategy 
evaluated by the relevance of the records identified and the detection of key 
articles, which were selected during background reading and discussion with 
supervisors. Examples of the terms excluded are listed in Appendix 4, along 
with the impact they had on the pilot search outputs. Additional guidance from 
an information specialist was sought to optimise the strategy. The final search 
strategy for Medline is shown in Table 2. 
 
The pilot searches also highlighted less of an overlap between two databases 
than had initially been anticipated. (Lefebvre et al., 2009) The provisional 
search strategies for Medline and EMBASE were kept sensitive with a target of 
5,000 results each. However, few duplicates were detected and the precision of 
the searches was further developed to reduce the combined search results from 
over 12,000 to around 3,000. This improved specificity while maintaining the 
relevance of the search output and its ability to detected key articles. 
 
4.1.2.6 Reducing error 
All versions of the search strategies were saved within database accounts in 
addition to being cut and pasted into Word to ensure that the searches were 
reproducible and the development process transparent, with all decisions 
documented in a research diary. (Lefebvre et al., 2009) To reduce the 
introduction of error, the complete search strategy outputs with full references 
for each record were downloaded into a reference manager (EndNote versions 
XV-X7) and notes made of insufficient details in any references and articles. 
(Lefebvre et al., 2009)   
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Table 2: Medline via Ovid search strategy 
1. ((patient* or client* or consumer*) adj3 decision making).mp. 
2. exp patients/ 
3. exp Patient Participation/ 
4. exp evaluation studies/ or exp validation studies/ 
5. psychometrics/ 
6. reproducibility of results/ 
7. (valid* or reliab*).mp. 
8. ((measur* or scal* or scor* or instrument* or survey* or tool* or question*) 
adj6 decision*).mp. 
9. exp Decision Making/ 
10. shared decision-making.mp. 
11. ((consider* or reflec* or deliberat*) adj3 decision*).mp. 
12. (decision* or choice* or prefer* or judg*).tw. 
13. or/1-3 
14. or/4-8 
15. or/9-12 
16. and/13-15 
 
 
/	 after	an	index	term	(MeSH	heading)	indicates	that	all	subheadings	were	selected.		
*		 before	an	index	term	indicates	that	that	term	was	focused	-	i.e.	limited	to	records	where	the	term	
was	a	major	MeSH/Emtree	term.		
"exp"		before	an	index	term	indicates	that	the	term	was	exploded.		
.tw.		 indicates	a	search	for	a	term	in	title/abstract		
.mp.		 indicates	a	free	text	search	for	a	term		
#	 retrieves	records	that	contain	the	search	term	with	substituted	character(s)	in	the	specified	
location.	
*	 at	the	end	of	a	term	indicates	that	this	term	has	been	truncated.		
*n	 The	limited	truncation	symbol,	$n,	Retrieves	records	that	contain	the	search	term	and	all	possible	
suffix	variations	of	a	root	word	with	the	maximum	number	of	characters	that	may	follow	the	root	
word	or	phrase,	specified	by	n.	
?		 in	the	middle	of	a	term	indicates	the	use	of	a	wildcard.		
adj		 indicates	a	search	for	two	terms	where	they	appear	adjacent	to	one	another		
(Source: Mann, 2011) 
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4.1.3 Databases and information sources 
4.1.3.1 Electronic databases 
Guidelines for systematic reviews highlight the need for both a detailed 
strategy and the use of multiple, overlapping resources when constructing a 
thorough search. (Lefebvre et al., 2009) Shared decision-making and 
measurement instrument development are growing fields, with a broad and 
varying terminology used in both. They are also areas that concern a range of 
disciplines, such as health, education and psychology.  As such, multiple 
electronic databases were used. (Joseph-Williams et al., 2011) 
 
Medline (including Medline in Process), EMBASE and the Cochrane Library 
were recommended as key resources and were supplemented with subject 
specific databases, including PsycINFO, CINAHL and ASSIA. (Lefebvre et al., 
2009) The citation index Web of Science was used for citation searching, which 
also allowed identification of corrections or errata. (Lefebvre et al., 2009) For 
each database, the service provider, date of search and time period searched 
were recorded. (Lefebvre et al., 2009) 
 
4.1.3.2 Adapting Medline search strategy to other databases 
Each database has differing subject coverage, search processes and 
standardised search terms. The Cardiff University Information Services guides 
to each database were consulted in order to adapt the core Medline search 
strategy to a resource, and the database thesauruses used to identify 
standardised search term variations for the three main search threads. (Cardiff 
University IT and Library Services, 2012) For example, PsycINFO database 
searches required the substitution of “client” for “patient”. The same iterative 
approach was repeated, with pilot searches run and search terms adapted 
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according to relevance of results and identification of key articles. The search 
strategies are included in Appendix 5. 
 
4.1.3.3 Additional resources 
Electronic database searches were supplemented with hand searches of the 
most frequently cited journals, with the reference lists of included reports also 
reviewed for further relevant studies. Specific follow-up searches using the 
name of the identified measurement instruments were performed to ensure 
that all development and evaluation studies for the scales were identified. 
(Mokkink et al., 2009) The resources used are summarised in Table 3. 
 
4.1.4. Search limits 
Systematic reviews should include relevant unpublished studies in order to 
limit publication bias. However, the reporting and indexing of published 
instrument development and evaluation reports are acknowledged as being 
highly variable. Grey literature and unpublished sources introduce further the 
possibility of incomplete reports. Due to the practical difficulties this would 
present along with time restrictions, resources for grey literature and 
unpublished studies were not searched. (Centre for Reviews and 
Dissemination, 2009)  
 
No restrictions were placed on language or date for the database searches. 
However, in the event of a translation being unfeasible, this was to be recorded 
as the cause for exclusion. (Centre for Reviews and Dissemination, 2009) 
 
 
 
	  31 
Table 3: Summary of resources  
Bibliographic	databases:	
Medline	(Biomedical)	
Medline	in	Process	(as	above,	with	very	recent	citations	and	abstracts,	and	non-
indexed	citations)	
Cochrane	Library	
EMBASE	(Biomedical	and	pharmaceutical	database)	
PsycInfo	(Psychology	and	psychological	aspects	of	related	disciplines)	
ASSIA	(Applied	social	sciences,	education	and	health)	
CINAHL	(Nursing	and	allied	health)	
Web	of	Science	(Social	Science	Citation	Index	and	Science	Citation	Index)	
	
Journals:	manual	searches	of	those	most	frequently	identified	by	database	searches	
(for	preceding	five	years)	
Health	Expectations	
Patient	Education	and	Counseling	
	
References:	
Examination	of	the	reference	lists	of	included	papers	
(Adapted from: Mann, 2011) 
 
4.1.5. Eligibility criteria  
Pre-specification of eligibility criteria is a key requirement of systematic 
reviews, in order to maintain transparency and limit the introduction of bias. 
The inclusion and exclusion criteria for this review are detailed in Table 4 and 
Table 5. They were developed using the review question and objectives, and 
kept broad where possible while also giving sufficient detail to appraise 
eligibility consistently. (Bossuyt and Leeflang, 2008)  
 
To be included, a study had to address the development or further evaluation 
of a measurement instrument for an aspect of shared decision-making, 
specifically considering the patient’s perspective of the decision-making 
process. Including a minimum number of the stages of deliberation described 
in Elwyn and Miron-Shatz’s decision process model as an inclusion criterion 
was considered unfeasible at the title and abstract screening phase, as it was 
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felt that this level of detail was unlikely to be present in references. (Patrick et 
al., 2009)  
 
Due to the different disciplines with an interest in shared decision-making, two 
main limitations were placed on study design. (Joseph-Williams et al., 2011) 
First, that the decision context related to healthcare and second, that the study 
must involve the psychometric evaluation of specific measurement. The latter 
meant that the study reports would include details of the design and 
measurement properties of the instrument, allowing appraisal of the quality of 
these aspects. While this meant excluding intervention studies and reviews, 
effort was made to search for original instrument development and evaluation 
reports. Broad eligibility criteria were used for the description of the 
psychometric evaluation of instruments due to the variation in reporting and 
terminology described by Mokkink and colleagues. (Joseph-Williams et al., 
2011, Mokkink et al., 2009)  
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Table 4: Inclusion criteria 
	 Criterion	 Clarification	 Justification	
Concept	to	be	
measured	
Shared	decision-
making	in	
healthcare	setting	
	
Construct	
measured	by	
instrument	is	an	
aspect	of	shared	
decision-making	
	
Can	be	for	research	
or	clinical	purpose	
Main	construct	
must	be	decision-
making	if	
deliberation	in	
decision-making	to	
be	assessed	
Population	of	
interest	
Patients	involved	in	
healthcare	
decision-making,	
for	decision	
regarding	their	own	
health	or	treatment	
Must	seek	to	
measure	patient’s	
perspective	of	
decision-making	
process	i.e.	patient-
reported,	though	
can	be	self-
completed	or	via	
interviewer	
Patient	deliberation	
can	only	be	
determined	by	
seeking	the	
patient’s	
perspective	on	their	
experience	
Instrument	of	
interest	
Reports	on	the	
development	and	
testing	of	
instrument	
designed	to	
measure	shared	
decision-making	
	
Psychometric	
evaluation:	at	least	
two	measurement	
properties	noted	
If	modified	version	
of	previously	tested	
scale:	further	
psychometric	
testing	reported.	
If	multidimensional	
instrument:	
separate	
psychometric	data	
for	SDM	relevant	
subscales	reported.		
Information	needed	
to	appraise	quality	
of	instrument	
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Table 5: Exclusion criteria 
	 Criterion	 Clarification	 Justification	
Concept	to	be	
measured	
Measured	
construct	is	not	an	
aspect	of	shared	
decision-making	in	
the	health-care	
setting	
e.g.	decision-
making	in	business	
or	management	
environment	
Not	relevant	to	
patient	deliberation	
in	shared	decision-
making	
Population	of	
interest	
Proxy-reported	or	
physician/	
researcher	rated	
	
	
	
Not	specific	to	
patient	
involvement	in	
decision-making	
regarding	their	own	
health	or	treatment	
Completed	on	
behalf	of	patient	by	
health	professional,	
guardian	or	carer.	
	
	
E.g.	Patient	rating	
of	service	quality	
	
Not	direct	
recording	of	
patients	
perspective	or	
recording	of	their	
experience	of	
decision-making	
process		
Not	relevant	to	
decision-making	
from	patients’	
perspective	
Instrument	of	
interest	
Paper	does	not	
focus	on	
development	and	
evaluation	of	
instrument	
	
	
	
Instrument	or	
evaluation	data	
unavailable	for	
scrutiny	
e.g.	intervention	
study	or	review.	
Unlikely	to	have	
evaluation	
information	for	
instrument.	
	
Limits	mapping	of	
instrument	items	
against	decision	
process	map	and	
evaluation	of	
instrument	quality.	
Information	needed	
to	appraise	quality	
of	instrument	
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4.1.6. Study selection 
Full references were downloaded into reference management software 
(Endnote versions XV-X7), with the search outputs of different databases 
merged and duplicates removed. The titles and abstracts were screened using 
the eligibility criteria and graded as include, exclude or uncertain. A full text 
report was then obtained for those graded as include or uncertain. (Higgins 
and Deeks, 2011, Centre for Reviews and Dissemination, 2009) 
 
One reviewer (SS) screened all titles and abstracts with a second reviewer (SM) 
independently examining 10% of the database search results. Guidelines 
recommend that more than one reviewer independently review all results to 
reduce the possibility of error and increase the reproducibility of results. 
However, in view of the resources available and high number of records 
produced by a sensitive search strategy, a second reviewer for a proportion of 
the results is considered an accepted compromise (Higgins and Deeks, 2011, 
Centre for Reviews and Dissemination, 2009) 
 
Study selection pilot was performed with 10 references to assess the clarity of 
the eligibility criteria and improve the consistency of its application between 
reviewers. A kappa statistic was calculated to assess inter-assessor reliability. 
Though not recommended as standard by Cochrane Collaboration, it is used to 
highlight problems at the piloting stage. Values of 0.6 - 0.74 are considered a 
good level of agreement between reviewers, with equal to or greater than 0.75 
defined as excellent. For this pilot, the kappa statistic obtained was 0.78. 
(Higgins and Deeks, 2011)   
 
There was a low threshold for suggesting a full text review due to concerns 
over the level of detail available in the titles and abstract of measurement 
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instrument studies. (Reeves et al., 2009) Following full text retrieval of 
potentially relevant reports, one reviewer (SS) determined study inclusion 
based on compliance with the eligibility criteria. At this stage, the individual 
items of the instruments were evaluated to assess their relevance to the 
measurement of shared decision-making from the patients’ perspective. 
(Patrick et al., 2009)  
 
In the event of uncertainty over study eligibility not being resolved by review of 
the full text or discussion with the second reviewer, the study would be 
referred for arbitration by an agreed third party (GE) with a record made of 
decision reached. (Higgins and Deeks, 2011) As suggested by the Cochrane 
Collaboration guidelines, the reviewers had different backgrounds, reducing 
the potential bias introduced by previous experience in the field under review. 
(Higgins and Deeks, 2011) 
 
4.1.7. Data extraction 
4.1.7.1. Selection of data extraction fields 
A key consideration in selecting data extraction fields was relevance to the 
research question and the practical application of the review findings. In 
addition, as recommended by the Cochrane Collaboration, systematic reviews 
of similar constructs were consulted and appraised. (Higgins and Deeks, 2011) 
Reproducible, pre-determined standards and criteria were applied to the study 
design and the measurement properties of the instrument developed, to 
increase transparency and minimise variation and bias. (Mokkink et al., 2009) 
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4.1.7.1.1 Descriptive features 
Study characteristics such as the setting, population and decision context were 
noted, along with instrument characteristics including language and 
readability. These details determine how practical the scales are to use and the 
generalisability of study findings to other populations. (Critical Appraisal Skills 
Programme (CASP), 2011) 
 
4.1.7.1.2 Methodological quality 
The standards applied to the study design were the COnsensus-based 
Standards for the selection of health Measurement INstruments (COSMIN) 
checklist for the methodological quality of studies of measurement 
instruments. The COSMIN checklist includes standards for validity, reliability, 
responsiveness, interpretability, IRT statistical methods and generalisability. 
These standards were used due to the availability of published reports of 
checklist development and application, along with recommendations made in 
previous reviews of shared decision-making measurement instruments. 
(Mokkink et al., 2010a, Scholl et al., 2011) Both the checklist and the 4-point 
rating scale versions of the standards were used, as the checklist gathered 
greater detail and was therefore used for data extraction, while the rating scale 
produced concise, easily comparable summaries more suited for synthesising 
the review findings. (Terwee et al., 2012) However, caution is needed with the 
use of rating scales as they can lead to a loss of detail and oversimplification of 
results. (Moher et al., 2009) A comparison of the two methods is detailed in 
Appendix 6.  
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4.1.7.1.3 Instrument quality 
Reproducible criteria for instrument measurement properties developed by 
Terwee and colleagues were used to evaluate the quality of the scales 
identified. This guidance was selected as it was developed by the same research 
team as the COSMIN checklist and has also been used in the Institute of 
Primary Care and Public Health at Cardiff University. (Terwee et al., 2007, 
Pink et al., 2009) 
 
4.1.7.1.4 Further evaluation studies 
Eligible further evaluation studies for included instruments were reviewed and 
information gathered to supplement data from original development studies. 
The extraction fields included the study context and design, and measure 
validity and reliability.  
 
4.1.7.2. Data extraction form  
A standardised form was created using Microsoft Excel and the fields used are 
summarised in Appendix 7. An electronic format was developed instead of 
paper forms due to the ease of gathering, recording, transferring and 
combining data. (Higgins and Deeks, 2011) 
 
4.1.7.3. Data extraction process 
Due to time and resource limitations, one reviewer (SS) extracted the data 
with a second (SM) reviewing the data extraction form and any queries. The 
form was piloted to ensure clarity and consistency of interpretation. The third 
reviewer (GE) was to be consulted if there was a disagreement. (Higgins and 
Deeks, 2011)   
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4.1.8. Narrative synthesis 
The final step in a systematic review is to summarise, or synthesise, the 
results, such that patterns can be identified and conclusions drawn in relation 
to the research question. (Ryan, 2013)  There are different methods for this 
process, with steps used dependent on the variation, or heterogeneity, of the 
data gathered and statistical processes applied in the included studies. (Ryan, 
2013)  As highlighted by Mokkink and colleagues, there is a wide variation 
both in the methodological approaches used for instrument development and 
the measurement properties evaluated. (Mokkink et al., 2009) It is therefore 
unlikely that a statistical meta-analysis will be possible and a narrative 
synthesis will be performed. As recommended by the Cochrane Collaboration, 
the findings will be tabulated to provide an overview of the results and 
comparison of the included studies. (Ryan, 2013)   
 
4.2. Instrument content mapping  
In addition to a systematic review of literature to identify and appraise the 
quality of existing measures, each identified scale was evaluated to determine 
the extent they address deliberation.  This was done by appraising the 
individual items forming the measures and mapping these against the stages of 
the decision process model described by Elwyn and Miron-Shatz. (Elwyn and 
Miron-Shatz, 2010) The mapping results for each scale were then gathered in a 
summary table to compare their content and performance, and also evaluate 
whether all stages of the decision process model were met. 	
4.3. Protocol amendments.  
While the electronic database Scopus was originally included as a search 
resource, it was excluded at the protocol stage due to potential overlap with 
other databases and resource limitations. Though not a deviation, a key aspect 
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of the eligibility criteria wording was demonstrated during the initial study 
selection pilot. The second criterion was that the population of interest in the 
study was patients involved in healthcare decision-making for a choice 
regarding their own health or treatment. This was clarified to include that the 
scale developed must seek to measure the patient’s perspective of the decision-
making process.  This emphasis excludes scales assessing role preference or 
consultation scoring, which are not concerned with the decision-making 
process itself. It also excludes scales that focus on testing patient knowledge of 
a specific condition or treatment. While knowledge appraisal is an aspect of 
shared decision-making, the ability to answer specific questions regarding 
screening accuracy, for example, does not address the patient’s perspective of 
their decision-making process. 
 
It was originally proposed that report authors would be contacted for further 
details or clarification to aid evaluation by the standards and criteria used in 
the review. However, the varying terminology and detail of the reports made 
this an unfeasibly lengthy and time intensive process that would be needed for 
all of the included studies. As such the data extraction was based on the 
published reports of instrument development and evaluation.  
 
4.3. Updating the review.  
The original database searches for the review were conducted between April 
13th and April 17th, 2012. These were supplemented with manual searches of 
the most frequently cited journals, Health Expectations (May 2007 to May 
2012) and Patient Education and Counseling (May 2007 to May 2012), and the 
references of included studies were reviewed. In order that the review findings 
were kept timely and relevant, the database searches were updated in July 
2014. The supplemental search strategies were not repeated in view of the low 
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yield and duplication of database results noted originally. A more in-depth 
report of each search output is detailed in Chapter 5, the results of the 
systematic review.  
 
 
This section described the systematic review process undertaken, which was in 
keeping with Cochrane Collaboration and the Centre for Reviews and 
Dissemination guidelines. Further guidance for systematic reviews of 
measurement instruments was utilised and the subsequent approach included 
a broad search strategy, with supplemental database searches performed in 
order to identify all development or evaluation studies for each instrument. 
Due to the known methodological heterogeneity in instrument development 
and evaluation, a narrative synthesis was used to summarise the review 
findings. In addition to a systematic review to identify and appraise the quality 
of existing measures, content mapping was performed to determine the extent 
scale items address the stages of a decision process model incorporating 
deliberation proposed by Elwyn and Miron-Shatz. (Elwyn and Miron-Shatz, 
2010) 
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5. Results of the systematic review 
 
This chapter describes the output of the search strategies undertaken, details 
progress through study selection and provides a summary of the included 
scales. For each of these scales, the descriptive features are outlined before 
analysis of the methodological quality and measurement properties is 
undertaken. These findings are then summarised in a narrative synthesis of the 
review findings.  
 
5.1. Summary of results 
5.1.1. Output of search strategies 
The final databases searches were performed between April 13th and April 17th, 
2012. From the seven databases, 5950 references were retrieved. Table 6 
details the references found from each database.  
 
Table 6: Individual database search outputs 
Database	 Service	Provider	 Dates	covered	 Number	of	references	
Medline	 Ovid	 1945	to	April	2012	 1878	
EMBASE	 Ovid	 1947	to	April	2012	 1550	
Medline	in	process	 Ovid	 As	listed	on	April	13th,	2012	 90	
Cochrane	Library	 Wiley	 1898	to	April	2012	 357	
PsycINFO	 Ovid	 1806	to	April	2012	 776	
CINAHL	 EBSCO	 1937	to	April	2012	 1208	
ASSIA	 Proquest	 1987	to	April	2012	 91	
 
 
The references were exported into EndNote XV and duplicates identified using 
the reference manager search option. On title and abstract review, further 
duplicates were identified and removed. The total number of duplicate 
references was 1034, leaving a final total of 4916. Following title and abstract 
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review, 159 references progressed to full text review.  From these, ten eligible 
studies concerned the initial development of an instrument and another eight 
considered further evaluation. 
 
Database searches were supplemented with manual searches of the most 
frequently cited journals, Health Expectations (May 2012 to May 2007) and 
Patient Education and Counseling (May 2012 to May 2007), and the references 
of included studies were reviewed. In addition, citations of the included studies 
were identified using Web of Science, and additional database searches 
performed using the names of the identified instruments. The results of these 
searches are detailed in Table 7. However, the supplemental searches did not 
add to the final yield of eligible studies.  
 
Table 7: Supplemental search outputs 
Source	 Detail	 Number	of	
potentially	
relevant	studies	
identified	
Number	
eligible	on	
further	
review	
Number	once	
database	
duplicates	
removed	
Manual	journal	
searches	
Health	Expectations	(May	
2007	to	May	2012)	and	
Patient	Education	and	
Counseling	(May	2007	to	
2012)	
14	 0	 0	
References	of	
included	
studies	
-	 39	 0	 0	
Citations	of	
included	
studies	
Identified	via	Web	of	Science	
(Thomas	Reuters),	from	1900	
to	May	2012	
827	 8	 0	
Instrument	
name	database	
searches	
Using	Medline	via	Ovid	(1945	
to	May	2012)	
136	 1	 0	
 
The database searches were updated in July 2014. In total, a further 1977 
references were identified. The individual database outputs are detailed in 
Table 8. These were exported into the reference manager EndNote X7 and 346 
duplicates removed. Following title and abstract review, 9 articles progressed 
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to full text review. No new instruments were identified, and one eligible study 
concerning the further evaluation of a measure was included. The 
supplemental search strategies were not repeated in view of the low yield and 
duplication of database results noted originally. 
 
Table 8: Updated individual database search outputs 
Database	 Service	Provider	 Dates	covered	 Number	of	references	
Medline	 Ovid	 April	2012	to	July	2014	 490	
EMBASE	 Ovid	 April	2012	to	July	2014	 684	
Medline	in	process	 Ovid	 As	listed	on	July	18th,	2014	 176	
Cochrane	Library	 Wiley	 April	2012	to	July	2014	 114	
PsycINFO	 Ovid	 April	2012	to	July	2014	 245	
CINAHL	 EBSCO	 April	2012	to	July	2014	 260	
ASSIA	 Proquest	 April	2012	to	July	2014	 8	
 
 
5.1.2. Progress through systematic review 
Figure 3 details the progress through the systematic review. In total, ten 
studies were identified addressing the development of an instrument and nine 
concerned the further evaluation of an instrument.  
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Figure 3: A PRISMA flowchart of progress through the systematic review  
 
5.1.3. Agreement between reviewers 
One reviewer (SS) screened all titles and abstracts. A second reviewer (SM) 
reviewed 10% of the titles and abstract. From the 500 titles and abstracts, 24 
were selected for full text review, with no disagreement between reviewers. Of 
the full texts considered for eligibility, the third reviewer contributed to the 
consideration of three studies. (Barry et al., 1997, Bunn and O'Connor, 1996, 
Hollen, 1994)  
 
5.1.4. Excluded scales 
A balance was made during the search strategy development to ensure strong 
sensitivity for detecting eligible studies. The resulting low specificity identified 
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a high number of references. At the title and abstract study selection stage, the 
main reasons for exclusion were not addressing shared decision-making or the 
patient’s perspective on their involvement in the decision process. These 
studies were often concerned with decisions from the perspective of clinicians 
or patient-reported outcomes for different treatment options. Other themes 
encountered were evaluations of decision capacity and competency.  
 
At full text review, ineligible studies often focused on patient or clinician 
preferences for involvement in consultations, and grading of subsequent 
encounters. Studies were also excluded where decision evaluation focused on 
testing patient knowledge of specific conditions or tests, as this was felt to not 
represent evaluation of the decisional process itself. Examples of key studies 
excluded at the full text stage are included in Table 9. (Barry et al., 1997, 
Elwyn et al., 2013, Finnell and Lee, 2011, Geiger et al., 2011, Kaltoft et al., 
2014, Kremer and Ironson, 2008, Kriston et al., 2010, Melbourne et al., 2010, 
Miller et al., 2009, Ogden et al., 2008, Sepucha et al., 2011, Sepucha et al., 
2012, Sung et al., 2010) 
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Table 9: Key excluded scales 
First	
Author,	
Year	
	
Instrument	name	 Reason	for	exclusion	
Kaltoft,	2014	
	
MyDecisionQuality	 Theoretical	with	no	psychometric	evaluation	
Elwyn,	2013	
	
CollaboRATE	 Rating	shared	decision-making	in	consultation	rather	
than	a	measure	of	the	process	of	decision	making	from	
the	patient	perspective.	
Geiger,	2011	
	
SDM-MASS	 A	compound	measure	considering	three	perspectives	in	
one	index	(patient,	clinician,	observer)	and	rating	shared	
decision-making	within	a	consultation.		
Sepucha,	
2012	
	
Herniated	disc-decision	
quality	instrument	(HD-DQI)	
Condition	specific	–	concerned	with	knowledge	and	
decisions	for	herniated	discs.	
Finnell,	2011	
	
Decisional	Balance	for	
Patient	Choice	in	Substance	
Abuse	Treatment	
Hypothetical	preference	for	involvement	in	future	
decision	making	for	a	specific	health	context.	
Sepucha,	
2011	
	
HK-DQI	 Condition	and	treatment	specific,	with	focus	on	testing	
knowledge	rather	than	decisional	process.		
Kriston,	2010	
	
SDM-Q-9	 A	measure	of	shared	decision-making	in	consultation	
than	evaluation	of	patient	decision	process	
Melbourne,	
2010	
	
Dyadic	OPTION	 A	measure	of	shared	decision-making	in	the	
consultation	rather	than	consideration	of	decision-
making	process	from	the	patient	perspective.	
Miller,	2009	
	
Decision	Making	Control	
Instrument	
Not	decisional	process	–	measure	of	perceived	freedom	
to	make	own	decision	
Ogden,	2008	
	
Choice	questionnaire	 Preference	for	involvement	in	shared	decision-making	
than	patient	evaluation	of	decisional	process	
Kremer,	2008	
	
Control	Preferences	Scale	 Preference	for	involvement	in	shared	decision-making	
than	patient	evaluation	of	decisional	process	
Sung,	2008	
	
Autonomy	Preference	Index	
(API)	
Preference	for	decision	involvement	and	disease	
specific.		
Barry,	1997	
	
BPH	Knowledge	and	
Satisfaction	Questionnaires	
Nested	in	randomised	controlled	trial	and	involving	
three	different	scales.	Addresses	determination,	
understanding	and	involvement	in	decision	for	specific	
condition	rather	than	patient	perception	of	decisional	
process.	
 
 
5.1.5. Summary of included scales 
Ten scales were included, and Table 10 outlines the key details for these. A 
further nine studies concerned additional evaluation of the Decisional Conflict 
Scale, the Satisfaction with Decision Scale, SURE, COMRADE and the 
Decision Evaluation Scale. The full scales are included in Appendix 8. 
	  48 
Table 10: Summary of included scales 
Name	of	scale	 First	author,	year		 Country	 Language	
Decisional	Conflict	Scale	 O’Connor,	1995	
	
Canada	 English	
Satisfaction	with	Decision	 Holmes-Rovner,	1996	
	
USA	 English	
Decision	Attitude	Scale	 Sainfort,	2000	
	
USA	 English	
Prep-DM	 Bennett,	2010	
	
Canada	 English	
SDM-Q	 Simon,	2006	
	
Germany	 German	
SURE	 Légaré,	2010	
	
Canada	&	USA	 French	&	English	
COMRADE	 Edwards,	2003	
	
UK	 English	
Decision	Evaluation	Scales		 Stalmeier,	2005	
	
Netherlands	 Dutch	
Decision-making	quality	scale	 Hollen,	1994	
	
USA	 English	
Decision	Self-efficacy	scale	 Bunn,	1996	
	
Canada	 English	
 
5.2. Evaluation of scales 
5.2.1. The Decisional Conflict Scale (DCS) 
5.2.1.1 Descriptive features 
Developed by O’Connor in 1995, the scale focuses on decisional conflict and 
perceived contributory factors. (O'Connor, 1995) It contains three subscales: 
three items for uncertainty, four for effective decision making and nine items 
assessing factors contributing to uncertainty. The uncertainty subscales can be 
used during the decision making process, while that for effective decision 
making is intended for use once a decision is reached. Designed for self-
administration or use over the telephone, it is structured in a five point Likert 
scale, takes five to ten minutes to complete and requires a Grade 8 reading 
level. A higher score is considered to represent higher decisional conflict.  
 
The scale was intended for application both in clinical and research uses. It was 
originally evaluated in two healthcare decision scenarios, with the DCS 
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administered immediately after the decision in all groups. A sample of 45 
students was also retested two weeks later.  
 
The first of these scenarios concerned a decision to receive an influenza 
vaccine. Nursing agency and teaching hospital staff (n=115), cardiorespiratory 
patients (n=283) and two groups of health science students (n= 45 and 106) 
were given information about the vaccine and asked regarding their decision or 
intention to be immunised. For the student groups, this represented a 
hypothetical choice as they were not eligible for the vaccine.  
 
The second concerned a hypothetical decision to undergo breast cancer 
screening. A random sample of 360 women aged 50 to 69 was recruited from 
the community via a telephone survey. As well as determining background 
knowledge, attitudes and approaches to health screening; the participants were 
asked what they would do if invited for screening.  
 
5.2.1.2 Methodological quality 
Table 11 outlines the measurement properties evaluated in the DCS 
development study, with the COSMIN checklist for methodological quality 
then applied to each. (Mokkink et al., 2012) 
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Table 11: DCS development study mapped against the COSMIN checklist for 
methodological quality 
 
COSMIN	methodological	quality	 Evaluated	in	DCS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
 
Internal consistency, that is the interrelatedness of items such that they 
measure the same construct without creating redundancy, was evaluated both 
for the global scale and each subscale. (Mokkink et al., 2012) A Cronbach’s 
alpha was calculated for each. However, there is no documented factor analysis 
for the scale or subscales. This is required to determine the presence of 
unidimensionality, an assumption to be met for internal consistency statistics. 
Its absence raises the query of whether the scale or subscales can truly be said 
to be measuring only one attribute or factor, and whether other elements could 
be influencing item endorsement and scoring. (Mokkink et al., 2012) 
Correlations between the subscales are considered, and noted to be consistent 
with the predicted relationship between uncertainty and decisional conflict. 
These results are included under reliability in the study report, although they 
are relevant for the validity of the scale.  
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Reliability is defined by COSMIN as “the proportion of total variance [….] due 
to true differences between patients”. (Mokkink et al., 2012) Two sets of 
measurements are available, collected at specified time intervals, though from a 
smaller subgroup of participants (n = 45). Limited information is given 
concerning test conditions and, while the decision is hypothetical, information 
concerning participant stability between measurements would be beneficial. 
For example, as students it is possible that they encountered further 
information about the vaccine between administrations of the scales. In 
addition, while a Pearson correlation coefficient is calculated, this is considered 
insufficient by COSMIN due to the potential influence of systematic error.  An 
intraclass correlation coefficient (ICC) is recommended instead. (Mokkink et 
al., 2012) 
 
Content validity evaluates how thoroughly the included items cover the 
domain of interest. (Mokkink et al., 2012) Limited information is provided of 
the early developmental stages of the scale. No details are given of expert 
opinion being sought, or the involvement of the target population. However, 
the author considers the theoretical foundation for the scale and whether the 
included items cover decisional conflict as a construct.  
 
Hypothesis testing, also referred to as construct validity, considers whether 
scores correlate with other instruments, participant subgroups or other traits 
in a manner consistent with existing knowledge of the construct of interest. 
(Mokkink et al., 2012) The proposed relationships can be convergent or 
divergent, with the latter also referred to as discriminant. (Streiner and 
Norman, 2008) In this study, the hypotheses are developed a priori, thus 
limiting post hoc bias. (Mokkink et al., 2012) However, while the expected 
directions of correlations are described, the magnitude is not. The DCS is not 
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tested against another instrument, with the hypotheses instead based on 
whether a decision is made and the level of knowledge demonstrated in a 
breast cancer knowledge test. Limited information is given concerning the 
validity and reliability of this test and it is also assumed that increasing 
knowledge decreases conflict. The results are reported with mean scale scores, 
standard deviations and p-values for the decision outcome analysis, which 
limits interpretation of the magnitude of any correlation. A Pearson r 
correlation coefficient and P value are provided for the breast cancer knowledge 
test, but the supporting data for these calculations are not provided.  
 
The interpretability of the scores obtained by the scale is limited. Mean scores 
and their standard deviations are given but no proportions given for those 
scoring the highest and lowest scores. While scores are given for some 
subgroups, such as decision outcome, none are given for subgroups such as age 
or gender. Finally, no minimal important change (MIC) or minimal important 
difference (MID) is outlined, which makes the clinical relevance of scores hard 
to determine. For example, results reported as statistically significant 
correspond to differences in scores of less than one, which may have limited 
meaning in practice. However, these omissions may also be due to the early 
stages of scale development. 
 
When considering the generalisability of the study findings, limited 
demographic details are given for some participant groups, with insufficient 
disease and treatment characteristics for the cardiorespiratory patient group. 
The selection criteria are not fully described and, while the proportion of 
missing responses is reported as 1%, further details, such as which items were 
incomplete and how such scales were handled in statistical analyses, are not 
provided.  
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Further limitations in study design include that different subscales are 
evaluated in different groups, limiting the interpretability of both the scale 
scores and measurement properties. The study report also describes varying 
versions of subscales being used, but provide few details of how and why the 
changes were made.  
 
5.2.1.3. Instrument quality 
Table 12 maps the measurement properties for the DCS against quality criteria 
developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 12: DCS development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	DCS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
For internal consistency, the Cronbach’s alpha obtained from the different 
participant groups for the complete scale ranged from 0.70 to 0.95. For 
individual subscales, the values ranged from 0.58 to 0.70, which fall outside 
the recommended levels of 0.70 to 0.95. (Terwee et al., 2007) The authors 
describe reliability in terms of test-retest scores, with a Pearson correlation 
coefficient of 0.81 and no statistically significant difference observed. However, 
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the quality criteria developed by Terwee and colleagues recommend the use of 
ICC or a weighted Kappa statistic. (Terwee et al., 2007) 
 
When evaluating content validity, a clear description is given of the 
measurement aim but not the target population, item development or of target 
group or expert involvement in scale development. For construct validity, 
specific hypothesis were described a priori with at least 75% of the results in 
accordance. Though mean scores and their standard deviation are reported, 
interpretation of measure scores beyond the study is limited as no MIC or 
subgroup score analyses are provided.   
 
5.2.1.4. Further evaluation studies 
The Web of Science identified 565 citations of the original development study 
for the DCS by the end of 2014. Of these, six further evaluation studies 
matched the eligibility criteria and reported the translation and adaptation of 
the DCS for use in different health fields. The evaluation studies are 
summarised in Table 13 below. These studies also highlight variation in 
measurement property terminology. 
 
The study by Koedoot and colleagues concerns the validation of a Dutch 
version of the DCS in two samples of oncology patients (N = 29, 141). 
(Koedoot et al., 2001) Psychometric evaluation included internal consistency, 
with Cronbach's alpha obtained for the three subscales in both groups (0.61-
0.75, 0.77-0.80, 0.83-0.81) and for the overall scale in both groups (0.75-0.82). 
The authors evaluate construct, criterion and factoral validity. For construct 
validity, correlations between subscales were examined. These matched 
predictions in the first group but no relation was found between decision 
uncertainty and the perceived effectiveness of decision-making in second group 
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with weak correlation between factors contributing and effective decision-
making. Criterion validity was assessed using known-group comparison, with 
significant support of the hypothesis noted in first group of participants, but 
the hypothesis was supported for only two of the subscales in the second 
group. For factoral validity, the confirmatory factor analysis performed did not 
find a similar structure to that proposed by O'Connor with subsequent 
exploratory factor analysis finding four rather than three factors. It is possible 
that one of these factors – uncertainty - reflected response tendencies and was 
influenced by bias from positive or negative wording of the item rather than its 
meaning, with the authors also suggesting that the timing of subscale 
completion influenced the results.  
 
Mancini and colleagues sought to validate a French version of the scale in a 
sample of patients (N=342) considering taking a genetic test for breast and 
ovarian cancer. (Mancini et al., 2006) The DCS is described here as having 16 
items that form 5 subscales: uncertainty, uninformed, unclear values, 
unsupported and ineffective choice. Of the respondents, 294 were patients 
with controls brining the total to 560. For internal consistency, the Cronbach's 
alpha obtained for the whole scale and subscales ranged 0.67 to 0.916, with the 
exception of 0.441 to 0.593 for the unsupported subscale. Exploratory and 
confirmatory factor analyses were performed in two control groups and the 
intervention group, with results varying between a four and five factor model. 
The authors conclude that the factorial structure of the DCS is dependent on 
the level of conflict involved in the decision. Criterion validity was tested by 
the relationship between the DCS score and whether a decision was made. For 
the control groups, the DCS score was significantly lower in those who wanted 
to have the test, but there was no statistically significant difference in the 
intervention group. However, as only three of the patients in the intervention 
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group were categorised as uncertain about the decision, the small numbers 
may have influenced the statistical significance obtained. Three items were 
identified as having unacceptable levels of item difficulty – “this is an easy 
decision to make”, “I am clear about how important the advantages are to me 
in this decision” and “I have the right amount of support from others in 
making this choice”. 
 
The study by Song and colleagues evaluates the use of DCS in a trial of a 
patient-centred advance care planning intervention. (Song and Sereika, 2006) 
The DCS is described here as having three subscales (uncertainty, factors 
contributing to uncertainty and decision effectiveness) with 16 items. The 
study uses combined data from two trials, where 59 participants were recruited 
from the 95 approached. For internal consistency, a Cronbach’s alpha of 0.81 
was obtained for the complete scale, and ranged from 0.50-0.73 for the 
subscales, with item to total correlation weakest for uncertainty items and one 
“contributing to uncertainty” factor item. Removing these raised the 
Cronbach's alpha for the complete scale to 0.84. For construct validity, 
Spearman correlation coefficients were obtained for the DCS and Quality of 
Communication questionnaire (r=-0.44, p = 0.001), and the DCS and anxiety 
rating (r=0.47, p=0.006), while the correlations varied for the DCS subscales. 
For discriminant construct validity, a statistically significant difference was 
found between the control and intervention groups.  
 
Knapp and colleagues sought to validate the properties of both the DCS and 
COMRADE for the parents of children with life-limiting illness involved in 
paediatric palliative care programmes. (Knapp et al., 2009) A sample of 936 
was contacted and 266 completed surveys returned. For internal consistency, 
the Cronbach's alpha was over 0.84 and confirmatory factor analysis indicated 
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that the original structure of the DCS persisted in this context.  Floor and 
ceiling effects were considered. Item-domain convergent/discriminant validity 
analysis, used to assess congruence between an item and its domain, was 
supported for two of the three domains and tests for known-group construct 
validity were statistically significant (p<0.001 and P<0.05).  
 
Katapodi and colleagues evaluated a modified DCS for decisions concerning 
genetic testing for hereditary breast and ovarian cancer. (Katapodi et al., 2011) 
The scale items were reworded to reflect a genetic testing decision and positive 
phrasing used. From a sample of 372, 354 scales were completed. Factor 
analysis for inter-item correlation was preformed, producing two new subscales 
from the items with one remaining subscale unchanged. A Cronbach's alpha of 
0.96 was obtained for internal consistency. Convergent and divergent validity 
were tested with other scales (r=-1.3 to r=-.31, p<0.05-.001) and (r = -0.30, 
p <0.01) respectively, predictive validity using risk reduction prophylaxis (r= 
0.24, p<.001) and contrast validity with known-group approach (p<.001). 
 
A study by Linder and colleagues evaluated a low literacy version of the DCS 
(DCS-LL). (Linder et al., 2011) The scale was adapted for ordered category 
responses, with the effective decision subscale omitted and an item removed 
from each of the remaining subscales. The reliability and validity of the DCS-
LL was evaluated before and after the use of a prostate cancer screening 
decision aid. The study had 149 participants before the intervention and 89 
afterwards. For internal consistency, a Cronbach's alpha of 0.80 was obtained 
and ICCs ranged from 0.246-0.748. An adequate model fit was found with 
factor analysis at baseline but not at follow up, with subsequent exploratory 
factor analysis suggesting a three rather than four factor model. Construct 
validity was evaluated using subscale correlation, with a good correlation was 
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noted for two of the three “uncertainty” subscales but poor correlation for the 
“supported” subscale. Discriminatory validity was based on whether a decision 
was made, and reported as statistically significant. There is uncertainty over 
which subscales are used in the study and some subscale data are removed 
from the statistical analyses. 
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Table 13: Summary of further evaluation studies for the DCS 
First	author,	
year	
	
Reliability	 Validity	
Koedoot,2001	
	
Internal	consistency	-	Cronbach's	alpha	
obtained	for	the	three	subscales	in	both	
groups	(0.61-0.75,	0.77-0.80,	0.83-0.81)	
and	for	the	overall	scale	in	both	groups	
(0.75-0.82).	
Mixed	results	from	the	two	participant	
groups	for	construct	and	criterion	validity.		
Mancini,	
2006	
(Mancini	et	
al.,	2006)		
Internal	consistency	-	Cronbach's	alpha	
obtained	for	the	whole	scale	and	
subscales	ranged	0.67	to	0.916,	with	the	
exception	of	0.441	to	0.593	for	the	
unsupported	subscale.	
Criterion	validity	and	factor	analysis	
outcomes	varied,	depending	on	whether	the	
groups	were	patients	or	controls.		
Song,	2006	
	
Internal	consistency-	Cronbach’s	alpha	
of	0.81	for	the	complete	scale,	ranging	
from	0.50-0.73	for	the	subscales,	with	
item	to	total	correlation	weakest	for	
uncertainty	items	and	one	contributing	
factor	item.	Removing	these	raised	the	
complete	scale	Cronbach's	alpha	to	
0.84.	
Construct	validity:	Spearman	correlation	
coefficients	were	obtained	for	the	DCS	and	
Quality	of	Communication	questionnaire	
(r=-0.44,	p	=	0.001),	DCS	and	anxiety	rating	
(r=0.47,	p=0.006),	with	varying	correlation	
between	the	subscales.	Scale	able	to	
discriminate	between	control	and	
intervention	group.	
Knapp,	2009	
	
Internal	consistency:	Cronbach's	alpha	>	
0.84.	
Known-groups	validity	statistically	
significant	(p<0.001	and	P<0.05).	
Katapodi,	
2011	
	
Internal	consistency:	Cronbach's	alpha	
of	0.96		
Convergent	(r=-1.3	to	r=-.31,	p<0.05-.001),	
divergent	(r	=	-0.30,	p	<0.01),	predictive	(r=	
0.24,	p<.001)	&	contrast	(p<.001)	validity	
were	tested.	
Linder,	2011	
	
Internal	consistency:	ICCs	ranged	from	
0.246-0.748	and	a	Cronbach's	alpha	of	
0.80	obtained,	although	this	involved	
excluding	the	supported	subscale.	
Discriminatory	validity	was	based	on	
whether	a	decision	was	made,	and	reported	
as	statistically	significant.	
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5.2.2 The Satisfaction with Decision Scale (SWD) 
5.2.2.1 Descriptive features. 
The Satisfaction with Decision (SWD) scale was developed to evaluate a 
decision-support intervention for hormone replacement therapy (HRT), 
although the scale was kept independent of a specific medical context. 
(Holmes-Rovner et al., 1996) It was intended both as an outcome measure and 
to provide insight into influences on treatment compliance.  
 
The scale measures global satisfaction with a decision, and three attributes of 
effective decision-making based on those outlined by O’Connor in the DCS 
scale. (O'Connor, 1995) It is intended for use after a decision is made, but 
before any consequences have occurred. The six items use a five point Likert 
scale. It is self-administered and requires an 8th grade reading level. A higher 
score is associated with higher decision satisfaction.  
 
The scale was piloted in a convenience sample of female university staff 
(n=120). For further evaluation, community volunteers wishing to gain 
information on menopause management were recruited via the local press into 
a randomised intervention trial (n=252). Three methods of decision support 
were included in the trial - brochures, lecture-discussion or individual. 
Participants were followed for twelve months and were noted by the authors 
“more likely to be white, college educated and [with] relatively high household 
income”. (Holmes-Rovner et al., 1996) As the intervention concerned was 
specifically concerned with the menopause, 58% of the participants were still 
menstruating, while 59% had menopausal symptoms either before or at the 
time of the study.  
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5.2.2.2.Methodological quality 
Table 14 outlines the measurement properties evaluated in the SWD scale 
development study.  
 
Table 14: SWD development study mapped against the COSMIN checklist for 
methodological quality 
COSMIN	methodological	quality	 Evaluated	in	SWD	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
Internal consistency is termed reliability in this study. Though a Cronbach’s 
alpha was calculated for each subscale separately, no factor analysis or other 
test of unidimensionality was performed. Three items were dropped at pilot 
stage due to poor internal consistency, with two more eliminated as they were 
considered condition specific and unsuitable for a generic scale. The sample 
sizes for both the pilot and main study were adequate in accordance with the 
COSMIN grading, at over a 100 or the number of items multiplied by seven (7 
x 6 = 42). (Mokkink et al., 2012) The number of missing or incomplete items 
was given for the main study but not the pilot, with no information provided 
on how such items were processed.   
 
Consideration of measurement error is only mentioned when the attributed 
variance is removed from a comparison of the correlation between SWD, DCS 
and Health Status Restriction (HSR) scales. 
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For content validity, although the theoretical foundations for the scale are 
addressed, it is not reported whether the items were chosen to reflect all 
aspects of the underlying construct, the target population or the intended 
purpose of the instrument. While the use of the scale as a predictive measure 
for decision uncertainty is evaluated, this is not clearly indicated in the initial 
aims of the study.  
 
The four of the six hypotheses to be tested were reported a priori, with the 
predicted direction of any supporting correlation given. Limited information 
was provided about the comparator scales. In particular, several of the 
measures were developed within the study, with no detail given as to the 
development process or of their validity and reliability. While a good response 
rate is noted for the SWD scale, no information is provided for the comparator 
measures. No information was provided of the correlation coefficient used, 
making its interpretation challenging.  The use of p-values is also questionable, 
as the direction and size of any correlation is considered of greater relevance. 
(Mokkink et al., 2012) 
 
Though the study was concerned with the evaluation of decision support, there 
was no pre-intervention exploration of decision intention or administration of 
the scales. As such, the responsiveness of the SWD was not evaluated.  
 
Limited information is provided to give context to the scores obtained by the 
SWD scale. While the mean and standard deviation of the scores are given, 
interpretability would be aided by the proportion of respondents achieving the 
highest and lowest score, subgroup analysis and consideration of MIC or MID. 
(Mokkink et al., 2012) 
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The study participants are noted to be largely homogenous in terms of 
ethnicity, education and income, and were by necessity restricted in age and 
sex due to the condition of interest. However, this carries consequences for the 
generalisability of a scale intended for use as a generic measure of decision-
making.  
 
5.2.2.3. Instrument quality 
Table 15 details the measurement properties evaluated for the SWD scale.  
 
Table 15: SWD development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	SWD	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
Principal component analysis is described rather than factor analysis, although 
it is used to assess discriminant construct validity of the SWD in comparison 
with the DCS and HSR measures, rather than to evaluate of the 
unidimensionality of the scale. The Cronbach’s alpha of 0.88 for the pilot and 
0.86 for the main study suggests an acceptable level of internal consistency. 
(Terwee et al., 2007)  
 
The quality of the content validity is limited by the lack of clear description 
concerning item development and target population involvement. Construct 
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validity is supported by four specific hypotheses with concordant results, 
although not all of these were clearly outlined a priori. Interpretability is 
hampered by the absence of a MIC and subgroup analysis.  
 
5.2.2.4. Further evaluation studies 
The SWD scale had been cited 8 times by the end of 2014, as identified using 
Web of Science. One study met the eligibility criteria. Wills and Holmes-
Rovner evaluated the use of the SWD scale in a sample of 97 depressed 
primary care patients, who were undertaking a new decision about 
antidepressant medication. (Wills and Holmes-Rovner, 2003) The wording of 
the scale was adapted for a decision concerning anti-depressant medication. 
The internal consistency was evaluated and a Cronbach's alpha of 0.85 
obtained. The presence of significant correlations with other scales for 
knowledge, conflict and depression were used to assess construct validity. 
With the exception of the relationship with a scale for depression, all 
correlations were statistically significant.  
 
5.2.3. Decision Attitude Scale (DAS) 
5.2.3.1 Descriptive features 
The Decision Attitude Scale (DAS) is intended to measure the perceived 
quality of both the process and outcome of decision-making. (Sainfort and 
Booske, 2006) In the development study, the decision of interest concerned 
healthcare plans, with further trials intended to study the impact of varying 
amounts of information on the decision-process. A decision about health plans 
was selected by the authors due to it being “complex, value-laden with 
uncertain long term outcomes”. 
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The scale contains ten items, two for each of the five separate subscales listed 
below: 
• Evaluative attitude for decisional process 
• Feelings about decisional process 
• Behavioural attitude for decisional process 
• Evaluative attitude for final choice 
• Feelings about final choice 
Each item is graded using a five point Likert, with a higher score on any item 
corresponding to a positive attitude towards the decision process and outcome. 
The scale is intended for completion immediately after the decision is made. 
Initially piloted on paper, the scale used in the trial was computerised.  
 
The development trial involved 197 employees of the State of Wisconsin, 
which provides health insurance with a variety of health plan options. The 
average age of the participants was 44, 63% were female and most were well 
educated with a high reported household income. 56.7% had been employed by 
the State of Wisconsin for over 10 yrs. The group was chosen due to their 
experience of health plan evaluation.  
 
5.2.3.2 Methodological quality 
The following measurement properties were evaluated in the development 
study: 
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Table 16: Decision Attitude Scale development study mapped against the 
COSMIN checklist for methodological quality  
COSMIN	methodological	quality	 Evaluated	in	DAS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 Yes	
Interpretability	 Yes	
Generalisability	 Yes	
 
The sample size is considered adequate for calculations addressing internal 
consistency by the COSMIN standards. (Mokkink et al., 2012) No account is 
given for missing or incomplete items, nor any detail for how such items would 
be handled. Factor analysis was performed, with one item subsequently 
excluded as it was considered to be in opposition to the others. Cronbach’s 
alpha was calculated, but not for the individual subscales - as these contained 
only two items each, a correlation was felt to provide more information.  
 
For content validity, the authors considered whether the scale sufficiently 
covered the theoretical foundation, although no detail was given for item 
development or target population involvement. For construct validity or 
hypothesis testing, supporting theories were outlined a priori, with the 
direction of the expected relationship described though not the magnitude. The 
authors predicted that “decision attitude [would be] better for individuals able 
to choose than those unable to choose”. (Sainfort and Booske, 2006) An f-
value was calculated, although this is a measure of statistical significance 
rather than a true value for correlation. In addition, only values for the 
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subscales are given rather than for the whole scale, and not all participants 
were given all subscales.  
 
For responsiveness, two measurements were taken either side of a decision 
support intervention. However, no clear time interval and consideration of 
external influences on the participants during this period are described. No 
comparator instrument or gold standard was used, though a clearly stated 
hypothesis was given as to the predicted impact of the intervention of the 
Decision Attitude Scale score. Only analysis results were provided with a focus 
on subscale scores, with no underlying data or complete scale evaluation.  
 
Interpretability is aided by the subgroup details provided, along with the mean 
and standard deviation scores for the scale. Highest and lowest scores are 
referred to but insufficient detail provided, such as the proportions of 
participants and the overall distribution of scores in the sample. No MIC or 
MID is given, with the actual difference in subscale scores often very small.  
 
Evaluating the generalisability of scale is aided by the demographic and setting 
details provided. However, insufficient information is given for the sampling 
strategy, which is described as being an “appropriate random sample of 
respondents”, but acknowledged as “…..not [being] representative of general 
population but chosen as [they] had experience in health-plan decisions”. 
(Sainfort and Booske, 2006) In addition, it is unclear how many declined to 
participate or failed to fully complete the intervention and evaluation.  
 
	  68 
5.2.3.3. Instrument quality 
The following table outlines the measurement properties evaluated for the 
Decision Attitude Scale in comparison to those outlined by the quality criteria 
(Terwee et al., 2007): 
 
Table 17: Decision Attitude Scale development study mapped against the 
quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	DAS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 Yes	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
Factor analysis demonstrated a three-factor scale with one overall dimension, 
and the sample size was adequate by COSMIN standards. The Cronbach’s 
alpha for the complete scale was 0.86, within recommended parameters for 
internal consistency. For the subscales, that for the first factor, satisfaction 
with choice, had a Cronbach’s alpha of 0.83. The subscale for usability of 
information had a correlation coefficient (r) of 0.64, while that for adequacy of 
information measured 0.49.  Correlation coefficients were used here instead of 
a Cronbach’s alpha as these subscales contained only two items. 
 
The content validity of the scale is impaired by uncertainty over how the items 
were developed and who was consulted during this process. For construct 
validity, while four hypotheses are proposed, results are given for only one 
subscale, with these providing variable degrees of support for the relationships 
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expected to exist should the construct tested be accurately represented. 
(Terwee et al., 2007) 
 
Doubtful design or method is used for the responsiveness, as none of the 
recommended statistical analyses such as MIC or area under the curve (AUC) 
calculations are used. (Terwee et al., 2007) In addition, the method is not 
reproducible and does not address external sources of bias. The absence of MIC 
also impacts on the interpretability of the results, despite the mean scores and 
subgroup analysis reported.  
 
5.2.3.4. Further evaluation studies  
The Decision Attitude Scale was cited 12 times by the end of 2014, when 
checked using Web of Science. No further evaluation studies meet the 
eligibility criteria.  
 
5.2.4. Preparation for Decision-Making scale (PrepDM) 
5.2.4.1. Descriptive features. 
The PrepDM scale is intended to evaluate the patient’s perception of how 
useful a decision aid is in supporting decision-making and communicating with 
a health professional. (Bennett et al., 2010) This study focuses specifically on 
evaluating the PrepDM scale, preceding its use in evaluating support for 
decisions concerning HRT, prostate cancer and breast cancer prevention 
options.  
 
The scale contains ten items, and is self-administered. It is completed before 
and after the intervention. A higher score indicates a higher perceived level of 
preparedness for decision-making. 
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The study evaluates the scale in a sample of patients who were referred by 
orthopaedic healthcare providers for decision support, which took the form of a 
condition-specific decision aid delivered in a rural academic medical centre. 
Consecutive consenting patients were recruited from clinics.    
 
A total of 400 people participated from the 966 referred, with a mean age of 
57.3 years, and 55% were female. By orthopaedic condition, 127 of the 
participants were diagnosed with spinal stenosis, 42 knee osteoarthritis (OA), 
105 herniated discs, 94 with chronic lower back pain and 32 hip OA. 
 
5.2.4.2. Methodological quality 
The Item Response Theory (IRT) approach to scale development was used in 
this study, differing to the Classical Test Theory (CCT) encountered so far. 
Both are methods of developing a measure and detailing its psychometric 
properties. (Streiner and Norman, 2008) CCT provides mainly scale-level 
information for the test sample. While its use is less dependent on pre-set 
assumptions, CCT exhibits “circular dependency” as the psychometric values 
obtained for the scale are dependent on both the test sample and measure as a 
whole. (Streiner and Norman, 2008) As such, subsequent scale application and 
interpretation are influenced by the original sample group and perceived item 
equivalence, where each item is considered to have the same properties.  
(Streiner and Norman, 2008) In comparison, IRT focuses instead on item-level 
information. It equates the probability of a specific item response to individual 
participant performance, and mathematically models the relationship between 
different levels of the examined trait and item scores. (Streiner and Norman, 
2008) As such, the models can be used to explore test performances for 
particular levels of a trait, and visa versa. (Streiner and Norman, 2008) The use 
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of IRT is dependent on two main assumptions being met, which are 
unidimensionality, where the items measure only one construct, and item 
independence.  (Streiner and Norman, 2008) 
 
Additional standards are provided by COSMIN for studies using IRT. 
(Mokkink et al., 2012) In accordance with these, the model used in PrepDM 
evaluation was described as partial credit. However, it is unclear which 
computer software package was used or the estimation method applied. In 
addition, of the assumptions required for the IRT model, only 
unidimensionality is clearly accounted for.  
 
The following measurement properties were evaluated in the development 
study: 
 
Table 18: PrepDM development study mapped against the COSMIN checklist 
for methodological quality  
COSMIN	methodological	quality	 Evaluated	in	PrepDM	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
When considering the methodology for internal consistency, no information 
was given on the proportion of missing items or on how these were then 
handled. The sample size was adequate for the internal consistency calculation 
at 400, although some of the subgroup samples fall below the recommended 
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standard of 100 or (7x number of participants). (Mokkink et al., 2012) Internal 
consistency was checked for each subscale, with an alpha correlation 
calculated. For IRT, COSMIN recommend the calculation of a goodness of fit 
statistic at a global level, such as a chi-squared statistic, to compare the actual 
and expected response patterns. This is not evident in this study. Although a 
test reliability score is calculated, no additional information is provided on how 
this was produced.  
 
The theoretical grounding for content validity is clearly reported, with items 
matched to the stages of the International Patient Decision Aid Standards 
(IPDAS) decision quality criteria and there is consideration of whether all 
aspects of the construct are addressed. However, the development does not 
seem to include the target group and the report lacks clarity for how the new 
items are produced. 
For hypothesis testing or construct validity, the majority of the hypotheses 
were formulated a priori, with the direction but not magnitude of correlations 
predicted. However, the hypothesis for the DCS is not explicitly stated.  
Limited details are given for the comparator instrument, the DCS, though this 
may be due to word count restrictions. In addition, no information is given to 
verify the stage of decision-making questionnaire used. The statistical methods 
used to test the hypothesis are correlation coefficients, along with p-values.  
 
Though pre and post intervention measurements were taken there is no clear 
description of evaluating responsiveness. For interpretation, the distribution of 
the scores in the sample is described, with values also given for each diagnostic 
subgroup. The proportions with the highest and lowest scores are not given, 
focusing instead how well the items discriminate between low and high levels 
of decision preparedness. The MIC and MID are not determined.  
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For evaluating generalisability, the mean age and sex of the participants are 
described, though there is no standard deviation for age, and other 
demographic details such as socioeconomic group and education level are 
absent. Limited detail is given for disease characteristics and the full setting of 
the study.  Further information is also needed about the participant 
recruitment process, as there is potential for bias in the referral for a decision 
aid. No information is given about non-returned questionnaires and the 
characteristics of the non-responders, who accounted for more than half of 
those who gave their consent at clinic.  
 
5.2.4.3. Instrument quality 
The measurement properties produced by the study for the PrepDM are 
mapped against the quality criteria below. (Terwee et al., 2007) 
 
Table 19: PrepDM development study mapped against the quality criteria  
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	PrepDM	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 Yes	
Interpretability	 Yes	
 
For internal consistency, the diagnostic subgroups had Cronbach’s Alpha 
ranging from 0.92 to 0.96. The higher value falls above the recommended value 
range, suggesting there may be redundancy among items. (Terwee et al., 2007) 
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It is unclear which results belong to each diagnostic subgroup. The item-total 
values range from 0.75 to 0.81 for each subgroup, within the quality criteria 
range. (Terwee et al., 2007) The sample of 400 is divided into five patient 
groups numbering from 32 to 127, which diminishes the power for statistical 
analysis. (Terwee et al., 2007) Little detail is given for the evaluation of 
reliability, though the total test reliability calculated is high at 0.944 
 
Limited information is provided in support of content validity, such as 
describing item development and target population involvement. For construct 
validity, a priori hypotheses are described for only some of the outcomes, 
though there is full congruence between the PrepDM and the proposed 
construct markers.  
 
While poor reliability is described at extreme scores there is no clear 
discussion of floor and ceiling effects, such as proportions and numbers. For 
interpretability, mean scores with their standard deviation are provided for 
diagnostic subgroups. The IRT analyses suggest good discrimination values for 
the items, with the scale measuring well across all but the extremes of 
readiness for decision-making. No MIC is provided.  
 
5.2.4.4. Further evaluation study 
The PrepDM scale had been cited 20 times by the end of 2014, as identified 
with the Web of Science. No eligible further evaluation studies for the PrepDM 
were identified.  
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5.2.5. The Shared Decision-Making Questionnaire (SDM-Q) 
5.2.5.1. Descriptive features 
This scale was developed following a research consortium on shared decision-
making in Germany from 2001 to 2005. (Simon et al., 2006) A total of ten 
projects explored shared decision-making interventions in different clinical 
scenarios, including breast cancer and hypertension. Pre-existing measures 
were found to have poor psychometric rating on translation into German.  A 
new instrument was therefore developed, intended to explore “patient 
preferences for information and participation as well as the process and 
outcome of decision-making”. (Simon et al., 2006)  
 
The original self-administered scale had 24 items, nine of which were 
dichotomous and fifteen used a four point Likert scale. The measure was to be 
completed immediately after a consultation. 
 
Set in both primary and secondary care, 773 participants were recruited with 
32 excluded as their responses missed out over 30% of the scale. For the 
general practice consultations, decisions involved medical management (n = 
210) or treatment for depression (n = 230). In secondary care, urology patients 
(n = 66) completed a score following a consultation concerning non-
emergency surgery, the gynaecology clinic patients (n = 111) considered a 
decision regarding in-patient treatment for breast cancer and the anaesthetic 
consultations (n = 156) covered preparation and discussion of analgesia for 
several forms of non-emergency surgery. The participants had a mean age of 
51.9 years with a standard deviation of 16, 59.1% were female and 66% had 
received higher education.  
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5.2.5.2. Methodological quality 
The Item Response Theory (IRT) model was utilised in this study. Applying 
the COSMIN standards, the model used was clearly described as the partial 
credit model and the software identified as Winsteps, although the method of 
estimation used within the model (such as conditional maximum likelihood or 
marginal maximum likelihood) is not fully described. (Mokkink et al., 2012) 
The assumptions required for the IRT model including unidimensionality, local 
independence and item fit were checked.  
 
Table 20 outlines the measurement properties evaluated in the SDM-Q 
development study, with the COSMIN checklist for methodological quality 
then applied to each. (Mokkink et al., 2012) 
 
Table 20: SDM-Q development study mapped against the COSMIN checklist 
for methodological quality  
COSMIN	methodological	quality	 Evaluated	in	SDM-Q	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
 
In assessing the evaluation of internal consistency, a clear description is given 
of the number of missing items and how these were subsequently dealt with. 
Participants were excluded if the scale was more than 30% incomplete (n=32). 
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Of the remaining participants, fewer than 5% of items were incomplete and 
these were handled using multiple imputation. The total sample size was 
adequate for testing internal consistency, but not in the subgroups as one 
contained only 66 participants. (Mokkink et al., 2012) A goodness of fit 
statistic, in-fit mean square, was calculated to assess for items disrupting the 
unidimensionality of the scale, and reliability values for person and item 
parameters.  
 
For content validity, a clear account is given of the theoretical foundation and 
expert involvement in item development. Consideration was given to construct 
coverage and the target population were involved. There is a lack of clear, a 
priori hypotheses for the construct validity, with little detail given for the 
comparator instruments. Correlation coefficients are used to test the 
hypotheses.  
 
Interpretability of the scale is aided by the use of IRT to evaluate score 
distributions, person fit and differential item functioning among different 
patient subgroups. Additional information concerning the MIC would have 
added further clarity. Applicability of the scale in other populations, or 
generalisability, can be judged using the clear description of the study setting 
and participant demographics provided. However, the IRT model revealed poor 
scale parameters in the urology subgroup, which was subsequently removed 
from further analysis. This limits the generalisability of the scale, a concern 
further exacerbated by the limited detail given for participant sampling, 
recruitment, and the characteristics of non-respondents. 
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5.2.5.3. Instrument quality 
Table 21 maps the measurement properties for the SDM-Q against quality 
criteria developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 21: SDM-Q development study mapped against the quality criteria  
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	SDM-Q	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 IRT	equivalent	
Interpretability	 Yes	
 
 
Four items were discarded due to poor fit with the overall scale and underlying 
construct, the remaining items having item-fit measures of 0.78-1.14. As 
described above, IRT methods mathematically model the relationship between 
different levels of the examined trait and item scores. (Streiner and Norman, 
2008) A reliability score of 0.77 was obtained for the person parameters and 
0.95 for item parameters, with Winsteps software guidance indicating that the 
person reliability is equivalent to the traditional test reliability. (Winsteps 
Software, 2014) 
 
Content validity is well covered, with clear descriptions of measurement aims, 
consideration of construct coverage and involvement of expert and target 
population in the development of the scale. Construct validity is less well 
covered, with a clear a priori hypothesis generation lacking and low correlation 
values between SDM-Q and the comparator scales.  
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While interpretability is aided by subgroup analysis, further detail such as the 
MIC would have further enhanced this measurement property. (Terwee et al., 
2007) The IRT analysis for participant responses indicates only 29.8% of the 
participants completed the scale in a pattern consistent with its proposed 
model. Differential item functioning suggests a high variation between 
subgroups in the interpretation and answering of items. The distribution of 
person and item fit parameters do not complement each other, with a high 
ceiling effect noted for person parameters. The latter suggests that items of 
higher difficulty are needed to differentiate between individuals reporting 
greater shared decision-making.  
 
Overall, the authors conclude that the scale was designed to cover too much, in 
view of the broad aims of measuring patient preference as well as the process 
and outcome of decision-making. (Simon et al., 2006) 
 
5.2.5.4. Further evaluation studies 
The SDM-Q study had been cited 34 times by the end of 2014, as checked with 
the Web of Science. One study was identified for the further development of 
the SDM-Q. This produced a new scale, SDM-9. (Kriston et al., 2010) 
However, this was not eligible for inclusion as it was a measure of the extent of 
SDM in a consultation, rather than decision-making process from the patient 
perspective.  
 
5.2.6. The SURE scale 
5.2.6.1. Descriptive features 
The SURE scale was developed as a rapid screening test for decisional conflict, 
styled on the CAGE alcohol dependency tool. (Légaré et al., 2010a) The latter 
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uses four questions to determine the extent of alcohol consumption. The 
SURE scale includes four dichotomous items based on the core concepts of the 
Ottawa Decision Support Framework, with the exception of decision 
effectiveness as this was not considered applicable to all stages of decision-
making. The test is self-administered in a paper format. A score of less than 
four indicates decisional conflict.  
 
The scale was developed in French and English. For the French version, the 
participants were pregnant women recruited from four family medicine groups 
in Quebec City. The scale was administered after the first prenatal 
consultation, during which screening for Down’s Syndrome was discussed. 
Those at high risk of a Downs’ syndrome were excluded from the study. From 
the 180 women approached, 148 were recruited with 21 found to be ineligible 
and 11 declining. The participants did not reflect a broad range of educational 
backgrounds, as 96% had some college education, a high school diploma or 
higher. Response rates for the included scales varied, with 141 participants 
completing the DCS and 123 completing the SURE scale.  
 
For the English version, participants were recruited from a rural academic 
medical institution. The scale was administered after the use of a decision aid, 
which concerned decisions relating to a broad variety of medical conditions 
such as musculoskeletal conditions, prostate and breast cancer. While 1474 
patients completed the scale, there was a poor response rate as only 34% 
completed and returned the questionnaire. Of these 1474 participants, 52% 
were women and 93% had received some college education, a high school 
diploma or higher.   
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5.2.6.2. Methodological quality 
Table 22 outlines the measurement properties evaluated in the SURE 
development study, with the COSMIN checklist for methodological quality 
then applied to each. (Mokkink et al., 2012) 
 
Table 22: SURE development study mapped against the COSMIN checklist for 
methodological quality 
COSMIN	methodological	quality	 Evaluated	in	SURE	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 Yes	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
For the French version of the scale, 25 of 148 questionnaires were incomplete 
and therefore excluded. Although only 34% of the English version of the scale 
were completed and returned, it is unclear how many of the scales were 
incomplete. There is also limited information about which items were 
incomplete and whether this varied between the versions of the scale. For 
internal consistency, the unidimensionality of the scale was tested with factor 
analysis, and a Cronbach’s Alpha calculated. Intra-rater reliability was not 
evaluated as the authors felt that decisional conflict represented a “state rather 
than a trait”, rendering this measurement property inappropriate. (Légaré et 
al., 2010a)  In addition, the self-administered nature was felt to preclude inter-
rater reliability. 
 
	  82 
When evaluating the content validity, limited information is given concerning 
how the items were developed. The scale is based on four core aspects of the 
Ottawa Decision Support Framework, and was tested on experts and graduate 
students taking a clinical course in decision support. However, there is no 
discussion of the involvement of the target population or of the adequacy of 
construct coverage.  
 
For the hypothesis testing, the authors believed that the score would 
discriminate between those who were able to make a decision about treatment 
options and those who could not. However, a clear a priori hypothesis is 
lacking, as is a predicted magnitude and direction for the relationship. A t-test 
was used rather than the recommended correlation coefficient. While the 
authors specify the comparison of SURE with the DCS as a measure of 
criterion validity, little evidence is given to support the use of the DCS as a 
gold standard. (Mokkink et al., 2012) The COSMIN standards also state that 
only the original version of shortened scales can be used as a gold standard for 
patient reported outcomes. (Mokkink et al., 2012) Only the French version of 
the scale is tested against the DCS, limiting the extrapolation of these findings 
to the English version of the scale. In addition, the sample size for this 
property is small, with only 148 participants in comparison with 1474 for the 
English scale. There was a higher response rate for the DCS in comparison 
with the SURE scale (141 versus 123 respectively), despite the latter being 
shorter.  
 
Facets of interpretability are clearly described, with details given for score 
distribution, proportions achieving the highest and lowest scores and a 
threshold level for clinical significance. Generalisability of the score can be 
evaluated, as clear demographic details are provided along with the context for 
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the decision considered and a description of the convenience sampling method 
used. This could have been further improved by including details such as 
socioeconomic status and ethnicity. In addition, the response rates of 34% for 
the English SURE and 82% for the French SURE may indicate a responder 
bias, as it is feasible that the non-responders might be experiencing greater 
decisional conflict. Limited information is given about the non-responders.    
 
5.2.6.3. Instrument Quality 
Table 23 maps the measurement properties for the SURE scale against quality 
criteria developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 23: SURE development study mapped against the quality criteria  
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	SURE	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 Yes	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 Yes	
Interpretability	 Yes	
 
 
The factor analysis for the French version of the SURE scale indicated that the 
items loaded on two factors or constructs rather than being unidimensional. 
The first factor was knowledge, value and certainty, with the second described 
as support. Furthermore, the support item negatively correlated with the other 
factor and poorly correlated with the overall score. This version of the scale had 
a Cronbach’s alpha of 0.54, which lies outside the recommended range of 0.70 
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and 0.95. (Terwee et al., 2007) The factor analysis for the English SURE found 
that the scale was unidimensional, with all items loading onto one factor. For 
this version of the scale, one factor accounted for 49% of the variance. A 
Cronbach’s alpha of 0.65 was obtained, which is also below the recommended 
range. (Terwee et al., 2007) 
 
Content validity is impeded by the lack of target population involvement in the 
development of the items. For construct validity, only a partial hypothesis was 
constructed a priori and it was difficult to judge whether 75% of the results 
were in concordance with this, as recommended by the quality criteria. 
(Terwee et al., 2007) There was little evidence provided to support the use of 
the DCS as a gold standard, and the correlation between the DCS and SURE 
was moderate at r = -0.46. (Terwee et al., 2007) 
 
For interpretability, a threshold score indicating decisional conflict was 
suggested, though not a minimal important change (MIC) or grading of the 
scores in relation to degrees of conflict. For the French SURE, 85% of 
respondents had the highest score while only 1% scored the lowest possible. 
For the English SURE, 67% had the highest score while 1% had the lowest. 
There is a heavy bias evident for scoring highly on this scale, with few of the 
respondents reporting scores consistent with decisional conflict.  
 
5.2.6.4. Further evaluation studies 
This scale has been cited 9 times, as identified using a Web of Science search at 
the end of 2014. The only eligible further evaluation study was by Ferron 
Parayre and colleagues in 2014. (Ferron Parayre et al., 2014) Further 
evaluation of the SURE scale is performed using data from a clustered 
randomised trial of a decision aid for the use of antibiotics in treating acute 
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respiratory tract infections (RTI). Patients diagnosed with an acute RTI, where 
either the patient or clinician had considered the use of antibiotics, were 
recruited from family practice teaching units. Of the 712 patients recruited, 
654 completed both SURE & DCS. The patients recruited were mostly women 
(64%), adult (71%), in employment (72%) and had received higher education 
(60%).  
 
Internal consistency of the SURE scale was evaluated using a Kuder-
Richardson 20 coefficient, which was calculated as 0.70 and considered 
adequate by authors. The DCS and SURE scores were compared using the 
Spearman correlation coefficient.  A moderate negative association was 
suggested with a correction coefficient of -0.45, with a statistically significant 
p-value of less than 0.0001. Using the SURE scale, decisional conflict was 
defined as a score of 3 or less. The sensitivity and specificity of the scale in 
detecting decisional conflict was then evaluated using DCS scores. A sensitivity 
of 94.3% was obtained, with a 95% confidence interval of 78.9 to 99.0% and 
specificity of 89.8%, with a 95% confidence interval of 87.1 to 92.0%. Two 
weeks later, the participants were evaluated for decisional regret, adherence to 
decision and attendance for further consultation. While a correlation was noted 
between decision regret and decision conflict as measured using the SURE 
scale, adherence to decision and re-consultation rates did not correlate with 
SURE scores. Sensitivity did not change with gender, clinician exposure to 
decision aid and did not differ with decision outcome. Overall, the evaluation 
approach taken for this study concerned screening more than the psychometric 
properties of a measure.  
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5.2.7. The COMRADE scale 
5.2.7.1 Descriptive features 
The COMRADE scale was developed to measure both risk communication and 
the effectiveness of decisions made during consultations. (Edwards et al., 
2003) The scale is self-administered and intended for completion after the 
consultation. It contained 43 items at first testing, with higher scores 
indicating a better outcome from the consultations.  
 
A pilot was carried out in five South Wales general practices, with the 
subsequent trial recruiting from twenty practices in urban, semi-rural and rural 
settings. The study formed part of a larger trial of risk communication and 
shared decision-making interventions for doctors in the UK, and the decisions 
concerned prostatism, atrial fibrillation, menorrhagia and menopausal 
symptoms. The pilot had 72 participants, with a mean age of 45.9 years with 
51% female participants. For the trial, consent was obtained from 1135 
patients, 43.9% of those approached. Of these, 960 were randomly selected and 
invited to attend an appointment. The participants had a mean age of 59 years 
and 58.8% were female. There were 335 non-attenders for the allocated 
appointments. This group had a younger mean age and a higher proportion of 
women. The trial was divided into three data collection points: baseline, first 
intervention and second intervention phases. Weekly reminders were sent out 
to encourage return of the questionnaires. In total, 715 (95.7%) of 
questionnaires were returned. From the baseline stage of the trial, 133 of 197 
(67.5%) of the full 43 item questionnaires were complete. 
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5.2.7.2. Methodological quality  
The following section outlines the measurement properties evaluated for the 
COMRADE scale, with the COSMIN checklist for methodological quality 
applied to each. (Mokkink et al., 2012) 
 
Table 24: COMRADE development study mapped against the COSMIN 
checklist for methodological quality  
COSMIN	methodological	quality	 Evaluated	in	COMRADE	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
In evaluating internal consistency, clear descriptions are given of the number of 
missing items, and how these were handled during statistical analysis. Only 
complete responses from the first 197 questionnaires returned were used for 
the factor analysis. Of these baseline responses, 67.5% had full data. There was 
a significant difference noted between those who completed the questionnaire 
and those who did not, in terms of age and the physical condition diagnosed. 
Factor analysis was used to evaluate unidimensionality, and Cronbach’s alpha 
calculated for internal consistency. 
 
For content validity, the items were generated following a systematic literature 
review and semi-structured focus group interviews with consumers and 
patients. Interviews were also conducted with general practitioners identified 
as key informants. The same groups also reviewed the questionnaire, with the 
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wording subsequently amended before it was piloted in a group similar to the 
target population. The authors highlight that this was an iterative process, with 
different groups involved at different stages of review in order to avoid 
overfamiliarity with the scale. Twenty semi-structured interviews were then 
performed with participants from the pilot to explore their views on the 
questionnaire and the consultation, and so assess congruence with their initial 
questionnaire responses.   
 
Clear hypotheses were described a priori for construct validity, with the 
expected direction and magnitude of the correlations. Detailed descriptions, 
including psychometric properties, were provided for the comparator 
instrument measuring enablement, though less information was provided for 
that evaluating anxiety.  
 
When considering the interpretability of the scale, the distributions of the 
scores are reported. These were also illustrated in a box plot with 
consideration of floor-ceiling effects, although the raw numbers and 
proportions involved are not clearly reported. No MIC or MID are given, 
though this may be due to the early stages of scale development.  
 
A comparison is made between non-responders and responders, and those 
returning complete and incomplete questionnaires. The authors note a 
significant difference between the groups, which impacts on the 
generalisability of the study findings. In addition, while details are given for the 
study setting, patient demographics and diagnoses, more information 
concerning disease characteristics, such as severity and duration, would be 
beneficial. In terms of recruitment, patients were invited to participate in a trial 
if they had one of the conditions of interest. A random 960 people were then 
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selected and invited to an appointment. No further information is given for 
inclusion criteria or the randomisation process.  
 
5.2.7.3. Instrument Quality 
Table 25 maps the measurement properties for the COMRADE against quality 
criteria developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 25: COMRADE development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	COMRADE	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 Yes	
Interpretability	 Yes	
 
For the initial factor analysis, 197 responses were used. This is too small a 
sample size for 43 items if the quality criterion of number of items multiplied 
by seven is used. (Terwee et al., 2007) Three factors were identified, with 
twenty items that failed to load on to a factor eliminated. The third factor, 
support, was transient and its presence varied in the different trial phases. The 
Cronbach’s alpha for the whole scale is 0.92, which falls within the 
recommended levels for internal consistency. However, as subscales were 
identified, statistical analysis should also have been performed on them. 
(Terwee et al., 2007) 
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The instrument scores strongly on content validity, with target group 
involvement and consideration of construct coverage although there is limited 
expert involvement evident for item selection. Five hypotheses were tested, 
with clear a priori predictions. Four of these had supporting results. The 
correlation between patient concerns about treatment with risk 
communication was not reported.  
 
For interpretation, the mean and distribution of scores are provided and 
illustrated with a box plot, which show that the confidence in decision subscale 
was scored highly. In addition, clear proportions are not given and therefore 
cannot be said to comply with the quality criteria of no more than 15% 
achieving the highest or lowest scores. No MIC is defined, though this is 
arguably less relevant at an early stage of instrument development.  
 
5.2.7.4. Further evaluation studies 
The COMRADE scale development study has been cited 53 times by the end of 
2014, as identified by Web of Science. One eligible study further evaluating the 
scale was identified. Knapp and colleagues, 2009, validated the properties of 
both DCS and COMRADE for children with life-limiting illness, specifically for 
the parents involved in paediatric palliative care programmes. (Knapp et al., 
2009) A sample of 936 was contacted with 266 completed surveys returned. 
For internal consistency, the Cronbach's alpha was over 0.93. Confirmatory 
factor analysis did not replicate the original structure of COMRADE and mixed 
results were obtained for the known groups construct validity. The authors 
conclude that the DCS was better suited for use in the context.  
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5.2.8. The Decision Evaluation Scale (DES) 
5.2.8.1 Descriptive features 
The Decision Evaluation Scale is intended to measure factors influencing the 
patient’s appraisal of treatment options. (Stalmeier et al., 2005) Measure 
development was set within a decision support intervention trial for women 
with or without breast or ovarian cancer who had chosen to undergo genetic 
testing. Possible decision outcomes included prophylactic mastectomy, breast 
cancer screening or remaining undecided. The self-administered scale 
contained 36 items at first testing, each with a five point Likert score.  
 
The trial was performed in family centre clinics, where 453 eligible patients 
were identified, of which 390 consented to participate. Half of the women 
received a brochure and video with information about the decision. 
Questionnaires were sent out at baseline (T1), the time of the blood test used 
for screening, then at 4 weeks after the test (T2), 2 weeks after a positive 
results (T3) and 3 months after a positive result (T4) and onwards (T5). 368 
women were still present in the study at the T2 stage. 22 women were 
ineligible to continue in the trial as they underwent bilateral mastectomy and 3 
participants were excluded due to incomplete data. As such, 343 participants 
remained for the measure evaluation. 91 participants were positive for the 
BRCA1 or 2 genes, three of which then withdrew from the trial. At T4 stage of 
follow up, 88 participants remained, with 87 continuing beyond this to the 
next evaluation stage (T5).  
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5.2.8.2. Methodological quality 
The following section outlines measurement properties evaluated for the DES 
scale, with the COSMIN checklist for methodological quality applied to each. 
(Mokkink et al., 2012) 
 
Table 26: DES development study mapped against the COSMIN checklist for 
methodological quality  
COSMIN	methodological	quality	 Evaluated	in	DES	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
For internal consistency evaluation, a clear account was given of the number of 
missing items and how these were handled. One item was deleted as it was 
missed in too many of the responses. An average 1.5% of the item responses 
were incomplete after these were eliminated, with 299 (87%) of the 
participants completing all 35 remaining items. Missing data analyses were 
performed on decision items. For incomplete items from multiple–item scales, 
an imputed mean was calculated when at least half of the items were 
completed. The sample size was adequate for assessing internal consistency 
and for evaluating unidimensionality, despite the large number of items 
involved (7*35= 245). (Mokkink et al., 2012) Factor analysis was performed, 
unidimensionality checked and a Cronbach’s alpha calculated for each 
identified subscale.  
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Experts were involved in item development, with consideration of construct 
coverage by the scale. However, content validity is impaired by no evident 
involvement of target group in measure development or any evaluation of the 
relevance of the items to the population of interest. For construct validity, 
hypotheses were developed after the scales were identified with factor analysis 
but before the relationship between the DES and other measures was tested. 
The direction but not the magnitude of expected correlation was outlined. 
Limited detail was provided for the comparator measures and it is also unclear 
which correlation coefficient is used.  
 
The scale was originally developed in Dutch before 15 items were translated 
into English by the first author, with an independent translation undertaken by 
a professional translator. Any discrepancies were resolved “by consensus”. 
(Stalmeier et al., 2005) There are limitations in the approach taken, as the 
proficiency of both translators for the medical context and languages are not 
explicitly outlined. There is no “forward and backward” translation to confirm 
that meaning of the items has been preserved through the translation process. 
(Mokkink et al., 2012) In addition, there is neither review of the translated 
scale by the original committee nor re-testing of the factor analysis and other 
measurement properties.  
 
The interpretability is limited by the provision of mean scores and their 
standard deviations only, grouped by treatment choice. There is no evaluation 
for floor-ceiling effects or statement of a MIC. For evaluating generalisability, 
the trial setting and participant characteristics, such as demographic and 
medical condition details, are provided. However, limited detail is given for the 
sampling strategy and it is difficult to keep track of the number of respondents 
involved in each stage of the measure evaluation.  
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5.2.8.3. Instrument Quality 
Table 27 maps the measurement properties for the DES against quality criteria 
developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 27: DES development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	DES	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
Factor analysis was performed, indicating the presence of three subscales with 
each containing five items. The remaining items were discarded. The subscales 
concerned satisfaction-uncertainty, informed choice and decision control. 
Correlations between the subscales were moderate. For internal consistency, 
the subscale Cronbach’s alphas are 0.79, 0.85 and 0.75 respectively which are 
within the acceptable range of 0.70 to 0.95. (Terwee et al., 2007) 
 
Content validity is limited by the absence of target group involvement. For 
construct validity, there is doubtful design in terms of hypothesis generation 
timing and the majority of correlations obtained are weak. The DES is tested 
against a broad number of comparator constructs. These include anxiety, 
strength of treatment preference, depression, avoidance, subjective knowledge, 
amount of information, satisfaction with quality of information, negative 
emotions and partner agreement. All but two have correlations statistically 
significant at P < 0.001. However, the correlations obtained are weak except 
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between strength of preference and satisfaction-uncertainty (0.64), and 
between informed choice and the three information/knowledge-related scores 
(0.52, 0.61 and 0.58). DES scores were significantly worse for undecided 
participants.  
 
The participant demographic details provided allow evaluation of the scale 
generalisability to different contexts. However, these details indicate that 
women who are married, employed and with a high school level of education 
are most represented by this sample. The interpretability of the scale can be 
considered using the mean scores and standard deviations provided, but this is 
limited by the absence of MIC or consideration of floor-ceiling effects. (Terwee 
et al., 2007) 
 
5.2.8.4. Further evaluation studies 
The DES development study had been cited 19 times by the end of 2014, as 
identified by Web of Science. The only eligible study addressing further 
evaluation of this scale was by Erci and colleagues, 2008 who adapted the DES 
for cancer patients in Turkey. (Erci and Özdemir, 2008) The trial used a 
convenience sample of 199 patients. Back translation was used in adapting the 
scale, but there was no target group involvement. For content validity, a panel 
of specialists reviewed the scale, with additional pre-testing in 30 patients from 
medical oncology groups. Factor analysis identified three factors: satisfaction-
uncertainty, informed choice and decision control. For internal consistency and 
homogeneity, Cronbach's alphas for the three factors were 0.74, 0.75 & 0.71, 
with item-total correlations ranging from 0.36 to 0.71. Evaluation of test-retest 
reliability indicated Pearson correlations of 0.74 (complete DES), 0.71 
(satisfaction-uncertainty), 0.78 (informed choice) and 0.70 (decision control). 
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The authors noted the need to test further in different regions and populations 
in Turkey.  
 
5.2.9. The Decision-Making Quality Scale (DMQS) 
5.2.9.1. Descriptive features 
The DMQS is intended to evaluate the decision process used by the 
respondent, and allow the targeted development of what is defined by Janis and 
Mann as a quality decision style. (Hollen, 1994, Janis and Mann, 1977) Its 
anticipated use was both as a measurement and counselling tool. In the study, 
respondents were asked to consider their approach to consequential decisions, 
described as “important choices, not everyday ones”. (Hollen, 1994)  
 
Two forms were developed, Form S for self-administration and Form O for 
completion by observers. The readability of the scale was evaluated, and the 
completion time estimated at 3 to 5 minutes. The seven items were graded 
using a four point Likert scale. Scores were evaluated using two indices:  a 
Total Adherence Index, where a higher score indicated greater adherence to the 
desired quality decision style, and Quality Index, which had a binary outcome 
of a quality or non-quality decision. 
 
Decisions were evaluated in two settings. The first two groups were healthy 
high school students attending a health course (n=147 and 374). The other 
two groups were children attending childhood cancer clinics with their parents 
for follow up care. Of the patients, 36 were adolescents aged 14 to 19 years, 19 
were young adults aged 20 to 26 years. All were five years post-diagnosis and 
two years clear of treatment. 67 parents of adolescent patients participated, 
completing a mailed DMQS. Two clinic nurses who were familiar with their 
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decision-making during the acute illness stage also graded the parents. The 
participants were recruited at the health course or clinic.  
5.2.9.2. Methodological quality  
The following section outlines the measurement properties evaluated for the 
DMQS scale, with the COSMIN checklist for methodological quality applied to 
each. (Mokkink et al., 2012) 
 
Table 28: DMQS development study mapped against the COSMIN checklist for 
methodological quality  
COSMIN	methodological	quality	 Evaluated	in	DMQS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
No information is given about the number of missing items or how these were 
handled, while the sample size included was adequate by the COSMIN 
standards. No details are given to suggest that the unidimensionality of the 
scale was assessed by factor analysis. However, a Cronbach’s alpha was 
calculated for internal consistency. Rather than test-retest reliability for the 
participant reported measures, the observer scale was tested for intra-rater and 
inter-rater reliability using Kendall Tau and Kappa statistics. While the latter is 
supported for an ordinal scale, there is no detail to suggest it was weighted as 
recommended in the standards. Two measurements were made one month 
	  98 
apart, though it is unclear whether the sample and test conditions were stable 
during this time.  
 
For content validity, a panel of three experts was consulted and there was a 
high rate of agreement for coverage of theory, domain representation and 
individual item coverage. However, there is no reference to tailoring the scale 
to a target group, nor of target population involvement. The hypotheses tested 
for construct validity were not explicitly outlined a priori, with correlations and 
p-values used to evaluate the strength of the relationships observed.  
 
Evaluation of scale generalisation beyond this study is impacted by the limited 
demographic details provided for the participants.  In addition, while clear 
details are given for the setting of the trial, little is given for the sampling 
strategy or the response rate. Limited information is provided to evaluate the 
interpretability of the scale, such as mean scores, score distributions, subgroup 
results or numbers achieving the highest and lowest scores.  
 
Other limitations include that the participants are asked to consider their 
decision-making generally, rather than for a decision they were actively 
working through. This is open to recall bias and may be more marked when 
considering past decisions of consequence. Limited information is given for the 
processes used in the observer assessments, which involved only two people. 
These observers were also involved in the care of the family and bias may be 
introduced both from emotional connection and knowledge of the health 
outcome.  
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5.2.9.3. Instrument quality 
Table 29 maps the measurement properties for the DMQS against quality 
criteria developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 29: DMQS development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	DMQS	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 Yes	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
Internal consistency is hampered by the absence of a factor analysis, though 
Cronbach’s alphas for the five groups involved span from 0.71 to 0.90, all 
within the quality criteria. (Terwee et al., 2007) Insufficient details for 
statistical analysis also impacts on reliability, as it is uncertain whether a 
weighted kappa statistic was used. Intra-rater reliability varied between the 
two clinic nurses, from 0.57 to 0.92. For inter-rater reliability, an average 
Kappa statistic of 0.28 was obtained, suggesting poor agreement. (Terwee et 
al., 2007) The study author also notes that the observers tended to score the 
participants highly for adherence with the decision-making quality criteria.  
 
No target group involvement reduces the instrument content validity, while 
construct validity meets the quality criteria with specific hypothesis formulated 
with the majority of the results in support with these. However, it is unclear to 
what extent the hypotheses were formulated a priori and limited information is 
provided for the comparison instruments. The DMQS scores for each group 
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were compared with a self-reported risk behaviour scale, with higher quality 
decision-making criteria expected to correlate with lower risk behaviour. The 
correlations for the two groups of high school students were – 0.23 (p < 0.01) 
and – 0.17 (p < 0.1) respectively, and -0.52 (p < 0.001) for the clinical group. 
The correlations are therefore weak to moderately negative, supporting the 
hypothesis.  
 
5.2.9.4. Further evaluation studies 
The DMQS development study has been cited 24 times by the end of 2014, as 
identified by Web of Science. No further development or evaluation studies 
matched the eligibility criteria.   
 
5.2.10. The Decision Self-Efficacy Scale (DSES) 
5.2.10.1. Descriptive features 
The DSES is intended to measure the respondent’s perception of their ability 
to complete varying stages of the decision-making process, though the authors 
focused on the social component of engaging with a healthcare team. (Bunn 
and O'Connor, 1996) The scale has 11 items, using a five point Likert scale, 
though this was reduced to three points after initial development work.  
 
Originally developed in the context of hormone replacement therapy (HRT) 
decisions, the scale was evaluated over a ten-week period at a clinic specialising 
in the treatment of schizophrenia at a large Ottawa hospital. Another scale, the 
Decision Emotional Control Scale (DECS), was also assessed. The sample of 94 
comprised of 68 men and 26 women, with an age range of 27 to 68 and mean 
age of 41 years. All were able to speak English and were currently taking long-
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acting anti-psychotic medications, 86% doing so for over 5 years with 2% for 
less than one year. Only those with stable schizophrenia were included, with 
exclusion of those experiencing acute psychosis. The participants were given 
information about long-term medication injections in a one-to-one setting with 
a research assistant, and then asked to make a choice – to accept the treatment, 
decline it or delay the decision. The DCS and DSES were then completed. 4% 
of the sample described difficulty concentrating on the entire scale during the 
testing process.    
 
5.2.10.2. Methodological quality  
The following section outlines the measurement properties evaluated for the 
DSES scale, with the COSMIN checklist for methodological quality applied to 
each. (Mokkink et al., 2012) 
 
Table 30: DSES development study mapped against the COSMIN checklist for 
methodological quality  
COSMIN	methodological	quality	 Evaluated	in	DSES	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Measurement	error	 No	
Validity	
Content	validity	 Yes	
Hypothesis	testing	 Yes	
Cross-cultural	validity	 No	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Interpretability	 Yes	
Generalisability	 Yes	
 
While the total percentage of missing items was reported, there was 
insufficient detail about these items and how they were handled during 
analysis. In addition, the sample size was insufficient by the COSMIN 
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standards at less than a hundred participants and there was no evaluation of 
the unidimensionality of the scale. (Mokkink et al., 2012) A Cronbach’s alpha 
was calculated to evaluate internal consistency.  
 
Content validity was assessed as face validity, with a panel of experts and a 
client pilot. As such, the target population was included in the development of 
the items and there was consideration of the theoretical, domain and item 
coverage. However, the pilot was small with only four participants. The known 
groups approach was taken for hypothesis testing, using the treatment choice 
made as a proxy for decision self-efficacy. Hypotheses were formulated a priori, 
with the direction but not the magnitude of the relationships predicted. 
However, no correlations were calculated, only mean differences in test scores, 
standard deviations and p-values.  
 
Limited information was given to support the interpretability of the scores 
beyond the mean score obtained and the standard deviation. Details of score 
distribution in the group, subgroup results and the proportions achieving the 
highest and lowest scores would have improved this measurement property. 
Demographic and setting information were given but not in enough detail for 
the sampling strategy, response rate or impact of the background condition on 
cognition, as most of the clients accepted the support of a research assistant in 
reading the scales. These aspects limit the generalisability of the scale.  
 
Other aspects to consider include that the scale asks people to consider their 
perceived ability to make a decision rather than the decision process itself, 
although the former will influence the latter. In addition, as eligibility to 
participate was dependent on clinical stability, the decisional context is 
relatively low in conflict, which may influence the results obtained.  
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5.2.10.3. Instrument Quality 
Table 31 maps the measurement properties for the DSES against quality 
criteria developed by Terwee and colleagues. (Terwee et al., 2007) 
 
Table 31: DSES development study mapped against the quality criteria 
Terwee	et	al	Instrument	
Quality	Criteria	
Evaluated	in	DSES	development	study	
Reliability	
Internal	consistency	 Yes	
Reliability	 No	
Agreement	 No	
Validity	
Content	validity	 Yes	
Construct	validity	 Yes	
Criterion	validity	 No	
Other	properties	
Responsiveness	 No	
Floor	and	ceiling	effects	 No	
Interpretability	 Yes	
 
Both content validity and construct validity match the quality criteria outlined 
by Terwee and colleagues. (Terwee et al., 2007) Internal consistency is limited 
by the absence of factor analysis, though a Cronbach’s alpha of 0.84 is 
obtained. No further consideration of reliability is reported. Interpretability is 
limited by the absence of subgroup analysis and consideration of floor-ceiling 
effects.  
 
The small number of participants in the pilot study limits content validity, with 
all other criterions covered. For construct validity, clients who were unsure or 
wanted to delay their decision scored higher on the DSES, indicating difficulty 
with decision self-efficacy. Comparing the mean scores and standard deviations 
between those who continued treatment and those who were uncertain found a 
difference statistically significant at the value of 0.05 (p = 0.037), which 
supports the hypothesis but no correlation statistics were calculated.  
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5.2.10.4. Further evaluation studies 
The DSES development study has been cited 48 times by the end of 2014, as 
identified by Web of Science. No further eligible development or evaluation 
studies were identified.  
 
5.3. Narrative synthesis of methodological and instrument quality 
Table 32 summarises the methodological quality behind the development of 
the included scales, with the adequacy of the measurement properties of each 
included in Table 33. 
 
A four-point scale of the COSMIN checklist was used to summarise the 
methodological quality of the included studies. For each facet of scale 
development methodology, a “worse score counts” approach is taken. (Terwee 
et al., 2012) For example, if one constituent element of the internal 
consistency methodology is graded as poor, then internal consistency is graded 
as poor overall. The summary focuses on the ten developmental studies as the 
further evaluation studies consider adapted versions of the scales or their 
suitability in new population groups. The adequacy of scale measurement 
properties are summarised as recommended by criteria authors. (Terwee et al., 
2007) 
 
The methodological quality is highly variable, both between and within 
studies.  None of the scales consistently score well for measurement properties 
when compared with the criteria of adequacy. (Terwee et al., 2007) 
 
Recurrent themes were identified in the summarising process: 
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• Explanations for choice of sample size, along with descriptions of 
recruitment processes and how missing items on the scales were 
handled, were often absent.  
• Factor analysis to confirm the unidimensional nature of the scale under 
development was frequently omitted.  
• Few of the studies described target population involvement in the 
measure development.  
• For hypothesis or construct validity, few hypotheses were clearly 
described as formulated a priori and the choice of statistical analysis 
varied. For the latter, there was often a reliance on p-values alone rather 
than using correlations.  
• There was often a lack of clarity concerning the exact processes used, 
especially for hypothesis or construct validity and reliability.  
• There was limited consideration of the meaningfulness of the scores, 
including assessment of how useful scores would be in practice and 
minimally important changes. This becomes more important should the 
scales be applied in intervention studies for decision aids where changes 
in scores are to be measured.  
• Related to this, measurement error was routinely not considered. The 
degree of background variation in repeated measurements and how this 
relates to the smallest detectable change (SDC) or minimal important 
change (MIC) in the overall score is of relevance if the tool is used for 
assessing the effectiveness of an intervention.  
• There was also limited consideration of the interpretability of scores, 
such as evaluating the overall spread of results, subgroup results, and 
floor-ceiling effects.  
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• Where measure development was performed alongside an intervention, 
the scale responsiveness to changes in the construct of interest was not 
evaluated.  
• Further evaluation studies illustrated the varying nature of scale 
psychometric properties, as they are heavily dependent on the 
population involved in the testing process and the study context. 
 
 
This chapter detailed the results of a systematic review, which sought to 
identify and evaluate the quality of existing measures of the patient’s 
perspective of the decision-making process.  
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Table 32: Summary of the methodological quality of the included scales 
		 		 Measurement	Properties	
Instrument	name	 First	author/year	 Internal	consistency	 Reliability	
Measurement	
error	
Content	
validity	
Hypothesis	
testing	
Cross-cultural	
validity	 Responsiveness	 Interpretability	
Decisional	Conflict	
Scale	 O’Connor,	1995	 Poor	 Fair	 -	 Poor	 Fair	 -	 -	 Poor	
Satisfaction	with	
Decision	Scale	
Holmes-Rovner,	
1996	 Poor	 -	 -	 Poor	 Fair	 -	 -	 Poor	
Decision	Attitude	
Scale	 Sainfort,	2000	 Poor	 -	 -	 Poor	 Fair	 -	 Poor	 Fair	
PrepDM	 Bennett,	2010	 Poor	 Poor	 -	 Poor	 Fair	 -	 -	 Fair	
SDM-Q	 Simon,	2006	 Good	 Fair	 -	 Excellent	 Fair	 -	 -	 Good	
SURE	 Legare,	2010	 Good	 -	 -	 Poor	 Poor	 -	 -	 Good	
COMRADE	 Edwards,	2003	 Poor	 -	 -	 Good	 Good	 -	 -	 Fair	
Decision	Evaluation	
Scales	 Stalmeier,	2005	 Excellent	 -	 -	 Poor	 Fair	 Fair	 -	 Poor	
Decision-Making	
Quality	Scale	 Hollen,	1994	 Poor	 Fair	 -	 Poor	 Good	 -	 -	 Poor	
Decision	Self-efficacy	
Scale	 Bunn,	1996	 Poor	 -	 -	 Fair	 Fair	 -	 -	 Poor	
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Table 33: Summary of the measurement properties of the included scales 
Where: + = positive, 0 = intermediate, - = negative, ? = no data 
	
		 		 Measurement	Properties	
Instrument	name	 First	author/year	
Content	
validity	
Internal	
consistency	
Criterion	
validity	
Construct	
validity	
Reliability	
Responsiveness	
Floor	&	
ceiling	
effect	
Interpretability	
Agreement	 Reproducibility	
Decisional	Conflict	
Scale	
O’Connor,	
1995	 0	 0	 ?	 +	 ?	 0	 ?	 ?	 0	
Satisfaction	with	
Decision	Scale	
Holmes-
Rovner,	1996	 0	 0	 ?	 +	 ?	 ?	 ?	 ?	 0	
Decision	Attitude	
Scale	 Sainfort,	2000	 0	 +	 ?	 0	 ?	 ?	 0	 ?	 0	
PrepDM	 Bennett,	2010	 0	 -	 ?	 0	 ?	 0	 ?	 0	 0	
SDM-Q	 Simon,	2006	 +	 0	 ?	 -	 ?	 +	 ?	 -	 -	
SURE	 Legare,	2010	 -	 -	 0	 0	 ?	 ?	 ?	 -	 -	
COMRADE	 Edwards,	2003	 +	 0	 ?	 +	 ?	 ?	 ?	 0	 0	
Decision	
Evaluation	Scales	
Stalmeier,	
2005	 -	 +	 ?	 0	 ?	 ?	 ?	 ?	 0	
Decision-Making	
Quality	Scale	 Hollen,	1994	 -	 0	 ?	 +	 ?	 -	 ?	 ?	 ?	
Decision Self-
efficacy Scale Bunn, 1996 + 0 ? 0 ? ? ? ? ? 
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6. Results of the instrument content mapping 
 
This chapter describes findings from the instrument content mapping, which 
evaluates the extent existing measures address stages of the decision process 
model incorporating deliberation, as proposed by Elwyn and Miron-Shatz. 
(Elwyn and Miron-Shatz, 2010) Items from each individual scale are mapped 
against the model and the findings synthesised in a summary table, allowing 
comparison of individual scale performance and evaluation of collective 
coverage of the model’s stages.  
 
6.1. Mapping results for individual scales 
6.1.1. The Decisional Conflict Scale (DCS) 
As shown in Table 34, individual items from the DCS were mapped against the 
decision process map incorporating deliberation and determination, as 
described by Elwyn and Miron-Shatz. (Elwyn and Miron-Shatz, 2010) No items 
mapped against the imagining counterfactuals and affective forecasting stages 
of preference construction, though the other stages were addressed by the 
DCS. 
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Table 34: DCS items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	
and	considered	
	
	
"I	am	aware	of	the	choices	I	have"	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	
(characteristics,	process	and	outcomes	probabilities)	
	
"I	feel	I	know	the	benefits	of	***"	
"I	feel	I	know	the	risks	and	side	effects	of	***"	
Appraisal	of	knowledge	sufficiency	 "I	need	more	advice	and	information	about	
the	choices"	
“I’m	unsure	what	to	do	in	this	decision”	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	
consequences	of	options	by	imagining	how	different	
futures	could	play	out	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	
futures.	
	
	
Ranking	options	
	
	
"	I	know	how	important	the	risks	and	side	
effects	are	to	me"	
"I	know	how	important	the	benefits	are	to	me	
in	this	decision"	
"It's	hard	to	decide	if	the	benefits	are	more	
important	to	me	than	the	risks,	or	the	risks	are	
more	important	than	the	benefits"	
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	
prior	to	enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“	I	expect	to	stick	to	my	decision”	
“I	feel	I	have	made	an	informed	choice”	
“	My	decision	shows	what	is	most	important	to	
me”	
“I	am	satisfied	with	my	decision”	
“It	is	clear	which	choice	is	best	for	me”	
	“This	decision	is	hard	for	me	to	take”	
	
Items	that	did	not	map	against	process	stages	
	
“I	feel	pressure	from	others	in	making	this	decision”	
“I	have	the	right	amount	of	support	from	others	in	making	this	choice”	
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6.1.2. The Satisfaction with Decision Scale (SWD) 
When the constituent items of the SWD scale are mapped against the decision 
process map, none match the option awareness, information search or 
preference construction stages, as shown in Table 35. (Elwyn and Miron-Shatz, 
2010) 
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Table 35: SWD items mapped against decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	
(characteristics,	process	and	outcomes	probabilities)	
	
	
Appraisal	of	knowledge	sufficiency	 “I	am	satisfied	that	I	am	adequately	
informed	about	the	issues	important	to	
my	decision”	
	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	
consequences	of	options	by	imagining	how	different	futures	
could	play	out	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	
		
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“I	am	satisfied	with	my	decision”	
	
“I	expect	to	successfully	carry	out	the	
decision	I	made”	
	
“I	am	satisfied	that	my	decision	was	
consistent	with	my	personal	values”	
	
“The	decision	I	made	was	the	best	
possible	decision	for	me	personally”	
	
Items	that	did	not	map	against	process	stages	
“I	am	satisfied	that	this	was	my	decision	to	make”	
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6.1.3. Decision Attitude Scale (DAS) 
As shown in Table 36, the Decision Attitude Scale items map against appraisal 
of knowledge sufficiency and determination, but not the option awareness, 
information search and preference construction stages of the proposed model. 
(Elwyn and Miron-Shatz, 2010) 
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Table 36: Decision Attitude Scale items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	considered	
	
	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	(characteristics,	
process	and	outcomes	probabilities)	
	
	
Appraisal	of	knowledge	sufficiency	 “More	information	would	
help”	
	
“Consulting	someone	else	
would	have	been	useful”	
• Preference	construction	
Imagining	counterfactuals	
	
“What	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	
	
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	enacting	a	
decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“My	decision	is	sound”	
	
“I	am	comfortable	with	my	
decision”	
	
“My	decision	is	the	right	one	
for	the	situation”	
	
“I	am	satisfied	with	my	
decision”	
	
“It	was	difficult	to	make	a	
choice”	
	
Items	that	did	not	map	against	process	stages	
“I	had	no	problem	using	the	information”	
	
“The	information	was	easy	to	understand”	
	
	
	  115 
6.1.4. Preparation for Decision-Making scale (PrepDM) 
Mapped against the decision process map incorporating deliberation and 
determination, the only stages not addressed are the imagining counterfactuals 
and affective forecasting within preference construction, as shown in Table 37. 
(Elwyn and Miron-Shatz, 2010) 
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Table 37: PrepDM items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
“Help	you	recognise	a	decision	
needs	to	be	made”	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	(characteristics,	
process	and	outcomes	probabilities)	
	
	
“Help	you	think	about	the	pros	and	
cons	of	each	option”	
Appraisal	of	knowledge	sufficiency	 	
“Identify	questions	you	want	to	ask	
your	doctor”	
	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	
	
	
“	Help	you	organise	your	thoughts	
re	the	decision”	
	
“Help	you	think	about	which	pros	
and	cons	are	most	important”	
	
“Know	that	the	decision	depends	on	
what	matters	most	to	you”	
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“Prepare	you	to	talk	to	your	doctor	
regarding	what	matters	most	to	
you”	
	
“Prepare	you	to	make	a	better	
decision”	
	
Items	that	did	not	map	against	process	stages	
“Help	you	think	regarding	how	involved	you	want	to	be	in	this	decision”	
	
“Prepare	you	for	follow	up	meeting	with	your	doctor”	
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6.1.5. The Shared Decision-Making Questionnaire (SDM-Q) 
As shown in Table 38, individual items from the SDM-Q were mapped against 
the decision process map incorporating deliberation and determination, as 
described by Elwyn and Miron-Shatz. (Elwyn and Miron-Shatz, 2010) No items 
mapped against the appraisal of knowledge sufficiency or preference 
construction stages. Eight items did not map against decision process, 
highlighting the additional purpose of this measure in evaluating shared 
decision-making within a consultation and eliciting patient preference for 
involvement.  In addition, items for equipoise and eliciting preferences were 
omitted from the scale following the IRT analysis due to poor item-fit.  
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Table 38: SDM-Q items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	(characteristics,	
process	and	outcomes	probabilities)	
	
“I	now	know	the	advantages	of	the	
individual	treatment	options”	
Appraisal	of	knowledge	sufficiency	 	
	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
Affective	forecasting	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	
	
"my	doctor	and	I	weighed	up	
different	treatment	options	
thoroughly”	
Determination	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“	I	now	know	which	treatment	
option	is	best	for	me”	
Items	that	did	not	map	against	process	stages	
	"I	was	able	to	discuss	the	different	treatment	options	with	my	doctor	in	detail"	
	
"In	the	selection	of	treatment	method,	my	thoughts	were	taken	into	account	just	as	much	as	the	
considerations	of	the	doctor"	
	
"There	was	enough	time	to	ask	questions"	
	
"My	doctor	and	I	selected	a	treatment	option	together"	
	
"During	the	consultation,	I	felt	included	in	the	treatment	decision"	
	
"Through	the	consultation	with	the	doctor	I	felt	jointly	responsible	for	my	further	treatment"	
	
"My	doctor	and	I	discussed	the	next	few	steps	of	the	treatment	plan	in	detail"	
	
"My	doctor	and	I	reached	an	agreement	as	to	how	we	will	proceed"	
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6.1.6. The SURE scale 
In mapping the SURE items against the decision process map, option 
awareness and the imagining counterfactual and affective forecasting stages of 
preference construction were not covered by this scale. (Elwyn and Miron-
Shatz, 2010) These findings are shown in Table 39 below. 
 
Table 39: SURE items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	(characteristics,	
process	and	outcomes	probabilities)	
	
“Do	you	know	the	benefits	and	
risks	of	each	option?	
Appraisal	of	knowledge	sufficiency	 "Do	you	have	enough	support	and	
advice	to	make	a	choice?”	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	
	
	
“Are	you	clear	about	which	
benefits	and	risks	matter	the	most	
to	you?”	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“Do	you	feel	sure	about	the	best	
choice	for	you?”	
	
Items	that	did	not	map	against	process	stages	
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6.1.7. The COMRADE scale 
As shown in Table 40 individual items from the COMRADE were mapped 
against the decision process map incorporating deliberation and determination. 
(Elwyn and Miron-Shatz, 2010) No items mapped against the imagining 
counterfactuals and affective forecasting stages of preference construction, 
although the other stages were addressed. Eight items did not map against the 
decision process stages. These items concerned evaluating the extent of shared 
decision-making in the consultation.   
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Table 40: COMRADE items mapped onto decision process map 
Decision	process	stage	 Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	
and	considered	
	
"The	doctor	made	me	aware	of	different	
treatments	available”	
“I	am	aware	of	the	treatment	options	I	have”	
Deliberation	
• Knowledge	
Information	search	
Gain	information	about	the	attributes	of	options	
(characteristics,	process	and	outcomes	probabilities)	
“I	know	the	advantages	of	treatment	or	not	
having	treatment”	
“I	know	the	disadvantages	of	treatment	or	not	
having	treatment”	
Appraisal	of	knowledge	sufficiency	 "The	doctor	gave	me	enough	information	
regarding	treatment	choices	available"	
"The	doctor	gave	me	enough	explanation	of	
the	information	about	the	treatment	choices"	
"I	am	satisfied	that	I	am	adequately	informed	
about	issues	important	to	the	decision"		
"Overall	I	am	satisfied	with	the	information	I	
was	given"	
• Preference	construction	
Imagining	counterfactuals	
“what	if”	scenarios:	provide	insight	into	possible	
consequences	of	options	by	imagining	how	different	
futures	could	play	out	
	
Affective	forecasting	
Forecasted	feeling	towards	different	counterfactual	
futures.	
	
Ranking	options	 “It	is	clear	which	choice	is	best	for	me”	
Determination	
Integrating	deliberation	input	and	making	a	choice,	
prior	to	enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
“I	am	sure	the	decision	made	was	the	right	
one	for	me	personally”	
“The	decision	shows	what	is	important	to	me”	
“I	feel	an	informed	choice	had	been	made”	
“I	am	satisfied	with	the	way	the	decision	was	
made	in	the	consultation”	
Items	that	did	not	map	against	process	stages	
"The	doctor	gave	me	the	chance	to	express	my	opinions	regarding	different	treatments	available"	
"The	doctor	gave	me	the	chance	to	ask	for	as	much	information	as	I	needed	for	the	different	treatment	
options"	
"The	information	was	easy	to	understand"	
"The	doctor	gave	me	a	chance	to	decide	which	treatment	I	thought	was	best	for	me"	
"The	doctor	gave	me	a	chance	to	be	involved	in	the	decisions	during	the	consultation"	
"The	doctor	and	I	agreed	about	which	treatment	(or	no	treatment)	was	best	for	me"	
"I	can	easily	discuss	my	condition	again	with	my	doctor"	
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6.1.8. The Decision Evaluation Scale (DES) 
As shown in Table 41, no items mapped against the preference construction 
stages on the decision process map. (Elwyn and Miron-Shatz, 2010) Four items 
did not map against the decision process stages. These items mostly addressed 
the patient’s ownership of the decision and desire to participate.   
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Table 41: DES items mapped onto decision process map 
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	considered	
	
	
Deliberation	
• Knowledge	
Information	search	
Gain	information	about	the	attributes	of	options	(characteristics,	process	
and	outcomes	probabilities)	
	
“I	know	the	pros	and	cons	of	
the	treatments”	
Appraisal	of	knowledge	sufficiency	 “I	am	satisfied	with	the	
information	I	received”	
	
“I	want	more	information	
about	this	decision”	
	
“I	want	clearer	advice”	
• Preference	construction	
Imagining	counterfactuals	
“what	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
Affective	forecasting	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
Ranking	options	 	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	enacting	a	
decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
"I	expect	to	stick	to	my	
decision"	
	
"I	am	satisfied	with	my	
decision"	
	
"I	am	still	doubtful	about	my	
choice"	
	
"I	find	it	hard	to	make	this	
choice"	
	
"I	made	a	well	informed	
choice"	
	
"My	decision	frightens	me"	
	
"I	regret	my	decision"	
Items	that	did	not	map	against	process	stages	
“This	is	my	own	decision”	
“This	decision	is	made	without	me”	
“I	feel	pressure	from	others	in	making	this	decision”	
“I	wish	someone	else	would	make	this	decision	for	me”	
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6.1.9. The Decision-Making Quality Scale (DMQS) 
As shown in Table 42, the DMQS items map against all stages with the 
exception of determination. (Elwyn and Miron-Shatz, 2010) Due to the 
wording, one item maps against two stages - information search and appraisal 
of knowledge sufficiency - as it describes seeking additional information if 
needed.  
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Table 42: DMQS items mapped onto decision process map  
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
Searches	for	three	or	more	choices	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	
(characteristics,	process	and	outcomes	probabilities)	
	
	
Finds	out	more	information	about	the	
pros	and	cons	when	needed	
	
Appraisal	of	knowledge	sufficiency	 	
Finds	out	more	information	about	the	
pros	and	cons	when	needed	
	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	consequences	
of	options	by	imagining	how	different	futures	could	play	out	
	
Weighs	pros	and	cons	of	consequences	
	
Makes	detailed	plans	with	back	up	
plans	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
Takes	into	account	values	and	all	goals	
desired	
	
Ranking	options	
	
	
	
Thinks	about	new	information	and	
what	experts	say,	even	if	against	first	
choice	
	
Reviews	carefully	before	making	a	final	
choice	
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
Items	that	did	not	map	against	process	stages	
	
	  126 
6.1.10. The Decision Self-Efficacy Scale (DSES) 
The DSES asks respondents to rate their confidence for each item. These match 
against each stage of the decision process, as outlined in Table 43, 
with the exception of imagining counterfactuals and affective forecasting. 
(Elwyn and Miron-Shatz, 2010) 
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Table 43: DSES items mapped onto decision process map  
	
Decision	process	stage	
	
	
Item	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	to	be	understood	and	
considered	
	
	
“get	the	facts	about	the	
medication	choices	available	to	
me”	
	
Deliberation	
• Knowledge	
Information	search	
	
Gain	information	about	the	attributes	of	options	(characteristics,	
process	and	outcomes	probabilities)	
	
	
“get	the	facts	about	the	benefits	of	
each	choice”	
	
“get	the	facts	about	the	risks	and	
side	effects	of	each	choice”	
Appraisal	of	knowledge	sufficiency	 	
“understand	the	information	
enough	to	be	able	to	make	a	
choice”	
	
“ask	for	advice”	
	
“delay	my	decision	if	I	feel	I	need	
more	time”	
• Preference	construction	
Imagining	counterfactuals	
	
“what	if”	scenarios:	provide	insight	into	possible	consequences	of	
options	by	imagining	how	different	futures	could	play	out	
	
	
	
Affective	forecasting	
	
Forecasted	feeling	towards	different	counterfactual	futures.	
	
	
	
Ranking	options	
	
	
	
“figure	out	the	choice	that	best	
suits	me”		
	
“express	my	concerns	about	each	
choice”	
	
Determination	
	
Integrating	deliberation	input	and	making	a	choice,	prior	to	
enacting	a	decision.	
	
Intention,	certainty	and	evaluation	of	decision	made.		
	
	
“let	the	clinic	team	know	what	is	
best	for	me”	
Items	that	did	not	map	against	process	stages	
“ask	questions	without	feeling	dumb”	
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6.2. Narrative synthesis of content mapping 
The extent each scale maps against the decision process map developed by 
Elwyn and Miron-Shatz, is summarised in Table 44. (Elwyn and Miron-Shatz, 
2010) None of the scales map against all of the proposed stages. Appraisal of 
knowledge sufficiency and determination are the most frequently addressed 
stages. Only one scale, the Decision Making Quality Scale (DMQS), addresses 
the imagining counterfactuals and affective forecasting elements of the 
preference construction stage. This scale also maps against most stages, 
although one of its items maps against both information search and appraisal 
of knowledge sufficiency due to the wording of the item.  
 
The words and phrases forming each item were then mapped against stages of 
the decision-making process, as shown in Table 45. (Elwyn and Miron-Shatz, 
2010) This shows that the exact phrasing of items and the timing of their 
completion in relation to decision-making are important in the stage allocation.  
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Table 44: Summary of the instrument content, mapped against the decision process model 
		 		 Decision	process	steps	
Instrument	name	 First	author/year	 Option	awareness	
Deliberation	
Determination	
Knowledge	 Preference	construction	
Information	
search	
Appraisal	of	knowledge	
sufficiency	
Imagining	
counterfactuals	
Affective	
forecasting	
Ranking	
options	
Decisional	Conflict	
Scale	 O’Connor,	1995	
✔	 ✔	 ✔	 ✖	 ✖	 ✔	 ✔	
Satisfaction	with	
Decision	Scale	
Holmes-Rovner,	
1996	
✖	 ✖	 ✔	 ✖	 ✖	 ✖	 ✔	
Decision	Attitude	
Scale	 Sainfort,	2000	
✖	 ✖	 ✔	 ✖	 ✖	 ✖	 ✔	
PrepDM	 Bennett,	2010	 ✔	 ✔	 ✔	 ✖	 ✖	 ✔	 ✔	
SDM-Q	 Simon,	2006	 ✖	 ✔	 ✖	 ✖	 ✖	 ✔	 ✔	
SURE	 Legare,	2010	 ✖	 ✔	 ✔	 ✖	 ✖	 ✔	 ✔	
COMRADE	 Edwards,	2003	 ✔	 ✔	 ✔	 ✖	 ✖	 ✔	 ✔	
Decision	Evaluation	
Scales	 Stalmeier,	2005	
✖	 ✔	 ✔	 ✖	 ✖	 ✖	 ✔	
Decision-Making	
Quality	Scale	 Hollen,	1994	
✔	 ✔	 ✔	 ✔	 ✔	 ✔	 ✖	
Decision	Self-efficacy	
Scale	 Bunn,	1996	
 ✔	 ✔	 ✔	 ✖	 ✖	 ✔	 ✔	
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Table 45: Mapping of words from scale items against stages of decision-making 
process 
	
Decision	process	stage	
	
	
Terms	encountered	during	mapping	
Option	awareness	
	
Options	exist	and	these	options	need	
to	be	understood	and	considered	
	
	
Awareness,	options,	choices,		
recognise,	different,	search,	more,	available,		
Deliberation	
• Knowledge	
Information	search	
	
	
Benefits,	risks,	pro,	con,	side	effects,	advantages,	disadvantages,	
think,	option,	facts,	know.	
Appraisal	of	knowledge	
sufficiency	
More,	advice,	satisfied	informed,	need,	enough,	unsure,	other	
person,	questions	want	to	ask,	support,	adequate,	clearer,	
understand,	delay.		
	
• Preference	construction	
Imagining	counterfactuals	
	
	
Consequences,	detailed	plans	and	back-up	plans	
	
Affective	forecasting	
	
	
Takes	into	account	all	goals	desired		
Ranking	options	
	
Best	for	me,	important	to	me,	matters	most	to	me,	hard	to	
decide,	organise	thought,	weighed	thoroughly,	clear,	considers	
new	information	against	initial	choice,	review	with	care,	each	
choice,	”I	know…	“,	concern.		
	
Determination	
	
Integrating	deliberation	input	and	
making	a	choice,	prior	to	enacting	a	
decision.	
	
Intention,	certainty	and	evaluation	
of	decision	made.		
	
	
Decision,	timing/tense,	satisfied,	sure,	hard	to	do,	intention	to	
act,	informed	choice	made,	prepared	to	talk,	best	possible,	
sound,	comfortable,	right	for	context,	difficult,	better,	know	
now,	right,	doubt,	frightened,	regret,	choice,	clear.	
	
	
 
This chapter reported the results of a content mapping process, which 
determined the extent existing measures addressed the stages of a decision 
process model incorporating deliberation.  
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7. Discussion 
In this chapter, the systematic review and content mapping findings are 
summarised and placed in the context of knowledge to date, with the 
implications for developing a new measure of the decision-making process 
considered. The study design is outlined and its strengths and limitations 
discussed.  
 
7.1. Summary 
This systematic review answers the research question: to what extent do 
existing measures of decision-making consider the processes of decision 
making such as deliberation? 
 
The aim was to systematically identify and analyse existing measures of 
shared-decision making that consider the process from the patient’s 
perspective, determining the extent the items map onto a decision process map 
incorporating deliberation. As part of the analysis, the rigour of measure 
development process was considered along with the measurement properties 
of the instruments themselves. (Mokkink et al., 2012, Terwee et al., 2007) 
 
The results indicate that current measures of decision-making do not consider 
all steps of the decision process. There is also marked variation in the 
methodological approach for instrument development and the quality of 
existing instruments’ measurement properties. The Decision Making Quality 
Scale (DMQS), developed by Hollen and based on Janis and Mann’s work on 
quality decision-making, addresses aspects of deliberation not covered by other 
measures. The recommendations for a new instrument will therefore consider 
the work of Hollen, Janis and Mann. (Hollen, 1994, Janis and Mann, 1977) 
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7.2. Discussion of findings  
7.2.1. Key findings 
Ten eligible measures were identified, along with nine further evaluation 
studies for these scales.  
 
The methodological quality was highly variable, both between studies and 
when considering the approach to different measurement properties within 
studies.  None of the scales were found to score consistently well across all 
measurement properties when compared to the quality criteria. (Terwee et al., 
2007) 
 
When mapped against the model of deliberation and determination proposed 
by Elwyn and Miron-Shatz, no scale addressed all stages. (Elwyn and Miron-
Shatz, 2010) The most frequently addressed stages were appraisal of 
knowledge sufficiency and determination. The Decision Making Quality Scale 
(DMQS) developed by Hollen was the only scale to address the imagining 
counterfactuals and affective forecasting elements of the preference 
construction stage. It also mapped against most stages of the decision process, 
with determination being the only one missing. (Hollen, 1994) 
 
7.2.2. Findings in the context of knowledge to date 
7.2.2.1. The methodological approach in existing studies concerning measures of shared 
decision-making 
The development and measurement properties of a scale have been shown to 
influence study outcomes. (Marshall et al., 2000, O'Connor et al., 1996) As 
such, the use of a poorly developed scale carries consequences for research 
findings and clinical practice.  Scholl and colleagues have previously 
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highlighted the variable methodological quality in the development of shared 
decision-making scales and also identified the COSMIN scale as possible 
guidance for future studies. (Scholl et al., 2011) This current work is the first 
application of such reproducible standards to a systematic review in this field. 
It confirms shortcomings in the methodological approaches taken to date for 
measures considering the patient perspective. That a measure reported as 
recently as 2014 was excluded due to the absence of any psychometric 
evaluation suggests this is an ongoing issue. (Kaltoft et al., 2014) However, 
with the development of COSMIN and a growing focus on measurement 
instruments and shared decision-making, future studies can access guidance 
and checklists from the early stages of scale development, leading to greater 
rigor and consistency in both methodology and reporting of measure 
development. (Johnston and Graves, 2008) 
 
7.2.2.2. The measurement properties of existing instruments 
Shared decision-making is a rapidly evolving field, which is likely to further 
increase with growing evidence-based medicine, healthcare options, patient 
autonomy and access to information. (Elwyn et al., 2012, Légaré et al., 2010b, 
Collings and Coulter, 2015) The impact of decision aids has been 
demonstrated in diverse fields and yet varying measurement property 
performances were found when a criteria of adequacy was applied to existing 
measures of shared decision-making. (Stacey et al., 2014) This needs to be 
taken into consideration when using these existing measures in studies of 
shared decision-making and interpreting findings based on their use in 
previous research.  
 
Measurement properties are not fixed characteristics of instruments and are 
instead influenced by the context in which they are used. As such, scales 
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should be retested when used in new settings or groups. (Streiner and 
Norman, 2008) This issue was emphasised by the shifting performance of 
instruments in further evaluation studies. For example, key features such as 
the number of subscales identified in a measure altered depending on the study 
context. (O'Connor, 1995, Koedoot et al., 2001) 
 
Scales measuring shared decision-making are increasingly used in intervention 
studies, such as those evaluating the impact of decision aids. The importance 
of reliability and responsiveness increases in contexts where scores obtained 
with an instrument are expected to change. (Mokkink et al., 2010b) However, 
these measurement properties are currently among the least often examined. 
To accurately measure the impact of decision support on the decision-making 
process in future, information is needed on these aspects of scale performance.  
 
It is understandable that in rapidly growing fields such as measure 
development and shared decision-making, initial studies were pragmatic, 
clinically-based investigations but a more robust approach is required for 
future findings to be meaningful. Johnson and Graves note that scales are often 
chosen due to tradition or popularity rather than consideration of “the quality 
of a measure for a particular construct or application.” (Johnston and Graves, 
2008) As such, researchers and clinicians should call for relevant, valid and 
reliable tools, encouraging the development of scales that meet quality 
standards.  
 
7.2.2.3. What is already known about shared decision-making and deliberation? 
Scholl and colleagues arranged existing measures of shared decision-making 
according to whether they addressed antecedents, processes or outcomes of 
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decision-making. (Scholl et al., 2011) The included measures considered the 
decision process from the perspective of patients, clinicians or observers. 
(Scholl et al., 2011) Of those they identified as measuring decision processes, 
such as the OPTION scale or the 9-item Shared Decision-Making 
Questionnaire, none were found to focus on the process of deliberation from 
the patient perspective in this review. The scales instead focused on appraising 
the shared decision-making process either from a patient, clinician or observer 
viewpoint. (Edwards et al., 2003, Simon et al., 2006) Yet, as Edwards and 
Elwyn suggest, without understanding the decision-making process, 
interventions are influencing outcomes without insight into the mechanism of 
action. (Edwards and Elwyn, 2006) In further work by these authors, decision 
processes such as deliberation are highlighted as a point where support may be 
needed to facilitate shared decision-making, as the patient may otherwise feel 
abandoned, wary of participating, surprised, unsettled, and uncertain about 
their decision and capacity. (Elwyn et al., 2012) 
 
Elwyn and Miron-Shatz highlighted the problem of using knowledge, 
preferences and outcomes to measure the decision-making process, suggesting 
instead the analysis of deliberation as an indicator of decision-making quality. 
(Elwyn and Miron-Shatz, 2010) The decision process model incorporating 
deliberation outlined by these authors has the following facets: option 
awareness, information search, knowledge gain, appraisal of knowledge 
sufficiency, imagining counterfactuals, affective forecasting and preference 
construction. This is illustrated in Figure 4, revisiting the diagram shown 
earlier in Chapter 1. (Elwyn and Miron-Shatz, 2010) 
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Figure 4: Model of decision-making process incorporating deliberation 
(revisited) 
 
 
Only one instrument was found to consider the facets of deliberation as 
described by Elwyn and Miron-Shatz. The Decision Making Quality Scale 
(DMQS) developed by Hollen considers each aspect of deliberation detailed 
above. (Hollen, 1994) This scale is based on Janis and Mann’s conflict model of 
decision-making, which considers decision-making in high stress contexts with 
potential losses regardless of the choice made. (Hollen, 1994)  This model, 
adapted by Hollen, has six non-linear stages: situation appraisal, option 
assessment, weighing choices, deliberation, evaluation and adherence to choice 
in the face of challenge. (Hollen, 1994)  Janis and Mann also describe styles of 
decision-making, both positive and negative, based on behaviour at each of 
these stages. (Janis and Mann, 1977) A feedback loop occurs between each 
stage of the decision process, with the decision maker appraising options 
available as well as their perceived hope and resources for finding a better 
	  137 
alternative. (Janis and Mann, 1977) Similar to the “bounded rationality” of 
decision heuristics, restrictions such as time and resources are considered both 
as contributing to the decision made and also influencing the decision style. 
(Janis and Mann, 1977, Elwyn et al., 2001a) This work also informed the 
development of O’Connor’s Decisional Conflict Scale, although this focuses on 
conflict as a marker of the decision-process, rather Janis and Mann’s criteria for 
quality decision-making, which are outlined in Table 46. (O'Connor, 1995) 
 
Table 46: Janis and Mann’s criteria for quality decision-making  
Janis	and	Mann’s	criteria	for	quality	decision-making	
Thorough	canvassing	of	alternatives	
Thorough	canvassing	of	objectives	
Careful	evaluation	of	consequences	
Thorough	search	for	information	
Unbiased	assimilation	of	new	information		
Careful	re-evaluation	of	consequences	
Thorough	planning	for	implementation	and	contingencies	
 
In focusing on deliberation due to concerns over the potential bias of post-hoc 
evaluation of decision quality, Hollen describes similar reasoning as Elwyn and 
Miron-Shatz. (Hollen, 1994, Elwyn and Miron-Shatz, 2010) That is, once a 
decision is made, it is difficult to evaluate the decision process without the 
influence of outcomes and opportunities lost. As such, the DMQS is the only 
included scale that did not measure determination. It is not driving the 
individual to a decision, instead reflecting on the decisional process and 
explicitly exploring desired goals and the potential for things not going to plan. 
(Hollen, 1994) In addition, the scale is generic rather than tailored to a specific 
decision context. Streiner and Norman highlight the strength of such scales 
due to their generalisability and breadth of perspective, concluding that they 
yield comparable results to disease or context specific scales. (Streiner and 
Norman, 2008) 
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However, there is some conflict between the work of Hollen, based on Janis 
and Mann, and that proposed by Elwyn and Miron-Shatz. (Elwyn and Miron-
Shatz, 2010, Hollen, 1994, Janis and Mann, 1977) The former explicitly 
emphasises the non-linear nature of decision processes and the recognition of 
external factors such as time pressure and stress, in contrast to the decision 
process model of Elwyn and Miron-Shatz. (Elwyn and Miron-Shatz, 2010, 
Hollen, 1994) There is also the influence of those around the decision maker, 
as described in Bandura’s Social Learning theory and the interlinked autonomy 
referenced by Elwyn and colleagues. (Bandura, 1977, Elwyn et al., 2012) 
These, along with past experiences, directly impact on an individual’s ability to 
gather and appraise information – influences that should be considered in the 
decision process.  
 
Elwyn and colleagues have noted these limitations in subsequent work. In 
2012, the clinical model of shared decision-making incorporating deliberation 
acknowledged the “psychological, emotional and social factors” involved. It 
also noted the contribution of others in the decision-making process. (Elwyn et 
al., 2012) In 2014, an expert-led discussion addressed the collective nature of 
decisions, developing a collaborative deliberation model that considered the 
role of people in addition to the individual at the centre of the process. (Elwyn 
et al., 2014) The decision process is seen as a social act, drawing on the 
support of others and influenced by socially constructed norms, rather than a 
choice made by an individual in isolation. This work also acknowledges the 
emotional context and resource constraints impacting on the decisional 
process. (Elwyn et al., 2014) 
 
The work of Elwyn and Miron-Shatz, along with the subsequent collaborations, 
are expert-led recommendations and as such can be argued to be opinion-based 
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and subjective. (Elwyn and Miron-Shatz, 2010, Elwyn et al., 2014, Elwyn et al., 
2012) Yet Janis and Mann made similar observations in 1970s and Hollen in 
the 1990s, suggesting a consistent theme that warrants further investigation. 
Despite this, Hollen’s work is among the least often cited of the included 
scales, with 24 citations on Web of Science in comparison with the 565 of 
O’Connor’s Decisional Conflict Scale. (Hollen, 1994, O'Connor, 1995) While 
this may reflect the challenge of measuring what seems hard to define – 
Edwards and Elwyn’s proposed “black box” of the decision-making process - it 
is important not to neglect further.  (Edwards and Elwyn, 2006) With the 
exception of the DMQS, current instruments are neglecting the personal, 
challenging aspects of decision making such as affective forecasting and 
imagining counterfactuals, the omission of which in health-related decisions 
could have a profound effect on the choices made.  
 
In addition, the varied approaches to defining and measuring decision-making 
suggest the need to move from a reductionist approach. With varying 
timescales, contexts, stresses and decision-making styles, it is unlikely that one 
measure will suit all needs. The recent collaborative deliberation model notes 
this, emphasising that preference construction can be achieved through a range 
of processes, both analytical and otherwise. (Elwyn et al., 2014) Perhaps what 
is needed is a decision evaluation toolkit, as also suggested by Scholl and 
colleagues, with measures for different circumstances just as there are different 
methodologies for different research, different investigations for different 
symptoms. (Scholl et al., 2011) Whatever is done, it must be robustly 
developed and evaluated to ensure validity and reliability in view of the impact 
of misleading measures in healthcare.  
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7.3. Implications for developing a measure of patient deliberation 
7.3.1. Specifications for a new instrument  
Streiner and Norman identify devising items as the first step in developing a 
measure, but also recommend avoiding duplication of efforts and unnecessary 
resource use by appraising the suitability of pre-existing scales and research, 
and building on these where possible. (Streiner and Norman, 2008) The 
DMQS was the only scale that covered all steps of deliberation in the decision-
making process proposed by Elwyn and Miron-Shatz. However, the 
methodological design and measurement properties for the scale performed 
poorly, limiting its further application. (Streiner and Norman, 2008, Johnston 
and Graves, 2008) 
 
The DMQS drew on the work of Janis and Mann, and therefore the new scale 
should be structured to cover each domain of Elwyn and Miron-Shatz’s 
decision process model and also Janis and Mann’s criteria for quality decision-
making. (Elwyn and Miron-Shatz, 2010, Hollen, 1994, Janis and Mann, 1977) 
In addition, the new scale could draw on items identified in pre-existing scales. 
However, it is also important to develop the affective forecasting and imagining 
counterfactuals items, as these were identified least often in existing measures. 
These foundation elements for a new scale are summarised in the first three 
columns of Table 47 below. 
 
Two versions of the scale could be developed. A quantitative measure would 
allow evaluation of scores and comparisons of repeated measurements, such as 
before and after an intervention. A more qualitative, open question style based 
on Janis and Mann’s decision quality criteria, as outlined in the fourth column 
of Table 47, would allow flexibility and individual reflection, which could then 
be used to guide more in-depth decision support counselling.  
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A further aspect to be considered is the timing of scale administration. Based 
on the findings of this work, the scale should be designed for completion 
before a decision is made, especially for consequential decisions, as post-hoc 
evaluation of the decisional process outcomes is open to the influence of 
outcomes and bias. (Hollen, 1994, Elwyn and Miron-Shatz, 2010) 
 
In practice, a measure considering the decisional process from the patient’s 
perspective would allow tailored, targeted support to areas of the decision-
making process. It would facilitate a more nuanced understanding of what 
makes a good decision for an individual, moving away from the rigidity of 
externally applied criteria such as those for knowledge, preference and 
satisfaction alone.   
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Table 47: Foundations for a new scale 
 
Elwyn	and	Miron-
Shatz’s	decision	process	
model	stages	
Pre-existing	terms	
encountered	during	
item	mapping	
Janis	and	Mann’s	
criteria	for	quality	
decision-making	
More	discursive	items	
to	gather	reflections	
	
Option	awareness	
Options	exist	and	these	
options	need	to	be	
understood	and	
considered	
	
Awareness,	options,	
choices,		
recognise,	different,	
search,	more,	
available.	
	 	
Deliberation	
• Knowledge	
Information	
search	
Benefits,	risks,	pro,	
con,	side	effects,	
advantages,	
disadvantages,	think,	
option,	facts,	know.	
Thorough	search	for	
information		
	
Thorough	canvassing	
of	alternatives	
	
Unbiased	assimilation	
of	new	information	
	
What	am	I	mostly	
basing	my	decision	on?	
	
Other	than	the	
information	given,	
what	extra	things	are	
influencing	my	choice?	
	
Appraisal	of	
knowledge	
sufficiency	
More,	advice,	satisfied	
informed,	need,	
enough,	unsure,	other	
person,	questions	
want	to	ask,	support,	
adequate,	clearer,	
understand,	delay.		
• Preference	construction	
Imagining	
counterfactuals	
	
Consequences,	
detailed	plans	and	
back-up	plans	
Careful	evaluation	of	
consequences		
	
Thorough	canvassing	
of	objectives		
	
Careful	re-evaluation	
of	consequences		
	
Thorough	planning	for	
implementation	and	
contingencies	
	
What	problems/goals	
can	I	see	coming	with	
each	choice?	
	
How	would	I	handle	
each	of	them?	
	
Has	looking	into	the	
choices	more	changed	
what	I	think	might	
happen?	If	so,	how?	
	
Has	it	changed	how	I	
feel?	
Affective	
forecasting	
Takes	into	account	all	
goals	desired		
Ranking	
options	
Best	for	me,	important	
to	me,	matters	most	to	
me,	hard	to	decide,	
organise	thought,	
weighed	thoroughly,	
clear,	considers	new	
information	against	
initial	choice,	review	
with	care,	each	choice,	
”I	know…	“,	concern.		
Determination	 	 	 	
Integrating	deliberation	
input	and	making	a	
choice,	prior	to	enacting	
a	decision.	
	
Intention,	certainty	and	
evaluation	of	decision	
made.		
	
Decision,	timing/tense,	
satisfied,	sure,	hard	to	
do,	intention	to	act,	
informed	choice	made,	
prepared	to	talk,	best	
possible,	sound,	
comfortable,	right	for	
context,	difficult,	
better,	know	now,	
right,	doubt,	
frightened,	regret,	
choice,	clear.	
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7.3.2. Assessing the decision context 
In addition to a scale measuring patient deliberation, limitations identified 
with the Elwyn and Miron-Shatz model could be further addressed with the 
development of complementary tools to assess the internal and external 
context in which the decision takes place, as illustrated in Figure 5 below. This 
would draw on Janis and Mann’s decisional conflict model, along with 
collaborative decision-making and shared decision-making for clinical practice 
models. (Janis and Mann, 1977, Elwyn et al., 2014, Elwyn et al., 2012)   
 
Figure 5: Assessing the decision context 
 
 
For the internal or individual decision context, potential facets to consider 
include the patient’s narrative of the situation; their emotional state, how they 
perceive their role in the decision and previous decision-making experiences 
and style.  
 
External or collective decision contexts to consider include the alternatives and 
resources available, the experiences and perspectives of other people involved 
in the situation, and any identifiable wider influences or patterns.  
External decision context
Internal decision context
Decision processDecision process
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Evaluation of internal and external decision contexts would allow 
consideration of all interconnected elements that might influence the decision, 
placing it both within the unique context of the individual and the wider 
setting. (Williams and Hummelbrunner, 2010) This offers learning relevant 
not just to the decision in question, but also for future decisions. Both the 
patient and others involved, such as the healthcare team, could benefit, with 
the external and collective factors likely to be of relevance to other patients and 
wider healthcare practice. For example, continued issues with staffing, 
treatment options or other resources may lead to a change in the provision of 
care or commissioning.  
 
These areas may be more suitable to collaborative exploration, for example 
with the patient, their support network and the healthcare team.  In addition, 
further work is needed to explore how such elements could be assessed 
efficiently in often time-pressured healthcare settings.  
 
7.3.3. Developing a new measure 
Methods for developing new scales include involving the population of interest, 
seeking expert opinion and basing items on research, clinical observation or 
theory. (Streiner and Norman, 2008) The work of Janis and Mann, which 
underpinned the DMQS, along with more recent decision-process models 
proposed by experts in shared decision-making, together provide a strong 
foundation for the development of a new measure and should be utilised in the 
development of a new scale. (Elwyn and Miron-Shatz, 2010, Hollen, 1994, 
Janis and Mann, 1977, Elwyn et al., 2012, Elwyn et al., 2014) However, the 
voices of the patients themselves are currently marked in their absence. As 
such, the next steps in scale development should involve the people for whom 
the scale is intended.  
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A key element to address is to further develop understanding of the decision-
making process from the patient perspective. Recent work by Barr and Elwyn 
has also supported the importance of target group involvement, highlighting 
the potential impact on scale interpretation and validity, and therefore on 
research findings. The authors suggest cognitive interviews as an alternative 
method, where item interpretation and participant responses are explored in 
depth. (Barr and Elwyn, 2015) Other possible methods include using focus 
groups, targeted interviews or observational studies to further explore and test 
the relevance existing theories and models. (Elwyn and Miron-Shatz, 2010, 
Streiner and Norman, 2008) 
 
While these methods move closer to incorporating patient’s views, they are 
more limited in their exploration of the patient’s experience of the decision-
making process and also of collaborating with healthcare professionals. In 
addition, they remain researcher-led, with researchers ultimately determining 
interview topics and provisional scale items. As such, another option is to use a 
more participative approach, with the study design developed and delivered by 
patients working with research and clinical teams. (Olshansky et al., 2005) 
This collaborative exploration of the decision-making process would be more 
in keeping with the underlying principles of shared decision-making, while the 
process itself would also provide insight into the mechanics of collaboration 
and co-production in healthcare.  
 
Another consideration is the sampling strategy and recruitment process used 
in future studies. The recent study by Barr and Elwyn highlighted the need for 
a representative or generalisable sample to be included in instrument 
development, as the participants involved were mostly university educated, 
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with no other demographic details described except age and gender. (Barr and 
Elwyn, 2015) Similar patterns were encountered in the development studies of 
instruments included in this review. There is a risk of contributing to health 
inequalities by omitting members of the population from such research and 
failing to gather insights from groups that may already find accessing shared 
decision-making challenging (Elwyn et al., 2014), and further research should 
specifically address this in the study design.  
 
The findings from a participative exploration of the decision-making process 
should then be used to review the recommendations made in this study, 
including the specifications for a new measure of patient deliberation and the 
proposed complementary tools for internal and external decision contexts.  
 
Once the foundations of the scale have been further established and the 
proposed scale revisited, robust measure development and evaluation is 
needed. This should include development work with patient groups, along with 
consideration of the accessibility of the tools produced. The COSMIN checklist 
should be used to guide which measurement properties to use and how to best 
evaluate them. (Mokkink et al., 2012) There must also be clear performance 
criteria for the scale’s measurement properties in keeping with guidance, such 
as those developed by Terwee and colleagues, and used in this review. (Terwee 
et al., 2007)  
 
The process of developing a measure of deliberation from the patient’s 
perspective will not be without challenges. Scale development is a resource 
intensive process. (Streiner and Norman, 2008) The nuance of terms and 
phrases as used in the scales identified in this review re-iterates the importance 
of target group involvement. Elwyn and colleagues confirm this in recent work 
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where the terms options, decisions and preferences were identified as 
unfamiliar and barrier forming by people attending a medical centre. (Elwyn et 
al., 2013) The steps of forecasting the future and imagining counterfactuals are 
potentially emotionally laden and psychologically challenging in some medical 
contexts, particularly where choices may alter long-term goals and plans. This 
would be more complicated in patient journeys that involve a change of 
perceived identity or life narrative by illness. (Hydén, 1997) In addition, the 
scale developed needs to be practical to use in time-pressured clinical settings. 
Such challenges underline the need for such measures to be robustly developed 
and evaluated.  
 
7.3.4. Next steps 
In summary, the recommended next steps for developing a scale to measure 
the patient’s perspective of decision-making processes are: 
1. Improve understanding of decision-making processes and collaboration in 
healthcare from the patient’s perspective using a participative research 
approach.  
2. Use the findings to revisit the proposed scale outlined in this study, along 
with the suggested use of recent models of shared decision-making and the 
work of Janis and Mann as foundations for the scale. 
3. Amend the proposed scale and develop complementary tools for the internal 
and external decision contexts, if still indicated. 
4. Design a robust and transparent instrument development study using the 
COSMIN standards, and evaluate the new scale’s psychometric properties 
using criteria such as those developed by Terwee and colleagues. 
5. Ensure an inclusive sampling and recruitment strategy at each step, along 
with evaluation of the accessibility and functionality of the scale produced.   
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7.4. Methodology of the review 
7.4.1. Overview of method 
The systematic review search strategy was developed in accordance with 
guidelines, with additional advice from an information specialist and medical 
librarian. (Critical Appraisal Skills Programme (CASP), 2011, Higgins and 
Green, 2011, Mann, 2011, Moher et al., 2009)Seven electronic databases 
(Medline, EMBASE, Cochrane Library, PsycInfo, Assia, CINAHL and Medline 
in Process) were searched with no restrictions placed on language or date. 
Additional searches included manual searches of the most frequently cited 
journals, the references of included reports and additional database searches 
using the name of each included scale. The searches were repeated in July 
2014.  
 
Studies were included if they reported on the development and psychometric 
evaluation of an instrument designed to measure shared decision-making in 
the health-care setting, specifically the patient’s perspective of the decision 
making process. A second reviewer reviewed ten per cent of the references 
independently. 
 
A total of 7,927 references were identified from the electronic databases. 1,380 
duplicates were removed. Following title and abstract review, 168 progressed 
to full text review. Of these, ten studies involving the development of measures 
were included and a further nine addressed the further evaluation of 
instruments. No further instruments or evaluation studies were identified 
through the additional searches.   
 
Data extraction fields were: i) the descriptive features of the study and scale ii) 
assessment of study methodological quality using the COnsensus-based 
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Standards for the selection of health Measurement INstruments (COSMIN) 
checklist as reproducible standards iii) assessment of the scale measurement 
properties using predefined criteria of adequacy and iv) content evaluation of 
the scale by mapping the items against decisional process map incorporating 
deliberation. (Elwyn and Miron-Shatz, 2010, Mokkink et al., 2012, Terwee et 
al., 2007)The results were summarised using narrative synthesis due to the 
heterogeneity of the included studies. (Higgins and Green, 2011) However, a 
COSMIN scoring system and summaries of the measurement properties and 
content mapping for included scales were used to improve the clarity of the 
results. (Terwee et al., 2012) 
 
7.4.2. Strengths 
Systematic reviews are rigorous, transparent summaries of research evidence 
where information is gathered and analysed according to a pre-agreed, 
reproducible process that reduces sources of bias where possible. (Hemingway 
and Brereton, 2009) 
 
A robust systematic review was developed using recognised guidance from the 
Cochrane Collaboration and the Centre for Reviews and Dissemination. 
(Higgins and Green, 2011, Centre for Reviews and Dissemination, 2009, de 
Vet et al., 2008) However, these guidelines were mostly concerned with 
systematic reviews of interventions or diagnostic tests and addressed different 
study designs to those used in the development of measures of shared 
decision-making.  Additional guidance was sought by searching the literature 
available on the development of measures and patient-reported outcomes. This 
led to the identification of the work by Mokkink and colleagues, which 
includes the development of the COSMIN checklists. (Mokkink et al., 2009) 
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The use of these resources contributed to a more robust, transparent 
systematic review. The protocol was presented to colleagues in the Decision 
Laboratory at the Institute of Primary Care and Public Health, Cardiff 
University and checked against the Preferred Reporting Items for Systematic 
Reviews and Meta-Analysis (PRISMA) statement. (Liberati et al., 2009) 
 
A thorough search strategy was developed, incorporating several diverse 
electronic databases and supplemented by manual searches, review of the 
references of included reports and additional measure-specific database 
searches. A sensitive strategy was used due to the limitations and challenges in 
searching for measures of patient reported decision-making processes, such as 
variation in the terms used by authors and indexing on databases. (Mokkink et 
al., 2009) While this produced a high number of references, it ensured greater 
detection of potentially eligible studies. Once the duration of the project 
became apparent, the searches were repeated in order to keep the findings 
relevant and up-to-date.  
 
Two independent reviewers were involved in the study selection, with a third 
reviewer available for consultation in the event of differing opinions. Both first 
and second reviewers are from fields separate to that of shared decision-
making and decision support, thus providing independent perspectives. The 
third reviewer has extensive experience in these fields and therefore provided 
expertise and guidance as needed without overly influencing the decisions 
made. (Lefebvre et al., 2009) 
 
The study selection and data extraction processes were piloted, allowing 
identification of any issues and assessment of inter-reviewer consistency. 
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Electronic data extraction forms were used to facilitate record keeping and 
sharing. (Higgins and Green, 2011) 
 
A previously identified issue in existing systematic reviews of measurement 
instruments is the limited use of reproducible standards for methodological 
quality and criteria for scale measurement properties. (Mokkink et al., 2009) 
These factors influence scale quality and also their suitability for use in 
research and clinical practice. As such, the COSMIN standards for study design 
and measurement property criteria produced by Terwee and colleagues were 
applied in this review. (Mokkink et al., 2012, Terwee et al., 2007) 
 
7.4.3. Limitations  
When developing the search strategy, a grey literature search was not included 
as the variations in indexing and terminology noted for published resources 
would be further compounded in unpublished work, placing it beyond the 
scope of this review’s resources. However, this does open the findings to 
publication bias. (Hemingway and Brereton, 2009) In addition, omitting grey 
literature meant that online resources about the scales, such as those for the 
Decisional Conflict Scale (DCS), were not identified. (O'Connor, 2010) In 
addition, the database Scopus was not searched as it was new at the time of 
project development and there was uncertainty over which databases would be 
covered by its use. The searches were repeated in July 2014 due to the duration 
of the project, but an alternative approach would have been to create search 
alerts on databases. (Higgins and Green, 2011) 
 
Resource limitations influenced what was possible during the project. For 
example, contacting authors for further information about scale development 
and leading experts to suggest measures in development was not possible with 
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the resources available. (Higgins and Green, 2011) However, this could have 
been anticipated due to known variation in terminology and reporting in the 
field of instrument development. (Mokkink et al., 2009) As such, future 
systematic reviews should allow sufficient time and resources for this step.  
 
A second reviewer participated in the study selection in order to reduce the 
potential selection bias introduced with only one reviewer. However, the 
sensitive search strategy produced a high number of results and time 
limitations meant that both reviewers screened only ten per cent of the 
references. This is considered an acceptable compromise by the Cochrane 
Collaboration guidance and ten per cent of the references still equated to 500 
titles and abstracts. (Higgins and Green, 2011) 
 
During the initial title and abstract review, a key aspect of the eligibility criteria 
wording was demonstrated. The second inclusion criterion was that the 
population involved in the study be patients involved in healthcare decision-
making for a decision regarding their own health or treatment. As such, the 
study and instrument had to measure the patient’s perspective of a decision-
making process. This emphasis excludes scales assessing role preference or 
consultation scoring and those testing patient knowledge of a specific 
condition or treatment. While the latter is an aspect of shared decision-making, 
answering specific questions regarding, for example, treatment side effect 
frequency does not reflect the patient’s perspective of the decision-making 
process. 
There were limitations in using the COSMIN checklist for methodological 
quality and the criteria for the measurement properties. At time of review, the 
checklist was only recently developed and still under evaluation. A Delphi 
process had been used during its production and aspects of the design are 
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debatable, such as exclusion of participants who were not published experts 
and the lack of justification for a 67% agreement threshold. (Mokkink et al., 
2010b) Similarly, for the four-point scoring version of the checklist, most of 
the development was led by one author, although a steering group oversaw the 
process and further evaluation planned. (Terwee et al., 2012) In addition, to 
date the COSMIN checklist is more frequently used for traditional clinical 
measures such as the evaluation of pain rather than shared decision-making. 
(Schellingerhout et al., 2012) 
 
The use of a checklist such as the COSMIN standards involves the application 
of a framework. While this creates transparency and reproducibility in the data 
extraction and evaluation, it can also be reductive, compressing study findings 
into a more standardised form with the potential loss of information. (Liberati 
et al., 2009) This is especially relevant for the four-point scoring version as, for 
example, the COMRADE scale was graded as poor for internal consistency, 
despite meeting all but one of the methodological standards for this property. 
(Edwards et al., 2003, Terwee et al., 2012) 
 
Systematic review and COSMIN guidelines recommend two independent 
reviewers for data extraction. (Higgins and Green, 2011, Centre for Reviews 
and Dissemination, 2009, Mokkink et al., 2009) Due to time restrictions, a 
second reviewer checked data extractions forms but did not independently 
perform data extraction. In addition, a suggested limitation of the COSMIN 
checklist is the intra-rater reliability, largely due to variation in item 
interpretation and study report terminology. (Mokkink et al., 2010a, 
Schellingerhout et al., 2012) Seeking additional reviewers to check data 
extraction would have addressed this issue, an option restricted by limited 
resources. However, in accordance with recommendations, the reviewers 
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discussed the data extraction fields before their use, reducing subjectivity 
introduced by individual independent interpretations. (Mokkink et al., 2010a, 
Schellingerhout et al., 2012 
 
Variation in the terminology was noted even between the COSMIN checklist 
and the quality criteria for instrument measurement properties, despite both 
having authors in common. In addition, there was repetition and variation in 
how the measurement properties were covered by the checklist and the quality 
criteria. For example, in the COSMIN checklist, the items for structural validity 
were already covered in other domains and this property was therefore omitted 
for clarity. Floor-ceiling effects are considered alone in the quality criteria but 
pooled with interpretability in the COSMIN checklist, while coverage of item 
response theory (IRT) was weak in the measurement property criteria in 
comparison with COSMIN. (Mokkink et al., 2012, Terwee et al., 2007) 
 
The variation in terminology and methods used were also notable between the 
studies identified. These are well illustrated by the further evaluation studies 
identified for the Decisional Conflict Scale (DCS), where the property 
identified as hypothesis testing or construct validity by the standards and 
criteria was termed criterion, contrast, discriminatory, convergent and 
divergent validity, and investigated using a broad range of approaches. 
(Katapodi et al., 2011, Knapp et al., 2009, Koedoot et al., 2001, Linder et al., 
2011, Mancini et al., 2006, Song and Sereika, 2006) As such, no meta-analysis 
was possible due to the variation in methods and statistical processes used. 
(Gopalakrishnan and Ganeshkumar, 2013) In addition, face validity was 
considered too subjective by the authors of COSMIN and was omitted from the 
standards, despite being an approach encountered often in measure 
development. (Mokkink et al., 2012) 
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When study authors were not explicit about the measurement properties 
assessed, this information was extrapolated from the reported approach taken 
as COSMIN advises, although this introduces the subjective analysis of the 
reviewer. (Mokkink et al., 2012) COSMIN also suggests that the measurement 
properties evaluated should depend on the perceived use of the scale. 
(Mokkink et al., 2012) In shared decision-making, for example, validity may be 
of greater relevance when determining decision readiness with reliability and 
responsiveness more so in a scale intended for decision aid evaluation. 
(Mokkink et al., 2012) In addition, for score interpretation, consideration of 
the minimally important change or difference (MID and MID) would aid 
application. (Mokkink et al., 2012, Terwee et al., 2007) However, such 
selectivity was rarely covered explicitly in study reports. It is also worth noting 
that the intended use of a scale may change over time especially with the 
increasing development of decision aids and interventions.  
 
The context specific nature of instrument measurement properties was 
illustrated by the further evaluation studies identified in this review, with the 
results of psychometric analysis differing between groups tested. For this 
review, the synthesis was therefore kept focused on the original development 
studies but this also highlights the need to re-evaluate measures when used in 
a new context or population. (Streiner and Norman, 2008) 
 
Items from the measures identified were compared to a decision process map 
incorporating deliberation. Elwyn and Miron-Shatz, drawing on their 
experience in the field of decision-making, developed the underlying model, 
which is described as “an agreed process map of decision-making”. (Elwyn and 
Miron-Shatz, 2010) However, the authors note its theoretical nature, with 
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further verification currently lacking. (Elwyn and Miron-Shatz, 2010) In 
addition, the item mapping performed in this review was subjective and based 
on the opinions of the reviewers involved. Alternative approaches would have 
been to include field experts or patient representatives in the process, while 
another option would have been to use a different review method, such as a 
realist synthesis. (Rycroft-Malone et al., 2012) However, these approaches 
would have been difficult with the resources available.  
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8. Conclusion 
This systematic review, the first in shared decision-making to utilise the 
COSMIN methodological standards, found that current measures of decision-
making do not consider all steps of the decisional process. (Mokkink et al., 
2012) Only the DMQS by Hollen, which is based on the work of Janis and 
Mann, considers the steps attributed to deliberation by Elwyn and Shatz. 
(Elwyn and Miron-Shatz, 2010, Hollen, 1994, Janis and Mann, 1977) In 
addition, the methodological approach and measurement properties for 
existing instruments are highly variable. As such, a suitable measure is needed 
to further explore the decision-making process and mechanism of action of 
decision support interventions. An instrument with robust methodological 
development and measurement properties, based on decision-process models 
incorporating deliberation and the work of Janis and Mann, is recommended.  
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9. Appendices 
Appendix 1: COSMIN measurement property definitions 
 
Term	 	
Definition	
Domain		 Measurement	
property		
Aspect	of	a	
measurement	
property		
Reliability		 	 	 The	degree	to	which	the	measurement	is	
free	from	measurement	error		
Reliability	
(extended	
definition)		
	 	 The	extent	to	which	scores	for	patients	who	
have	not	changed	are	the	same	for	repeated	
measurement	under	several	conditions:	e.g.	
using	different	sets	of	items	from	the	same	
health	related-patient	reported	outcomes	
(HR-	PRO)	(internal	consistency);	over	time	
(test-retest);	by	different	persons	on	the	
same	occasion	(inter-rater);	or	by	the	same	
persons	(i.e.	raters	or	responders)	on	
different	occasions	(intra-rater)		
	 Internal	
consistency		
	 The	degree	of	the	interrelatedness	among	
the	items		
	 Reliability		 	 The	proportion	of	the	total	variance	in	the	
measurements	which	is	due	to	‘true’	
differences	between	patients		
	 Measurement	
error		
	 The	systematic	and	random	error	of	a	
patient’s	score	that	is	not	attributed	to	true	
changes	in	the	construct	to	be	measured		
Validity		 	 	 The	degree	to	which	an	HR-PRO	instrument	
measures	the	construct(s)	it	purports	to	
measure		
	 Content	
validity		
	 The	degree	to	which	the	content	of	an	HR-
PRO	instrument	is	an	adequate	reflection	of	
the	construct	to	be	measured		
	 	 Face	validity		 The	degree	to	which	(the	items	of)	an	HR-
PRO	instrument	indeed	looks	as	though	they	
are	an	adequate	reflection	of	the	construct	
to	be	measured		
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	 Construct	
validity	
	 The	degree	to	which	the	scores	of	an	HR-
PRO	instrument	are	consistent	with	
hypotheses	(for	instance	with	regard	to	
internal	relationships,	relationships	to	
scores	of	other	instruments,	or	differences	
between	relevant	groups)	based	on	the	
assumption	that	the	HR-PRO	instrument	
validly	measures	the	construct	to	be	
measured	
	 	 Structural	
validity		
The	degree	to	which	the	scores	of	an	HR-
PRO	instrument	are	an	adequate	
reflection	of	the	dimensionality	of	the	
construct	to	be	measured		
	 	 Hypotheses	
testing		
Item	construct	validity		
	 	 Cross-
cultural	
validity		
The	degree	to	which	the	performance	of	
the	items	on	a	translated	or	culturally	
adapted	HR-PRO	instrument	are	an	
adequate	reflection	of	the	performance	of	
the	items	of	the	original	version	of	the	HR-
PRO	instrument		
	 Criterion	
validity		
	 The	degree	to	which	the	scores	of	an	HR-
PRO	instrument	are	an	adequate	
reflection	of	a	‘gold	standard’		
Responsiveness		 	 	 The	ability	of	an	HR-PRO	instrument	to	
detect	change	over	time	in	the	construct	
to	be	measured		
	 Responsiveness		 	 Item	responsiveness		
Interpretability		 	 	 Interpretability	is	the	degree	to	which	one	
can	assign	qualitative	meaning	-	that	is,	
clinical	or	commonly	understood	
connotations	–	to	an	instrument’s	
quantitative	scores	or	change	in	scores.		
 
Reproduced with permission (Mokkink et al., 2010c) 
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Appendix 2: COSMIN checklist sample 
 
Box F. Hypotheses testing  
Design requirements  
1  Was the percentage of missing items given?   
2  Was there a description of how missing items were handled?   
3  Was the sample size included in the analysis adequate?   
4  Were hypotheses regarding correlations or mean differences formulated a priori (i.e. before data 
collection)?   
5  Was the expected direction of correlations or mean differences included in the hypotheses?   
6  Was the expected absolute or relative magnitude of correlations or mean differences included in the 
hypotheses?   
7  for convergent validity: Was an adequate description provided of the comparator instrument(s)?   
8  for convergent validity: Were the measurement properties of the comparator instrument(s) 
adequately described?   
9  Were there any important flaws in the design or methods of the study?   
Statistical methods  
10 Were design and statistical methods adequate for the hypotheses to be tested?  
Source: COSMIN manual (Mokkink et al., 2012) 
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Appendix 3: Quality criteria for instrument measurement properties 
Reproduced with permission (Terwee et al., 2007) 
  
Property	 Definition	 Quality	criteria	
1.	Content	validity	 The	extent	to	which	the	domain	
of	interest	is	comprehensively	
sampled	by	the	items	in	the	
questionnaire		
	
+	A	clear	description	is	provided	of	
the	measurement	aim,	the	target	
population,	the	concepts	that	are	
being	measured,	and	the	item	
selection	AND	target	population	
and	(investigators	OR	experts)	were	
involved	in	item	selection;		
?	A	clear	description	of	above-
mentioned	aspects	is	lacking	OR	
only	target	population	involved	OR	
doubtful	design	or	method;		
-	No	target	population	involvement	
	0	No	information	found	on	target	
population	involvement.		
2.	Internal	
consistency	
The	extent	to	which	items	in	a	
(sub)scale	are	intercorrelated,	
thus	measuring	the	same	
construct		
	
+	Factor	analyses	performed	on	
adequate	sample	size	(7	*	#	items	
and	≥	100)	AND	Cronbach’s	alpha(s)	
calculated	per	dimension	AND	
Cronbach’s	alpha(s)	between	0.70	
and	0.95;		
?No	factor	analysis	OR	doubtful	
design	or	method	
-		Cronbach’s	alpha(s)	<	0.70	or	>	
0.95,	despite	adequate	design	and	
method			
0	No	information	found	on	internal	
consistency.		
Key: MIC = minimal important change; SDC = smallest detectable change; LOA = limits of agreement; 
ICC = Intraclass correlation; SD, standard deviation.  + = positive rating; ? = indeterminate rating; - = 
negative rating; 0 = no information available.   Doubtful design or method = lacking of a clear 
description of the design or methods of the study, sample size smaller than 50 subjects (should be at 
 least 50 in every (subgroup) analysis), or any important methodological weakness in the design or 
execution of the study.  
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3.	Criterion	validity	 The	extent	to	which	scores	on	a	
particular	questionnaire	relate	to	
a	gold	standard		
	
+	Convincing	arguments	that	gold	
standard	is	‘‘gold’’	AND	correlation	
with	gold	standard	≥0.70;		
?	No	convincing	arguments	that	
gold	standard	is	‘‘gold’’	OR	
doubtful	design	or	method;		
-	Correlation	with	gold	standard	
<0.70,	despite	adequate	design	
and	method;	
0	No	information	found	on	
criterion	validity.		
4.	Construct	
validity	
The	extent	to	which	scores	on	a	
particular	questionnaire	relate	to	
other	measures	in	a	manner	that	
is	consistent	with	theoretically	
derived	hypotheses	concerning	
the	concepts	that	are	being	
measured		
	
+	Specific	hypotheses	were	
formulated	AND	at	least	75%	of	
the	results	are	in	accordance	with	
these	hypotheses;		
?	Doubtful	design	or	method	(e.g.,	
no	hypotheses);	
	-	Less	than	75%	of	hypotheses	
were	confirmed,	despite	adequate	
design	and	methods;	
	0	No	information	found	on	
construct	validity.		
	
5.	Reproducibility	 	 	
	
	  163 
  
5.1.	Agreement	 The	extent	to	which	the	scores	
on	repeated	measures	are	close	
to	each	other	(absolute	
measurement	error)		
	
+	MIC	<	SDC	OR	MIC	outside	the	
LOAOR	convincing	arguments	that	
agreement	is	acceptable;		
?	Doubtful	design	or	method	OR	
(MIC	not	defined	AND	no	
convincing	arguments	that	
agreement	is	acceptable);		
-	MIC	≥	SDC	OR	MIC	equals	or	
inside	LOA,	despite	adequate	
design	and	method;		
0	No	information	found	on	
agreement.		
	
5.2.	Reliability	 The	extent	to	which	patients	can	
be	distinguished	from	each	
other,	despite	measurement	
errors	(relative	measurement	
error)		
	
+	ICC	or	weighted	Kappa	≥	0.70;		
?	Doubtful	design	or	method	(e.g.,	
time	interval	not	mentioned);	
	-	ICC	or	weighted	Kappa	<	0.70,	
despite	adequate	design	and	
method;		
0	No	information	found	on	
reliability.		
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Responsiveness	 The	ability	of	a	questionnaire	to	
detect	clinically	important	
changes	over	time		
	
+	SDC	or	SDC	<	MIC	OR	MIC	
outside	the	LOA	OR	RR	>	1.96	OR	
AUC	≥	0.70;		
?	Doubtful	design	or	method;			
-	SDC	or	SDC	≥	MIC	OR	MIC	equals	
or	inside	LOA	OR	RR	≤	1.96	OR	AUC	
<	0.70,	despite	adequate	design	
and	methods;		
0	No	information	found	on	
responsiveness.		
	
Floor	&	ceiling	
effects	
The	number	of	respondents	who	
achieved	the	lowest	or	highest	
possible	score		
	
+	≤15%	of	the	respondents	
achieved	the	highest	or	lowest	
possible	scores;		
?	Doubtful	design	or	method;		
-	>	15%	of	the	respondents	
achieved	the	highest	or	lowest	
possible	scores,	despite	adequate	
design	and	methods;		
0	No	information	found	on	
interpretation.		
	
Interpretability	 The	degree	to	which	one	can	
assign	qualitative	meaning	to	
quantitative	scores		
	
+	Mean	and	SD	scores	presented	
of	at	least	four	relevant	subgroups	
of	patients	and	MIC	defined;		
?Doubtful	design	or	method	OR	
less	than	four	subgroups	OR	no	
MIC	defined;		
0	No	information	found	on	
interpretation.		
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Appendix 4: Terms excluded from search strategy 
Concept	 Term	 Impact	on	search	results	
Shared	decision-making	 Choice	behaviour	
Decision	support	
techniques	
Decision	theory	
Too	broad:	focus	not	on	
decision-making	process		
Patient	education	
Comprehension,	
understanding	and	
knowledge	
Health	attitudes,	
knowledge	and	practice	
Focus	on	education	and	
knowledge	rather	than	
decision-making	
Co-operative	behaviour	
Physician-patient	
relationship	
Aspects	of	relationship	
rather	than	decision-
making	
Population	 Person,	subject		
Family,	carer	
Too	broad	
Not	from	patients’	
perspective		
Patient-centred	care	
Focused	or	orientated	
Shift	to	consultation	
approach	
Advocacy	or	empowerment	
Satisfaction,	opinion	or	
evaluation		
Empower,	involve,	promote	
or	support	
Shift	to	service	provision	
Healthcare	 Incorporates	clinician	
decision-making	
Instrument	 Data	collection	or	research	
design	
Interviews	or	self-report	
Too	broad	
	
Shift	to	qualitative	or	
diagnostic	
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Appendix 5: Search strategies 
5.1. Medline via Ovid 
 
1. ((patient* or client* or consumer*) adj3 decision making).mp. 
2. exp patients/ 
3. exp Patient Participation/ 
4. exp evaluation studies/ or exp validation studies/ 
5. psychometrics/ 
6. reproducibility of results/ 
7. (valid* or reliab*).mp. 
8. ((measur* or scal* or scor* or instrument* or survey* or tool* or question*) adj6 decision*).mp. 
9. exp Decision Making/ 
10. shared decision-making.mp. 
11. ((consider* or reflec* or deliberat*) adj3 decision*).mp. 
12. (decision* or choice* or prefer* or judg*).tw. 
13. or/1-3 
14. or/4-8 
 
 
5.2 EMBASE via Ovid 
 
1. ((measur* or survey* or scal* or scor* or instrument* or tool* or question*) adj6 decision*).mp. 
2. reproducibility/ 
3. evaluation/ 
4. validation study/ 
5. (valid* or reliab*).mp. 
6. or/1-5 
7. patient participation/ 
8. ((patient* or client* or consumer*) adj6 decision-making).mp. 
9. or/7-8 
10. patient decision making/ 
11. medical decision making/ 
12. shared decision-making.mp. 
13. (delib* adj3 decision-making).mp. 
14. ((consider* or reflec*) adj3 decision-making).tw. 
15. or/10-14 
16. 6 and 9 and 15 
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5.3.  The Cochrane Library via Wiley Online Library 
 
ID Search  
#1 ((patient* or client* or consumer*) near/3 "decision making"):ti,ab,kw  
#2 MeSH descriptor: [Patient Participation] 1 tree(s) exploded 
#3 #1 or #2  
#4 MeSH descriptor: [Evaluation Studies as Topic] explode all trees 
#5 MeSH descriptor: [Psychometrics] this term only 
#6 (measur* or scal* or scor* or survey* or instrument* or tool* or question*):ti,ab,kw  
#7 (valid* or reliab*):ti,ab,kw  
#8 #4 or #5 or #6 or #7  
#9 MeSH descriptor: [Decision Making] explode all trees 
#10 "shared decision making":ti,ab,kw  
#11 ((deliberat* or choice* or reflec*) near/3 "decision making"):ti,ab,kw  
#12 (decision* or choice* or prefer*):ti,ab,kw  
#13 #9 or #10 or #11 or #12  
#14 #3 and #8 and #13 
 
 
 
5.4. PsycINFO via Ovid 
 
1. exp Decision Making/ 
2. shared decision-making.mp. 
3. (decision* or choice* or prefer*).tw. 
4. ((consider* or reflec* or deliberat*) adj3 decision making).mp. 
5. or/1-4 
6. exp client participation/ 
7. ((patient* or client* or consumer*) adj6 decision making).mp. 
8. or/6-7 
9. ((measur* or survey* or scal* or scor* or instrument* or tool* or question*) adj6 decision*).mp. 
10. (valid* or reliab*).mp. 
11. exp Psychometrics/ 
12. or/9-11 
13. 5 and 8 and 12 
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5.5 . Medline in Process via Ovid 
 
1. ("evaluation studies" or "validation studies").mp. 
2. psychometric*.mp. 
3. "reproducibility of results".mp. 
4. ((measur* or survey* or scal* or scor* or instrument* or tool* or question*) adj6 decision*).mp. 
5. (valid* or reliab*).mp. 
6. or/1-5 
7. shared decision-making.mp. 
8. decision making.mp. 
9. (deliberat* adj3 decision making).mp. 
10. ((consider* or reflec*) adj3 decision making).mp. 
11. (decision* or choice* or prefer*).tw. 
12. or/7-11 
13. (patient adj (perspective or opinion)).tw. 
14. ((patient* or client* or consumer*) adj3 decision*).mp. 
15. or/13-14 
16. 6 and 12 and 15 
 
 
5.6. CINAHL via EBSCOhost 
 
Search	ID	number	 Search	terms	 Search	options	
S6	 S3	and	S4	and	S5	 Search	modes	–	
Boolean/Phrase	
S5	 (MH	"Decision	Making+")	OR	
(MH	"Decision-Making	Support	
(Iowa	NIC)")	OR	"deliberat$"	OR	
"reflec$"	OR	"deliberat$"	OR	
"shared	decision	making"	
Search	modes	–	
Boolean/Phrase	
S4	 (MH	"Patients+")	OR	(MH	
"Decision	Making,	Patient+")		
	
Search	modes	–	
Boolean/Phrase	
S3	 S1	or	S2	 Search	modes	–	
Boolean/Phrase	
S2	 (MH	"Validation	Studies")	OR	
(MH	"Evaluation	Research")	OR	
"valid$"	OR	"reliab$"	OR	(MH	
"Psychometrics")		
Search	modes	–	
Boolean/Phrase	
S1	 "measur$"	OR	"survey$"	OR	
"scal$"	OR	"scor$"	OR	
"instrument$"	OR	"tool$"	OR	
"question$"	
Search	modes	–	
Boolean/Phrase	
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5.7:  ASSIA via ProQuest 
 
(SU.EXACT("Patient participation") OR SU.EXACT("Patient control") OR SU.EXACT("Health 
professional-Patient interactions") AND SU.EXACT("Patients")) AND (SU.EXACT("Psychometric 
properties") OR all((valid* OR reliab*)) OR all((measur* OR survey* OR scal* OR scor* OR 
instrument* OR tool* OR question*))) AND (SU.EXACT("Decision making") OR all("shared 
decision making") OR all((deliber* OR consider* OR reflect*))) 
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Appendix 6: Comparison of COSMIN 4-point scale and checklist 
  
COSMIN	4-point	scale	
	 Pro	 Con	
Purpose	 Rating	system	where	
methodology	classified	
into	different	quality	
levels,	allowing	ease	of	
summary	and	
comparison	
	
Development	 Has	been	utilised	in	
published	systematic	
reviews	
Still	in	development	as	
main	reporting	paper	
based	on	conclusions	of	
only	one	reviewer	
Grading	system	used	in	
COSMIN	
	 Worst	score	counts	with	
conclusions	at	
measurement	property	
level	rather	at	individual	
item	or	components	
level,	with	subsequent	
loss	of	detail	
General	use	of	scoring	
system		
Quality	score	combines	
information	on	several	
features	into	one	value	
“Numerical	scales	
summarising	different	
components	can	be	
misleading…better	to	
describe”	(Liberati	et	al.,	
2009)	
COSMIN	checklist	
	 Pro	 Con	
Purpose	 Allows	separate	
standardised	judgement	
of	methodological	
quality	of	included	
studies	and	their	results.	
	
Component	based	
approach	to	
methodological	quality	
assessment	
Uses	component-based	
approach,	where	key	
dimensions	of	trial	
quality	are	individually	
examined	without	
calculating	a	score,		as	
recommended	by	
(Liberati	et	al.,	2009)	
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Appendix 7: Data extraction fields 
  
For	each	full	text	report:	 Data	extraction	field:	
Reference	details	
-	for	records	only	
Reviewer		
Date	of	review	
Descriptive	features		 Scale	name	
First	author,	year	
Reference	
Country		
Setting	
Population	
Decision	
Purpose	
Description	
Language	Citation	
Comments	
Methodological	quality	
-	COSMIN	checklist	and	COSMIN	4-point	
scale	
Reliability	
- Internal	consistency	
- Reliability	
- Measurement	error	
Validity	
- Content	validity		
																								-	Face	validity	
- Criterion	validity	
- Construct	validity		
																							-	Structural	validity	
																							-	Hypotheses-testing	
																							-	Cross-cultural	validity	
- Responsiveness	
- Interpretability	
- Generalisability	
Instrument	quality	
-	Terwee	et	al,	2007:	quality	criteria	for	
measurement	properties	of	instruments	
Content	validity	
Internal	consistency	
Criterion	validity	
Construct	validity	
Reproducibility	
- Agreement	
- Reliability	
Responsiveness	
Floor	and	ceiling	effect	
Interpretability	
Map	items	onto	
deliberation/determination	
components	
Option	awareness	
Deliberation	
-Knowledge	construct	
- Information	search	
- Appraisal	of	knowledge	sufficiency	
-	Preference	construction	
- Imagining	counterfactuals	
- Affective	forecasting	
- Ranking	options	
Determination	
Time	scale	between	deliberation	and	assessment	
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Appendix 8: Measurement scales 
  
8.1.  Decisional Conflict Scale (O'Connor, 1995) 
1. I know which options are available to me.  
2. I know the benefits of each option.  
3. I know the risks and side effects of each option.  
4. I am clear about which benefits matter most to me.  
5. I am clear about which risks and side effects matter most.  
6. I am clear about which is more important to me (the benefits or the risks and side effects).  
7. I have enough support from others to make a choice.  
8. I am choosing without pressure from others.  
9. I have enough advice to make a choice.  
10. I am clear about the best choice for me.  
11. I feel sure about what to choose.  
12. This decision is easy for me to make.  
13. I feel I have made an informed choice.  
14. My decision shows what is important to me.  
15. I expect to stick with my decision.  
16. I am satisfied with my decision.  
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8.2.  The Satisfaction with Decision Scale (Holmes-Rovner et al., 1996) 
1. I am satisfied that I am adequately informed about the issues important to my decision 
2. The decision I made was the best decision possible for me personally 
3. I am satisfied that my decision was consistent with my personal values 
4. I expect to successfully carry out (or continue to carry out) the decision I made 
5. I am satisfied that this was my decision to make 
6. I am satisfied with my decision 
 
 
8.3. Decision Attitude Scale, (Sainfort and Booske, 2006) 
1. My decision is sound 
2. I am comfortable with my decision 
3. My decision is the right one for my situation 
4. I am satisfied with my decision 
5. It was difficult to make a choice 
6. I had no problem using the information 
7. The information was easy to understand 
8. Consulting someone else would have been useful 
9. More information would help 
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8.4. Preparation for Decision Making scale (Bennett et al., 2010) 
 
Please show your opinion of [the educational material] by circling the number to show how much 
you agree with each statement.  
•  Help you recognize that a decision needs to be made?  
•  Prepare you to make a better decision?  
•  Help you think about the pros and cons of each option?  
•  Help you think about which pros and cons are most important?   
•  Help you know that the decision depends on what matters most to you?  
•  Help you organize your own thoughts about the decision?   
•  Help you think about how involved you want to be in this decision?   
•  Help you identify questions you want to ask your doctor?    
•  Prepare you to talk to your doctor about what matters most to you?  
•  Prepare you for a follow-up visit with your doctor?   
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8.5. SDM-Q (Simon et al., 2006) 
1. In the selection of the treatment method, & my thoughts were taken into account just as much as 
the considerations of my doctor   
2. There was enough time for questions  
3. My doctor and I weighed up the different  treatment options thoroughly   
4. I was able to discuss the different treatment  options with my doctor in detail   
5. My doctor and I selected a treatment option together    
6. I now know the advantages of the  individual treatment options   
7. I now know which treatment option is the  best one for me   
8. During the consultation, I felt included in  the treatment decision   
9. Through the consultation with the doctor,  I felt jointly responsible for my further treatment   
10. My doctor and I discussed the next steps  of the treatment plan in detail   
11. My doctor and I reached an agreement as  to how we will proceed   
 
8.6 The SURE test (Légaré et al., 2010a) 
A response of yes scores 1 and a response of no scores 0; a score of < 4 is a positive result for decisional conflict.  
1. Sure of myself – do you feel SURE about the best choice for you? 
2. Understand information – do you know the benefits and risks of each option? 
3. Risk-benefit ratio – are you clear about which benefits and risks matter most to you? 
4. Encouragement – do you have enough support and advice to make a choice? 
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8.7. COMRADE (Edwards et al., 2003) 
 
Satisfaction with communication  
1. The doctor made me aware of the different treatments available  
2. The doctor gave me the chance to express my opinions about the different treatments available   
3. The doctor gave me the chance to ask for as much information as I needed about the different 
treatment choices   
4. The doctor gave me enough information about the treatment choices available  
5. The doctor gave enough explanation of the information about treatment choices  
6. The information given to me was easy to understand   
7. I know the advantages of treatment or not having treatment  
8. I know the disadvantages of treatment or not having treatment   
9. The doctor gave me a chance to decide which treatment I thought was best for me  
10. The doctor gave me a chance to be involved in the decisions during the consultation  
 
Confidence in decision  
1.  Overall, I am satisfied with the information I was given  
2.  My doctor and I agreed about which treatment (or no treatment) was best for me  
3.  I can easily discuss my condition again with my doctor   
4.  I am satisfied with the way in which the decision was made in the consultation  
5.  I am sure that the decision made was the right one for me personally  
6.  I am satisfied that I am adequately informed about the issues important to the decision  
7.  It is clear which choice is best for me   
8.  I am aware of the treatment choices I have  
9.  I feel an informed choice has been made   
10. The decision shows what is most important to me  
 
	  177 
 
8.8. Decision Evaluation Scales (Stalmeier et al., 2005) 
1. I expect to stick with my decision  
2. I am satisfied with my decision  
3. I am still doubtful about my choice  
4. This is my own decision  
5. I find it hard to make this choice  
6. I am satisfied with the information I received  
7. I know the pros and cons of the treatments  
8. I want more information about this decision  
9. I want a clearer advice  
10. I made a well informed choice  
11. This decision is made without me 
12. I feel pressure from others in making this decision  
13. I wish someone else would decide for me  
14. My decision frightens me  
15. I regret my decision 
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8.9. Decision Making Quality scale (Hollen, 1994) 
“How true are these statements about your decision making choices?” 
1. Searches for three or more choices 
2. Takes into account values and all goals desired 
3. Weighs the pros and cons of consequences 
4. Finds more information about the pros and cons, when needed 
5. Thinks about new information and what experts say, even if against first choice 
6. Reviews carefully before making a final choice 
7. Makes details plans with back up plans 
 
8.10. Decision Self-Efficacy Scale (Bunn and O'Connor, 1996) 
I feel confident that I can:  
1 Get the facts about the medication choices available to me  
2. Get the facts about the benefits of each choice  
3. Get the facts about the risks and side effects of each choice  
4. Understand the information enough to be able to make a choice  
5. Ask questions without feeling dumb  
6. Express my concerns about each choice  
7. Ask for advice  
8. Figure out the choice that best suits me  
9. Handle unwanted pressure from others in making my choice  
10. Let the clinic team know what’s best for me  
11. Delay my decision if I feel I need more time  
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